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CHAPTER 1. INTRODUCTION 
This calcium phosphate ceramic implant research consists of two separate 
experiments. These experiments, transcortical implants and guide tube implants, will be 
introduced separately since their intended orthopedic applications are different. 
A. Transcortical Implants 
Synthetic materials, such as ceramics, metals, polymers, and their composites have 
been used as replacements for bone for many different applications ranging from bone grafts 
to total joint replacements. The assurance of fixation of the implant-bone interface through 
either cemented, mechanical or biological methods, is extremely important for implant 
success. However, for prosthetic joint replacements, aseptic loosening continues to be the 
major factor limiting the success of these devices. Unfortunately, large studies on cemented 
hip replacements are reporting failure rates due to aseptic loosening to be 10% to 30% after 
15 years of implantation (Algan and Horowitz, 1995). 
The continual loosening problem of prosthetic components within osseous tissue has 
increased the interest in alternate methods of cementless fixation such as bone growth into 
porous, mesh or beaded surfaces and chemical bonding between bone and bioactive ceramic 
materials (Thomas, 1994). The bone ingrowth fixation methods have also had many clinical 
loosening problems. For porous surfaces, the large porosity required for bone ingrowth on 
the surface greatly decreases the stif&iess and strength of the material. Bone ingrowth into 
the porous, mesh, and beaded surfaces requires restricted weight-bearing and is difficult to 
achieve. With porous metal or beaded metal, the large amount of surface area can cause 
more corrosion and loss of metal ions into the tissue (Bundy, 1989). Calcium phosphate 
ceramics, such as tricalcium phosphate and hydroxyapatite, are an appealing material for 
prosthesis applications since they offer bone the chance to chemically bond to their surfaces. 
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Healthy osseous tissue can attach and remodel next to the implant while providing increased 
stabilization. However, bioactive ceramics are difiBcult to incorporate into load-bearing 
applications because of their brittleness, high elastic modulus, inability to withstand high 
impacts and low tensile strength. Thtis, the use of calcium phosphate ceramics in load-
bearing applications has been very limited. Therefore, there is a need for a new material to 
interface with bone in bone and joint replacement devices. 
The objective of the transcortical implant research was to make and test new materials 
to interface with bone in orthopedic applications. These materials would have both bone 
bonding capabilities and appropriate mechanical properties for highly loaded conditions. The 
bioactive nature of calcium phosphate ceramic materials, along with the mechanical 
properties of the metals and polymers, were some very desirable characteristics for such a 
material. If the biocompatibility of calcium phosphates could be combined with the good 
mechanical properties of metals or polymers, the new composite might have a better 
combination of properties than either would have alone. In order to take advantage of each 
material's desirable properties, composite materials were designed and manufactured. The 
calcium phosphate ceramic material used as the tissue interface material for this research was 
a ceramic-ceramic composite material made from tricalcium phosphate and magnesium 
aluminate spinel. This material, called an osteoceramic, has shown excellent 
biocompatibility with osseous tissue and enduring strength (Olson, 1992). 
For this research, the tissue response of composites made from the osteoceramic 
embedded in stainless steel and the osteoceramic embedded in polyethylene were compared 
with 316L stainless steel and with the osteoceramic fired in air and in hydrogen. The 
materials designed and tested in this research were the following: osteoceramic fired in air, 
osteoceramic fired in hydrogen, 316L stainless steel mixed with large aggregates of 
osteoceramic, 316L stainless steel, and ultra high molecular weight polyethylene mixed with 
large aggregates of osteoceramic. The material properties were analyzed using scanning 
3 
electron microscopy, energy dispersive spectrometry along with sxirface roughness, porosity, 
and density measurements. 
In order to test the different material combinations in bone, transcortical implants 
were designed, manufactured, and stirgically implanted. The five implant types were 
evaluated and compared by measuring their surface roughness, porosity, and density. The 
implants were placed transcortically into the proximal femurs of twenty-five rabbits for 18 
weeks. Evaluations of the bone-implant interfaces included mechanical push-out testing, 
microradiography, image analysis, and histological staining. 
B. Guide Tube Implants 
The treatment of large defects in bone is still a difficult problem for orthopedic 
surgeons. The increasing needs of the surgeon to repair bone loss have resulted in a growing 
need for replacement materials that can permanently and effectively replace the defect. Bone 
grafts are commonly used in surgery to: provide structural support to the region; span defects 
due to injury, tumors, or diseased bone; offer a structure for new bone to grow into; and 
stimulate new bone growth (Park and Lakes, 1992). 
For most applications autogenous bone is the best grafting material. However, 
obtaining this material requires an extra surgical procedure to harvest the tissue. This 
increases the amount of trauma and healing that the patient has to endure. Another 
disadvantage of autograph material is the limited amount available, especially if the defect is 
large or if the patient is young (Jahnke et al., 1990). Therefore, sometimes allogenous bone 
from a bone bank is used to eliminate the need for a second area of surgery and to reduce 
operation time, blood loss, pain at the donor site, and hospital stay. The bone bank must 
consist of a very large assortment of allograft bone to make it easier to match the size and 
shape of lost bone. Allogenous grafts are less reliable than autogenous ones due to their 
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tendency to trigger the host's immune system causing effects that range from a local 
inflammatory response to complete rejection of the graft (Bajpai, 1983). 
The objective of the second research project was to make a new bone-bridging device, 
called a guide tube, to direct bone's repair and remodeling across a defect that exceeds the 
natural healing ability of bone and that would otherwise be unable to repair itself without the 
guide tube. According to Key's hypothesis, the long bones of adult dogs are unable to span a 
defect that exceeds 1 '/z times the diameter of the femoral midshaft (Key, 1934). Thus, the 
concept of the guide tube implant was to provide a new way of overcoming this bridging 
limit. The guide tube was not supposed to support the bone but instead use the 
osteoconductive nature of the osteoceramic material and the design of the implant to help to 
repair the defect with healthy natural bone. This device could, for many situations, replace 
the need for bone grafting materials and the problems associated with their implantation 
because new bone would be able to heal, support, nourish, and revascularize itself with the 
help of the guide tube. The unique tubular design of the guide tube, developed at Iowa State 
University, was made by extruding the osteoceramic material before firing. 
The guide tube implant, slightly smaller in outside diameter than the endosteum of 
diaphyseal bone, was used to bridge a surgical ostectomy at midshaft measuring 
approximately 40 mm in length. Because the bone diameter was approximately 20 mm, this 
length exceeds the healing ability of bone (Key, 1934). Ten mongrel dogs with an average 
age of approximately two years were used for the guide tube implant study. The implant was 
stabilized in seven canines using a lengthening plate and screws. Three other canines, used 
for controls, had similarly sized defects and internal fixation but did not receive implants. 
The clinical performance of all animals was evaluated usmg macroradiographs. Radiographs 
were taken to evaluate the internal fixation, the reaction of bone to the osteoceramic material, 
and the effectiveness of the implant design at controlling the bridging process of bone. 
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Radiographs were also taken of the femur of each of the control dogs to evaluate the internal 
fixation and the reaction of bone to the non-implant situation 
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CHAPTER n. LITERATURE REVIEW 
The literature review consists of seven major sections: skeletal system; repair and 
healing of bone fractures; the replacement of bone with autographs and allograph material; 
overview of push-out testing; Key's hypothesis; ceramic materials used for transcortical and 
bone bridging implants; and the experimental implant materials. 
The first section, skeletal system, describes the macrostructure of bone along with the 
anatomy of the femur and tibia. The second section, repair and healing of bone fractures, 
describes the major stages of the bone's repair process. The third section, the replacement of 
bone defects with autograph and allograph material, gives some of the advantages and 
disadvantages of using these materials and why there is a need for producing synthetic 
materials to replace sections of bone. The fourth section, mechanical testing of implants, 
explains how the shear strength of the bone-implant interface can be measured mechanically 
and some of the important factors to consider before testing. The fifth section. Key's 
hypothesis, introduces Key's estimate of the ability of bone to bridge defects. In the sixth 
section, ceramic materials used for transcortical and bone bridging implants, research 
performed using tricalcium phosphate, hydroxyapatite, and a tricalcium phosphate/ spinel 
composite are described. Previously described bone bridging devices are also discussed in 
this section. The seventh section, steel, steel and ceramic composites, polyethylene and 
ceramic composites used for transcortical implants, describes some of the reasons for using 
these materials along with results from transcortical implant research. 
A. Skeletal System 
1. IntrQdwtion 
The skeletal system is composed of the bones of the body along with the connective 
tissues that support or join these bones. Muscles and fascia cover the skeletal system and are 
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associated with its functions. Bones come together and move upon each other. The skeletal 
system offers rigidity, support, protection, muscle attachment, and leverage. Bones also 
produce red blood cells and are a mineral reserve for the maintenance of the calcium and 
phosphate ions in body fluids (Gardner and Osbum, 1978). 
2. Components of Bone 
Bone is similar to other connective tissues in that it contains specialized cells, cell 
products, and a fluid matrix. On the average, approximately 22 weight percent of the matrix 
of bone is collagen fibers, 70 weight percent (w/o) of bone matrix is inorganic portions, and 
eight weight percent is water. The inorganic matrix has a density of 3.156 g/ cm^ and the 
organic matrix is approximately 1 g/ cm^, so the volume firactions for the organic and 
inorganic matrixes are almost equal (Bauer, 1990). The inorganic matrix of bone is 
embedded in the frame of the collagen. The 70 w/o inorganic matrix is composed of 
approximately 58 w/o calcium phosphate in the form of crystalline hydroxyapatite, 7 w/o 
calcium carbonate, 1 to 2 w/o calcium fluoride and magnesium phosphate, and less than 1 
w/o sodium chloride. These inorganic substances give bone its hardness and rigidity (Mears, 
1979). 
The calcium phosphate crystals provide the strength of bone but are inflexible. The 
crystals can withstand compression but may shatter when exposed to bending, twisting or 
sudden impacts (Martini, 1989). The formula for these major crystalline salts, known as 
hydroxyapatite, is Caio(P04)6 (0H)2. These crystals are approximately 400 angstroms 
long, 10 to 30 angstroms thick, 100 angstroms wide, and have a long, flat shape. The ratio of 
calcium to phosphate on a weight basis in bone varies from 1.3 to 2.0. 
The collagen fibers are tough and quite flexible. The fibers can withstand stretching, 
twisting, and bending but when placed under compression they bend. Collagen fibers in 
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osseous tissue provide an organic framework for the formation of mineral crystals (Martini, 
1989). 
3. Macrostrucftire of Bone 
a. Structures J2f bone The two different structures of bone are cancelloiis and 
compact. Cancellous bone, also known as trabecular or spongy bone, has a network of bony 
shafts with many marrow spaces (Martini, 1989). The amount of marrow spaces ranges from 
approximately 30 to 95%. In contrast, compact bone is a relatively solid structure without 
marrow spaces. The diaphyses of long bones have a very large component of compact bone 
encircling a small composition of cancellous bone. The epiphyses of long bones are mainly 
composed of cancellous bone with a thin covering of compact bone (Junqueira, 1983). 
b. Types of bone The two types of osseous tissue found in bone are woven and 
lamellar. Woven, also called immature bone, is very cellular with an irregular arrangement 
of collagen fibers. It is a temporary bone with a smaller mineral content and higher osteocyte 
content than lamellar bone (Junqueira, 1983). 
Lamellar, also called mature bone, normally replaces woven bone. The majority of 
the adult skeleton is composed of this type of bone. In the diaphysis of long bones, typical 
lamellar bone consists of four systems: Haversian or osteon, inner circumferential, outer 
circumferential, and interstitial (Figure 1). The organization of the Haversian system is 
concentric lamellas of bone encircling a canal with blood vessels, nerves, and loose 
cotmective tissue. Within the lamellas of bone are lacunas containing osteocytes. Collagen 
fibers are aligned parallel to each other in the lamellas. As shown in Figure 1, the inner 
circumferential system is located around the endosteum and the outer circumferential system 
is located inside the periosteum. The inner and outer circumferential systems have a circular 
distribution of lamellas. The interstitial systems fill the spaces between the Haversian 
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showing microscopic characteristics (Banks, 1986) 
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systems. They have triangular or irregular shapes consisting of parallel lamella (Junqueira, 
1983). Communication between the Haversian canals, marrow cavity, and periosteum is 
accomplished through the Volkmaim's canals. Smaller canals called canaliculi connect 
lacunae with nearby blood vessels. Canaliculi contain the cytoplasmic extensions of the 
osteocyte (Martini, 1989). 
c. Periosteum The entire external layer of long bones except where articular 
cartilage is present is called the periosteum. This layer, seen in Figure 1, is composed 
of an irmer cellular layer (cambium), which provides appositional growth and an 
outside fibrous layer, which is mainly for support. Over most of the surface of mature 
long-bones, the periosteum is barely attached to the surrounding muscles (Sumner-
Smith, 1982). The periosteum isolates the bone from surrounding tissues, provides 
a path for the nervous supply, lymphatics, nutrient blood vessels for bone cells, and 
participates in bone growth and repair. The fracturing of bone stimulates the inner layer 
to form osteoblasts and to generate new bone. The fibers of the periosteum join with 
those of the tendons, thus attaching skeletal muscles to the bones that they move (Martini, 
1989). 
d. Endosteum Inside the periosteum and compact bone layers, a cellular 
endosteum covers the marrow cavity. The endosteum has the same components and similar 
structure as the periosteum, except it is a thinner structure that does not exhibit two separate 
layers. This layer, shown in Figure 1, lines the trabeculae of spongy bone and the irmer 
surfaces of the central canals. The endosteum is extremely active during repair or remodeling 
and when bone is growing. The endosteal lining is not a complete epithelium, and the matrix 
is sometimes exposed. At these exposed areas, there are osteoclast cells that contain acids 
that dissolve the bony matrix and then release the stored minerals. This is known as the 
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osteolysis process, which is very important for regulation of calcium and phosphate levels in 
body fluids (Martini, 1989). Therefore, the periosteum and endosteum are made of 
connective tissue and are packed with specialized cells, which make these regions more 
important for their biological fimctions than for their mechanical fionctions (Ducheyne and 
Hastings, 1984a). 
e. Marrow The marrow tissue of bone is located within the medullary cavity in all 
bones. This tissue is a form of connective tissue that is highly cellular and vascularized. In 
developing and growing bones, all of the marrow is red bone marrow. In adult bones, red 
bone marrow is replaced by yellow bone marrow except in the stemebrae, ribs, vertebrae, and 
cranial bones (Banks, 1986). 
The red bone marrow is a hemopoietic tissue also known as myeloid tissue. The 
myeloid tissue produces erythrocytes, granulocytes, platelets, and agranulocytes. The red 
bone marrow consists of two main compartments: vascular and hematopoietic. The vascular 
compartment contains the vessels of the bone marrow. The hematopoietic compartment 
includes: fibroblasts, reticular fiber stroma, reticular cells, erthyrocytic line of cells, white 
blood cell lines, phagocytic cells, many blood cell forms, adipose tissue, and other connective 
tissue cells like plasma cells and mast cells. The main function of the red bone marrow is 
blood cell production (Banks, 1986). 
The red bone marrow is largely reduced after adulthood and replaced with yellow 
bone marrow. The yellow bone marrow consists mainly of adipose tissue. The adipose 
tissue replaces the blood cell-producing sections of the hematopoietic compartment. When 
bone is under stress or disease conditions, the yellow bone marrow can change into active 
hematopoietic tissue again (Banks, 1986). 
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4. The Femur 
The femur, sometimes called the thighbone, is the longest and strongest bone of the 
body. The distal end of this bone is connected at the knee joint with the tibia of the lower 
leg. Proximally, the head of the femur articulates with the pelvis at the acetabulum. The 
head of the femur has a depression medially called the fovea capitis femoris (Figure 2). This 
depression is where the ligamentum capitis femoris attaches from the acetabulum. Below the 
head of the femur lies the neck. The neck connects the head of the femur with the shaft in the 
area of the greater and lesser trochanter. The neck forms an angle with the shaft that ranges 
from 115° to 140°. The greater trochanter is a large, square projection on the top end of the 
shaft of the femur. The lesser trochanter is a small cone-shaped projection that is between the 
neck and shaft of the femur along the inferior border (Woodbume, 1973). These trochanters 
are the areas of attachment for muscles and tendons. The gluteus medius and gluteus 
minimus muscles connect the femur's greater trochanter to the lateral surface of the pelvic 
bone's ilium. The gluteus maximus is the largest of the gluteal muscles and it is also the 
farthest posterior on the ilium. This muscle extends and laterally rotates the thigh (Martini, 
1989). The main lateral rotators of the thigh are the obturator and the piriformis. The 
internal and external obturator muscles connect the obturator foramen of the pelvis 
with the trochanteric fossa of the femur. The piriformis muscle connects the anterolateral 
surface of the pelvic bone's sacrum with the greater trochanter of the femur. These muscles 
laterally rotate the thigh. The adductor group of muscles attach to the low ridges of the 
posterior surface of the femur and also produce lateral rotation when contracted (Martini, 
1989). 
The shaft of the femur has a tubular shape that broadens slightly at its ends. The 
surface of the shaft is quite smooth except for a thickened ridge called the linea aspera. The 
linea aspera runs longitudinally on the posterior side of the femur, and this is where the 
adductor muscles attach. In the middle of the linea aspera there is a nutrient foramen where 
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the nutrient artery enters the medullary cavity and supplies the shaft region (Woodbume, 
1973). Distally, the shaft of the femur broadens to about three times its mid-shaft size to 
articulate with the tibia at the knee. Anterior to the knee joint is a small bone called the 
patella or kneecap. The femoral contact surfaces for the patella are the lateral and medial 
condyles which curve downward from side to side. The epicondyles of the femur are located 
above and within the curvature of the condyles. The medial epicondyle gives attachment to 
the tibial collateral ligament. The lateral epicondyle provides attachment for the fibular 
collateral ligament, lateral head of the gastrocnemius, and the plantaris muscle (Woodbume, 
1973). 
The specialized areas at the ends of the femur are called the epiphysis. The area in 
the center section of the femur is called the diaphysis or shaft. This is a tubular structure with 
thick walls, composed of dense, compact bone surroimding a center marrow cavity with 
lower density bone. Between the epiphysis and the diaphysis there is an area called the 
metaphysis or growth zone. The metaphysis and epiphysis are composed of spongy (lower 
densification) bone that is covered with a thin layer of compact bone. The epiphysis is 
capped with articular cartilage (Sumner-Smith, 1982). 
5. The Tibia 
The large medial bone of the lower leg is called the tibia and the slender lateral bone 
that parallels the tibia is called the fibula (Figures 3a and b). The proximal end of the tibia is 
expanded to form two tibial condyles (medial and lateral) with the region between them 
known as the intercondylar area. The smaller anterior projection below the knee joint, cjilled 
the tibial tuberosity, is the region of attachment for the ligament from the patella. The upper 
area of the tibia provides an adequate region of load bearing for transmission of body weight 
from the two condyles of the femur (Warwick and Williams, 1973). 
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The medial condyle of the tibia is larger with less overhang than the lateral condyle. 
The articular surface forms a concave area. The lateral condyle has a circular outline that is 
slightly concave. The menisci increase the concavity of the tibial surfaces (Warwick and 
Williams, 1973). 
The intercondylar area is the region between the articulating surfaces of the two 
condyles. The center region narrows and raises slightly to form the intercondylar eminence. 
The lateral and medial portions of the eminence projecting upward are called the lateral and 
medial intercondylar tubercles. The intercondylar area widens in front and in back of the 
eminence as the condyles subside from each other (Warwick and Williams, 1973). 
The shaft of the tibia is approximately triangular in cross section with medial, lateral, 
and posterior surfaces. The shaft is thin in the center region but expands towards the 
proximal and distal ends. The posterior surface at its upper end has a roughened ridge 
crossing medially and downwards, called the soleal line. The area beneath this line is 
separated by a faint vertical line that is visible in the middle section of the shaft. At the top 
of the vertical line there is a vascular groove in the bone that descends to a large nutrient 
foramen (Warwick and Williams, 1973). The anterior surface has a projecting crest, also 
called the shin, extending along most of the length of the tibia. Distally, the expanded tibia 
forms a hinge joint with the bone of the ankle with a large projection, called the medial 
malleolus, medially supporting the ankle. The lateral malleolus located at the distal end of 
the fibula, laterally stabilizes the ankle (Martini, 1989). 
B. Repair and Healing of Bone Fractures 
1. Introdygtion 
Along with lower vertebrates, mammals have the remarkable ability to repair injured 
bone and even replace sections of the skeleton that are missing. When a bone is injured, it is 
not repaired solely with scar tissue as is the case for many other organs. Bone repair is often 
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completed so well that it is hard to find the same area one year after the injury occxirred. 
Formation of new-bone is a spontaneous reaction after any tj^e of bone injury (McLean and 
Marshall, 1968). Aoki et al. (1977) stated that healing of bony tissue in the presence of 
biomaterials may be similar to normal fracture healing if materials that are biotolerant are 
used. 
2. Stages of Bone Fracture Repair 
The process of fracture repair is a set of cellular events that continues from the injury 
through the complete remodeling of this site. Second intention healing is one type of healing 
that has many stages of cellular events. This type of healing involves the creation of a callus 
that is a hard supportive structure of cartilage. This type of repair occurs especially when 
casts, screws, and other supportive devices are used. In order for this type of repair to occur, 
the stability of the fracture site is not perfect and/or the vascular integrity may have been 
changed. Repair is achieved through the combination of intramembranous ossification, 
endochondral ossification, and remodeling. The stages of repair include: impact stage, 
induction stage, inflammatory stage, reparative stage, and remodeling stage (Banks, 1986). 
a. Impact stage The type and extent of damage to bone are caused by the energy 
absorbed during injury. Injury results in the loss of osseous continuity and sometimes soft 
tissue damage. The loss of osseous continuity causes the death of tissues because of the 
interruption of vascular blood flow. Clots soon form that cause more vascular damage in the 
hard and soft tissues. Therefore, on both sides of the fi^cture, the periosteal and marrow 
elements, the endosteal components, and bone cells die (Banks, 1986). 
b. Induction stage This stage actually occurs throughout the repair process but it is 
important to note its significance. Cells must be induced to change into many new cellular 
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populations. The alterations in blood flow, tissue hypoxia, and increases in hydrogen ion 
concentrations may stimulate this cellular differentiation. The time needed for union of bone 
can be affected by changing the induction (Banks, 1986). 
c. Inflammatory siagS The inflammatory stage occurs soon after injury because of 
the damaged blood vessels, hemorrhaging, and resulting hematoma. The environment of the 
injured area is acidic and hypoxic. The necrosis that results stimulates inflammatory cells to 
invade the area. Inflammation is a very important part of fracture repair because dead tissue 
is removed and the hematoma is reorganized and also removed. In order for repair to be 
achieved, inflammation must occur. The inflammation stage is termed over when redness, 
pain, swelling, and heat are no longer evident (Banks, 1986). 
d. Reparative stage This stage includes cellular activities that are started by 
induction, continue through inflammation, and end with callus formation. At the same time, 
the hematoma is reorganized and filled with phagocytic and fibroblastic cells, and the 
osseous envelopes have a large amount of mitotic activity of osteogenic and endothelial cells. 
The cells of the intact endosteum and periosteum, which are usually relatively inactive, 
undergo rapid mitoses (Martini, 1989). Blood vessels and the new cells from the endosteum 
move toward the fracture site, fill the hematoma and gap with fibrocellular, hyperplastic 
tissue that will turn into bone. This tissue will form in the marrow cavity and between 
fracture fragments. The newly formed woven bone that initially came from the endosteum is 
called the internal (endosteal) callus (Banks, 1986). 
At the same time that the endosteal callus is forming, the cells of the periosteirai 
move into the fractured area and produce a hypercellular mass. This mass of cells changes 
into bone and cartilage and is called the external (periosteal) callus (Banks, 1986). 
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e. Callus formation The callus is defined as the new tissue that develops 
between and around the ends of the fractured area. The callus changes from its 
original fibrocellular tissue into bone, then grows, reproduces, and is soon remodeled (Banks, 
1986). 
i. External callus Growth and reproduction of osteogenic cells of the 
periosteum begin in a good vascular environment. Therefore, osteogenic cells produce new 
bone along the boundary of the fracture. This layer of cells eventually bridges the gap made 
by the fracture and creates a large cellular layer away from the center of the hematoma. One 
theory is that the osteogenic cells grow and reproduce faster than their periosteal blood 
vessels and consequently, they change into chondroblasts. As a result, the external callus is 
made of new bone away from the center of the fracture gap and of cartilage close to the 
fracture gap. The outside of the external callus is covered by the periosteum. As the amount 
of cartilage increases by appositional and interstitial mechanisms, it moves away from its 
blood vessel supply (Banks, 1986). The chondrocytes near the cartilage/ bone interface 
increase greatly in size and their surrounding matrix starts calcifying (Martini, 1989). 
Starting at the center of the gap and moving outward, there is calcified cartilage, and 
proliferating cells (Banks, 1986). Blood vessels and osteoblasts move into the heart 
of the cartilage, taking over the spaces left by the chondrocytes that died because of a 
lack of nutrients. This process continues until the calcified cartilage matrix is replaced 
by woven bone (Martini, 1989). It so happens that this development of the callus is the 
same set of events as the process of endochondral ossification (Banks, 1986 and Junqueira, 
1983). 
ii. Internal callus While the external callus is mainly responsible for 
stabilizing the injured area, the actual repair of the injured area occurs within the internal 
callus. The origin of the tissue that makes up the internal callus is the endosteal envelopes. 
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The events described above for the external callus occur at the same time the following 
events happen for the internal callus. The growing and reproducing cells of the trabecular 
bone, together with the cortical endosteum, take over the area left by the retreating 
hematoma. These cells form bone on the inside surface of the bone that eventually attaches 
on each side. The gap is filled with bone tissue and becomes continuous with the bone from 
the other side of the fracture. The internal callus has two main features, bone forms without 
having a cartilage intermediary and the internal callus is the tissue that causes the actual 
repair of the fracture (Banks, 1986). 
f Remodeling After the external and internal calluses create a brace at the fracture 
site, osteoclasts and osteoblasts remodel the region for the next four months to over a year 
(Martini, 1989). Since the fibrous bone has bridged the gap from one fragment to the other, it 
is quite stable and some normal bone fimction occurs. The mechanical situation allows bone 
to be formed where needed so temporary repair is replaced by more permanent bone 
(Sumner-Smith, 1982). 
The callus continues to be converted into dense cancellous and compact bone. The 
new bone that is created next to the ftacture site bonds to both dead and live bone. At this 
time of repair the marrow cavity and fracture gap should be filled with bone and the fi^cture 
should be enclosed by an enlarged sleeve of bone. Any extra bone is removed by the 
osteoclasts. At the same time, new osteons travel across the fracture site (Banks, 1986). 
After the remodeling of the fracture is fmished, the dead bone fragments and trabecular bone 
of the calluses will be gone and only living compact bone will be at the site. Usually the 
repair will leave the bone as it was prior to the injury, except maybe slightly thicker than 
normal at the injured site (Martini, 1989). 
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3. Bone-Implant Healing and Transfer of Force 
The implant and tissues are subjected to a complex state of mechanical stress when 
force is applied. This mechanical stress can be either tension, compression, or shear, 
depending on: the direction of the applied force, the form of the body to which the force is 
applied, and the position of the interface of transfer. Most surgical implant interfaces have 
regions of tension, compression, and shear (Lemons, 1983). It is important to remember that 
stress is defined as the force per imit area and strain is the change in length per unit length 
experienced by a material placed under stress (Meade, 1989). When stress is applied to bone, 
it responds by developing strain within it. If the strain causes a lengthening of the structure, 
then this strain is termed tensile. If there is a shortening of the structure, then this is called 
compressive. Other important stresses include flexure, shearing, and torque. In bone, the 
collagen fibers supply the tensile strength while the hydroxyapatite crystals supply the 
compressive strength. The compressive properties of cortical bone are two times higher than 
the tensile properties (Banks, 1986). 
The main mechanical requirement for uninterrupted healing of bone is motionlessness 
at the injured area. However, Heimke (1990) noted that this did not require an absence of 
forces. The only forces that disturb healing are the ones that cause excessive movement at 
the two surfaces of the fracture. If the fracture site is not siifiiciently stabilized, proper 
healing will not occur and a soft tissue layer will grow in its place. This soft tissue layer 
contains dense layers of collagen fibers that are usually aligned parallel to the surface and to 
the main direction of motion and a small amount of cells. After the soft tissue layer forms, a 
layer of densified bone that looks like lamella of cortical bone forms between the soft tissue 
and underlying bone. Clinically, this is considered a nonunion case (Heimke, 1990). 
Bone is able to remodel according to mechanical demands placed upon it. Bone has 
the ability to adapt by changing its size, shape, and structure. The adaptation of bone follows 
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Wolffs law which states that bone is laid down where needed and resorbed where not needed 
to acconunodate the forces imposed (Frankel and Nordin, 1980). 
The structure of cortical and cancellous bone is highly dependent on the stress 
developed within the bone. The osteoblasts (bone producing cells) and osteoclasts (bone 
removal cells) are constantly working together to remodel bone according to mechanical 
stress. In particular, bone remodels with a turnover of collagen and hydroxyapatite so the 
orientation and spatial distribution of the elements are arranged for ideal load transmission. 
Many of the features of bone such as shape, size, cross section, cortical wall thickness, are a 
result of the need to transmit loads. It is very important to the cells and remodeling bone that 
the stress level is in the normal range. If the stress level is lowered significantly, the bone 
mass and apatite volume fractions decrease, with minimal growth of new bone. This creates 
bone with less strength and stif&iess (Williams, 1990). Uhthoff et al. (1985) along with other 
researchers, showed that the loss of bone mass is initially evident in the trabecular bone. 
Bone loss includes an increase in blood flow and cortical bone eventually begins losing tissue 
mass (Meade, 1989). Similarly, if the stress is too high, resorption and loss of bone will 
occur (Hassler et al., 1983). 
If the interface between the implant and bone tissue forms a callus, this callus 
enlarges the cross sectional area of the region while reducing the mobility of the fragments. 
The gain in cross sectional area causes an increase in the moment of inertia of the fractured 
bone about its axis (Mullen and Perren, 1972). The moment of inertia rises in proportion to 
the 4th power of the radius of the fracture. Therefore, the enlarging callus leads to a growth 
in the stifftiess of the fracture. Along with the widening in diameter, there is an increase in 
the stiffiiess of the tissues in the region of the bone at the fracture site. First, granulation 
tissue is replaced by connective tissue (cartilage), then connective tissue is replaced by bone. 
The stiffening of the tissues helps reduce the movement between fragments. The initial 
tissues that fill the fracture site are able to handle elongation so they will not tear but have a 
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limited stiffiiess and very low ultimate strength. The increase in stiffiiess of the tissues 
reduces the amount of motion and increases the ultimate tensile strength. The final tissue 
(compact bone) has a high ultimate tensile strength to handle normal stresses without 
breaking (Perren and Boitzy, 1978). 
The stress level of bone is greatly affected during healing by the stiffiiess of the 
stabilizing plate or other implantable devices. Depending on the implant site, the stiffiiess 
may have a large or small effect on the trauma at the interface (Lemons, 1983). Stabilizing 
plates are commonly used along with bone screws to secure bone firagments together. In the 
plated bone situation, bone will remodel by adding or removing cortical and/or cancellous 
bone. The plate will share some of the load (stress) that is placed on the bone. The 
percentage of load of the plate or bone depends on the geometry and material properties of 
each structure. If a plate is carrying most of the load, it will tend to unload the bone and 
resorption of the bone will occur. An increased profusion of Haversian canals especially in 
the compact lamellar bone causes a loss of bone mass. These increased haversian systems 
seriously weaken the bone in tension and compression and a repeat break can occur (Sumner-
Smith, 1982). This bone loss problem, which is called stress protection or stress shielding, 
includes the histological events that occur in bone when the rigid plate immobilizes it. 
Moyen et al. (1978) found that increasing the rigidity of a bone plate placed on the femur of 
dogs caused a decrease in bone mass without a reduction in size. After a six months 
implantation period, the femurs with the more flexible plates had lost 15.4% of their bone 
mass compared to non-plated femurs. The same length of time was used for the rigid plated 
bone and this bone had lost 26.4% of its bone mass when compared to non-plated femurs. 
The endosteal surface was the major area of bone tissue loss. The increased resorption of the 
intra-cortical and periosteal areas had very little effect on tissue loss. 
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Muscle activity also affects the stress pattern in bone (Frankel and Nordin, 1980). 
Immediately after a bone fracture, pain induces reflex muscle contraction that helps stabilize 
the fracture a certain amount (Perren and Boitzy, 1978). 
C. The Replacement of Bone Defects with Autograph and Allograph Materials 
1. Introduction 
There are many types of materials that could be used for replacing bone in load 
bearing applications. These materials provide the bending rigidity, strength, wear resistance, 
fatigue resistance, and other mechanical properties that are required for loading over a long 
period of time in vivo. The problem that may occur using these biomaterials is not because 
of their lack of engineering properties but because of their lack of biocompatibility. Many 
materials have been shown to react with the body tissue and/or produce products that are not 
tolerated by the body (Bundy, 1989). Bone grafts are commonly used in orthopedic surgery 
to help provide: support to the region, a structure for new bone from the patient to grow into 
and, stimulus for new bone to grow. (Park and Lakes, 1992) The most common materials 
used to replace bone defects are autographs and allographs. 
2. Autoeraphs 
Autographs are tissue or organs grafted into a new area in the body of the same 
individual. The common donor sites for obtaining bone autographs are the iliac crest, tibia, 
fibula, greater trochanter, and posterior elements of the spine. Occasionally bones from the 
distal radius and hyoid bone are also used. Autogenous bone is mainly used to replace bone 
in oral and maxillofacial surgery. They are also used to correct defects in the tibia, fibula, 
femur, cervical bones, vertebrae, cricoid arch, and perichondrial space of the ear (Bajpai, 
1983). Since autogenous bone grafts offer excellent biocompatibility, they are generally 
25 
considered to be the best material for replacing bone defects (Patka, 1984). The main reason 
for their success is the rapid vascularization of the implant along with the migration of living 
osteoprogenitor cells that produce bone cells within the transplant (Sauer et al., 1978). 
Bone autographs can be many shapes including chips, fragments or other shapes 
needed to replace the defect. The replacement can be cortical and/ or cancellous bone. 
Cortical bone is used if strength and mechanical support are needed. Cancellous bone, on the 
other hand, is used to promote lattice formation and increase the regeneration of new bone 
(Bajpai, 1983). 
For most applications, autogenous bone is the best grafting material. However, 
obtaining this material requires an extra surgical procedure for harvesting the tissue. This 
increases the amount of trairaia and healing that the patient has to endure. Another 
disadvantage of autograph material is the limited amount available, especially if the defect is 
large or if the patient is a child (Jahnke et al., 1990). 
For a bone graft to survive, it must be placed in a well-vascularized site and be 
rapidly vascularized (Zins and Whitaker, 1979). In the bone graft, the bone cells do not 
survive but it is possible that other cells of the periosteum, endosteum, and undifferentiated 
marrow may survive. The live cells may be very important for replacing the dead parts of the 
graft with new bone. Cloward (1980) suggested that the host provides both vascularization 
and bone cells for remodeling the graft. Partial resorption of osteons in bone grafts could be 
the reason that new bone in the autographs doesn't completely regenerate (Burchardt et al., 
1975). Experiments with canines have shown that autografts change from cancellous bone to 
lamellar and cortical bone after six to twelve weeks (Burchardt et al., 1975 and Sauer et al., 
1978). Vascularization in the graft was observed from one to three weeks after implantation 
(Sauer et al., 1978). Although autogenous bone is considered the best bone grafting material, 
failure does occur. A smdy by Burchardt and Ermeking (1978) found that fifteen to twenty 
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five percent of autogenous cortical transplants failed. The lack of success was attributed to a 
failure to satisfy biological, physiological, and mechanical requirements. 
Researchers at the Department of Orthopaedic Surgery at the University of California 
reviewed the morbidity associated with the autogenous bone grafting of 239 patients that 
received 243 bone grafts. They found an overall complication rate of 8.6% related to bone 
harvesting. The major reasons for complications were: infection (2.5%); prolonged wound 
drainage (.8%); large hematomas (3.3%); reoperation (3.8%); pain diu-ation of 6 months or 
more (2.5%); and sensory loss (1.2%). If the incision for the surgery was the same incision 
used to harvest the bone graft, the major complication rate increased to 17.9%. They 
concluded by noting that the autogenous graft harvest has an undesirable complication rate 
and they recommended possible banked allograft or other suitable biomaterial with 
equivalent effectiveness (O'Leary and Prewett, 1990). 
3. Allographs 
When a section of bone needs to be replaced, transplant volume may be insufficient 
or unavailable. Therefore, bone from a bone bank is sometimes used which eliminates the 
need for a second area of surgery to retrieve a bone graft. Using bone from the bone bank 
reduces operation time, blood loss, pain at the donor site, hospital stay, and morbidity. A 
large assortment of allograft bone makes it easier to match the size and shape of lost bone. 
However, allogenous grafts are less reliable than autogenous ones due to their tendency to 
trigger the host's immune system. There have been many attempts by investigators to use 
allograft bone in orthopedic and maxillofacial surgery. They have used procedures like 
chemical treatment, boiling, freezing, freeze-drying, irradiation, lyophilization, 
decalcification and demineralization of the bone to increase the success of the allograft 
(Bajpai, 1983). Recently, additional problems for the allografts include the HIV virus that 
adds increased risk in using bone banks and produces the need for synthetic bone substitutes. 
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Fresh and frozen bone used for allographs create cellular and humoral responses. 
However, blocking antibodies may protect the bone allograft (Bajpai, 1983). Oikarinen and 
Korhonen (1979) reported that the vascularization of preserved bone allografts begins slower 
than autogenous bone due to the host versus graft response and to the density of cortical 
bone. 
The allograft's success is influenced by many factors. One of the most important 
factors is the ability of the graft to stimulate the formation of bone. When bone cells are 
removed from their original blood supply, they rarely survive (Bajpai, 1983). Therefore, the 
host must supply the osteogenic cells needed to repair the area of the transplant. The repair is 
affected by the site of transplantation, surgical trauma, and the ability of the transplant to 
induce differentiation of osteogenic cells (Burchardt and Enneking, 1978). 
D. Mechanical Push-Out Testing of Implants 
Implants or materials that may be used for load-bearing applications can be tested by 
placing devices into animal bone to evaluate the tissue reaction to the material by mechanical 
and histological methods. The mechanical, also called push-out, test is a common method of 
quantitative evaluation of the shear strength of the healed interface between bone and an 
implant. It can be used to determine differences between various materials, coatings and 
surface properties. Excellent push-out test results do not ensiore similar results under actual 
loaded conditions. However, poor push-out test results give a good indication that the 
implant will not perform well under higher loaded conditions (Thomas, 1994). 
For a transcortical push-out model, implantation is performed by placing one or more 
cylindrically shaped implants through both cortices of the bone. Typically, the diaphysis 
region of the femur, tibia, or humerus is used for this test. After the implant has healed for a 
certain time period, the animal is sacrificed, and the section of the bone containing the 
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implant is removed and placed in a support jig. Using a testing machine to measure 
compression, the implant is pushed from the bone. The peak force to move the implant is 
considered the push-out force. Calculation of the interfacial shear strength can be 
accomplished by using the following formula: 
Equation 1. S = F/7cxdxt 
where S is the interface shear strength (MPa), F is the push-out force (N), d is the plug 
diameter (mm), and t is the average cortical bone thickness (mm) in contact with the implant 
(Dhert et al., 1992). 
It is important to remember that there are many factors that can affect the results of a 
push-out test as seen in Table 1. With ail of the different variables involved with push-out 
tests, comparisons between published studies should be made with caution. Comparisons 
should be made with investigators that used as similar as possible experimental procedures 
(Cooketal., 1988a). 
Dhert et al. (1992) evaluated the push-out model by finite element analysis to better 
understand the biomechanics of the test. The effects of the following four parameters on the 
interface stress distribution were tested: (a) clearance of the hole in the support jig, (b) 
cortical thickness, (c) implant diameter and, (d) Young's modulus of elasticity of the implant. 
Results from the model showed that a small oversizing of the hole in the support jig created 
high stresses where the jig edge supports the bone. If the clearance of the hole is larger than 
.7mm, the stress peak is reduced to a minimum. The interface stress distribution remained 
uniforai when the cortical thickness and/or implant diameter were changed. Finally, 
changing the Young's modulus of elasticity of the implant, while having the same modulus of 
elasticity for bone, demonstrated in most cases a non-uniform distribution of the interface 
stresses. They concluded that materials with different Yoimg's modulus should not be 
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Table 1. Factors that can affect the results of mechanical push-out tests 
(Black, 1989) 
Specimen 
Dimensions 
Surface Geometry 
Composition 
Host 
Species 
Implant Location 
position 
relation to others surface 
bulk 
Preparation (cleaning, etc.) 
Implantation 
Site Preparation 
Intra-Operative Cortical Thickness 
Fit (loose, interference, etc.) 
Retrieval 
Animal Age 
Tissue Handling Post-Mortem 
Mechanical Testing 
Alignment and Mounting 
Fit of Support Jig 
Load/Displacement Rate 
Calibration: 
Transducers 
Test Apparatus 
Results 
Mode of Failure 
True Interfacial Surface Area 
Error Estimates 
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compared by in order for continuity to be maintained at the material-bone interface during 
stress situations, a stress distribution occurs between the material and bone. The amount of 
stress depends on the surface roughness, Young's and shear moduli of the materials. A large 
difference in elastic moduli produces a high interfacial shear stress that can cause weakening 
of the interface bond and eventual loosening. Their recommendation to reduce this loosening 
problem is to use a biocompatible implant material with an elastic modulus similar to bone. 
E. Key's Hypothesis 
Bone is one of the few organs that can regenerate and repair itself. The repaired 
region demonstrates the same anatomic and histologic structure of the original bone. Bone is 
only capable of healing certain sized defects, nonunion will occur if the growing potential of 
bone is exceeded (Peacock and Van Winkle, 1976). 
In 1934, J. A. Key quantitatively estimated the distance that bone can regenerate and 
created this hypothesis (known as Key's hypothesis): A segmental long bone defect 1.5 times 
the diaphyseal diameter will not progress to union in adult dogs, unless bone healing is 
augmented in some fashion; in younger dogs with open physes, defects of this magnitude and 
greater will often heal spontaneously (Key, 1934). Key's research did not fiilly support his 
own hypothesis but other research groups have more fully supported it (Waisman and 
Schweppy, 1979, Zadek and Robinson, 1961). The study by Waisman and Schweppy (1979) 
used two dogs, with an average weight of 15 kg, as controls to test the bone healing of a 10 to 
20nim ostectomy created in the mid-diaphysis of the femur. Internal fixation consisting of a 
plate and screws was utilized to stabilize the area. The radiological and histological 
observations of these dogs showed no indication of union even after 170 days. A 
pseudoarthrosis had formed and connective tissue filled the region between the distal and 
proximal sections of the femur. 
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F. Ceramic Materials Used for Transcortical and Bone Bridging Implants 
1. Introduction to Calcium Phosphate Ceramics 
Bone is a composite material consisting of both organic collagenous tissue and an 
inorganic mineral phase. Mature bone can consist of up to 80 w/o mineral (Skiimer, 1979). 
In 1932, Klement determined that the main component of bone mineral is the calcium 
phosphate ceramic known as hydroxyapatite [Caio(P04)6(OH)2]. Bone stores the body's 
calcium and phosphorus supply but these minerals are continuously being deposited and 
resorbed for body functions and hemostasis. Due to the resorption and deposition of 
minerals, the mineral phase of bone has different structures consisting of highly crystalline 
and amorphous forms (Engstrom, 1972). 
Calcium phosphate ceramics offer some very good properties for hard tissue 
replacement. These properties include very low toxicity, minimal fibrous tissue growth 
at the surface, the possibility of forming a direct bond with bone, and the possibility of 
stimulating bone growth. Since calcium phosphate ceramics bond directly with bone 
they are classified as bioactive ceramics. The surrounding tissues and fluids affect the 
rate of ions released from the resorbable calcium phosphate ceramics (Ducheyne and 
Hastings, 1984b). 
The replacement of hard tissue in any part of the body requires a compatible interface 
between the biomaterial and bone along with a strong enough material to handle the loaded 
conditions. The biocompatibility of implant materials is optimal when the material allows 
normal tissue growth and normal transferring of loads at the surface. Calcium phosphates 
can be made with properties that are very similar to hard tissue (Klein et al., 1990). Calciimi 
phosphate ceramics are stronger in tension and compression in comparison to spongiose bone 
transplants. For cortical bone replacement, bone grafts have similar compressive strength 
and a higher tensile strength than these ceramics. Therefore, these ceramics might be 
effective as a replacement for cancellous bone grafts or to replace bone where cancellous or 
32 
cortical bone grafts cannot be applied. It is important that these ceramics are placed in areas 
where they will not fail due to high tensile stress (de Groot, 1983). 
There are many calcium phosphate salts available that are present in, or similar to, 
bone and tooth mineral (de Groot, 1983). The average compositions of the major minerals in 
specimens of calcified tissues are shown in Table 2. 
Hydroxyapatite and tricalcium phosphate are the most commonly researched calcium 
phosphate ceramics. Both of these ceramics are remarkably biocompatible. They have the 
ability to form a biochemical bond with bone because of their chemical similarity to natural 
bone mineral (Engstrom, 1972 and Koeneman et al., 1990). 
Table 2. Average composition ofminerals in calcified tissues (Driessens, 1980) 
Components of Bone Weight Percent 
Calcium (Ca) 36.7 
Phosphorus (P) 16.0 
Carbonate (CO3) 8.0 
Sodium (Na) .77 
Magnesium (Mg) .46 
Fluorine (F) .04 
Calcium/ Phosphorus ratio (Ca/ P) 1.77 
a. Tricalcium phosphate 
i. Introduction Tricalcium phosphate (TCP) with a chemical composition of 
Ca3(P04)2 has shown biocompatibility in similar ways to alumina and hydroxyapatite (HA). 
TCP (beta whitlockite crystal structure) along with HA are the most widely investigated 
calcium phosphate biomaterials (Jarcho, 1981). TCP has shown that it can encourage the 
ingrowth of soft tissue and bone, especially when it is porous. TCP has a Ca/ P ratio of 1.5 
and a chemical name of anhydrous alpha or beta-tricalcium phosphate. The TCP can be 
resorbed, and it may aid in the regeneration and healing of bone, so it has been used as a bone 
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scaffold (Boretos, 1987). The products that are resorbed from the TCP are identical to the 
natural calcium and phosphate ions in the body fluids. The resorption process is normally 
very slow (Bucholz et al., 1987). Jarcho (1981) found that a fully dense 100% TCP ceramic 
dissolved 12-22 times faster than a fiilly dense HA ceramic depending on the pH of the 
solution. For in vivo studies, comparison of different biodegradation is very difficult because 
the rate of degradation is affected by: the type and age of an animal, the location and stress 
placed on the implant, and the microporosity of the ceramic implant (Ducheyne and Hastings, 
1984b). 
ii. Transcortical implants Klein et al. (1994) performed an in vivo study of 
alpha-tricalcium phosphate (alpha-TCP) and hydroxyapatite plasma-sprayed onto a titanium 
alloy with titanium implants used as controls. Cylindrical rods were placed through a 4.7mm 
hole drilled into the cortical bone of canine femurs. The implants were removed at different 
time periods up to 112 weeks. They found that the interface shear strength of the alpha-TCP 
plugs and titanium increased during the time of implantation (Table 3). At three months of 
implantation, alpha-TCP coatings showed more than 50% degradation, increasing to 80-90% 
at five months and longer. The bone was remodeling as the coating was degrading. After 
five months, the degradation of alpha-TCP had probably decreased so the remodeling was 
lowered, leading to increased bone contact and higher push-out data (Table 3). They foimd 
that within three months the hydroxyapatite (HA) coating formed a strong bonding with bone 
tissue creating higher shear strengths. They concluded that the degradation of HA probably 
occurred more gradually so this was the reason for stronger bone bonding to the HA than the 
alpha-TCP within the first three months. They attributed the low shear strength results of the 
titanium to its lower surface roughness (Table 3). 
Table 3. Mean push-out strengths (MPa) ± standard deviation found in selected studies 
Weeks Klein etal., 1994 Hayashi et al.(1993b) I.i, 1993 Hayashi et al.(1993a) Verheyen et al. (1993) 
3 0.7 ±0.3. n=4^ 
0.7 ±0.3, n=4^^ 
1.0 ±0.3, n=4^^^ 
0.0, n=4^^^* 
1.0 ±0.3, n=4*^^^^ 
4 7.7 ±1.8. n=6* 
7.7 ±1.7. n=6" 
0.1 ±0.1, n=l*»* 
>=0.3 ±0.2, n»3* 
«0.3±0.2, n»3** 
»2.0±0.3. n=3*** 
a6.0±1.0. ns:3^^^^ 
0.1 ± 0.1, n=7^ 
6.8 ± 2.3. n=7»* 
O.I ± 0.2, n=7^^^ 
O.l ± 0.1, n=7^^^^ 
12 34.2 ±6.5, n=5*'» 
10.0jt3.6, n=5** 
9.9± 1.1. n=5*** 
9.7 ± 1,8, n=6* 
ll.7±3.5. n=6** 
0.5 ±0.4. n=6*»» 
o4.2±1.2. n»3^ 
»5.6±I.O. n«.3^^ 
•»9.5±0.7. n«.3^»^ 
»14.2±l.4, n»3*** 
0.5 ± 0.4, n=8^ 
12.1 ± 3.4, n = 8^^ 
0.8 ± 0.7. n = 8^^^ 
0.9 ± 0.7. n = 8^^^^ 
1 8±0.4, n=4* 
2.3 ±0.7. n=4^^ 
5.2 ± 1.3. n=4^^^ 
0.0 n=4^^^^ 
20 21.3 ± 8.8, n=4» 
14.5 A 2.8, n=4** 
21.4 jt 7.6. n=5»»» 
112 44.7 ± 17.5, n=3» 
31.4 ± 9.2, n=3** 
30.8 ± 6.8, n=4»*» 
Substrate and 
Surftce Structure 
*HA coated TI-6AI-
4V 
•*a-TCP coated Ti-
6A1-4V 
•••Ti(conlrol) 
*HA coaled Ti-6AI-
4V 
••dense HA 
•**Uncoaied Ti-6AI-
4V,control 
•c.p. Ti 
••Ti 
•••Ti/ HA 
••••HA 
•3I6L.S.S 
•'dense HA 
•••AI2O3 
««*«Zr02 
•PLLA 
••PLLA + 30wl% HA 
•••PLLA + 50wt% HA 
••••316LS.S. 
•••••.sandbla.sied PLLA 
Surface 
Roughness (Ra) 
• ll.25±1.9um 
••U.25± 0.51 urn 
••»3.88± 0.26um 
* 3.38±0.51um 
•• 0.88±0.21un) 
•••0.42 ± 0.07uni 
• 0.61 ± 0.20um 
•• 0.42 ± 0. ISum 
••• 0.53 ± O.I4um 
•••• 1.50 ± 0.24um 
• 1.0± 0.22um 
•• 0.9±0.2lum 
••• l.3±0.40um 
••••0.9±0.26um 
• 1.1 ± 0.3um 
•• 1.5±0.3um 
••• l.4±0.lum 
•••• 0.5±0.lum 
••••• 12,1 ±1.5um 
Location Femur Femur Femur Femur Femur 
Condition Fresh Fresh Fresh Fresh Fresh 
Animal Canine Canine New Zealand While Rabbits Canine Goal 
These asterisks refer to the surface roughness values seen below in the column 
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iii. Bone bridging implants Claes et al. (1990) were trying to leam whether 
the success of bridging large diaphyseal cortical defects by means of implants is dependent 
on the material and if there is a critical bridging distance. The materials (HA, TCP, titanium, 
polymethylmethacrylate (PMMA) and polyacetal resin) had the shape of semicylinders that 
were twenty millimeters long with 2% residual porosity. Each semicylinder consisted of two 
shells. The inside shell had an outer radius of five millimeters and an inner radius of three 
millimeters. The outside shell fit over this shell and had an inner radius of five millimeters 
and an outer radius of eight millimeters. The shells were screwed together in the middle of 
the implant with a two millimeter screw. The inner surface of the outside shell had two 
square canals that were milled to 1.5 x 1.5 mm^ and two other square canals that were milled 
to .5 X .5 mm^ through the entire axial length of the implant. Five of each ceramic implant 
were placed in the right metatarsals of sheep for sixteen weeks. Histological examination of 
the interface of bone with titanium, PMMA, and PAR showed connective tissue with many 
fibroblasts. In the canals of these materials, bone was growing circumferentially and close to 
the bone bed. In contrast, the HA and TCP had newly formed bone in direct contact with the 
surface. The twenty millimeter canals for these ceramics were almost completely filled with 
bone, and blood vessels had grown in the center of the canal. Overall, longitudinal and cross 
sections of bone showed much higher density of bone for the bioactive ceramic materials. 
Since the TCP had a higher density of bone in the cross sections and longitudinal sections 
than HA, the authors preferred TCP over HA for repairing defects. The authors also felt that 
since TCP and HA offered direct contact and had the ability to guide growing bone into the 
interior of an implant, TCP and HA should be added to bone replacement devices. They 
suggested using ceramic implants with macro canals and micro porosity for better guiding 
function of bone. 
Koster et al. (1976) implanted compact and macroporous cylindrical calcium 
phosphate ceramics with Ca/P ratios of 1, 1.5, and 2 in dog tibias. They felt that the 
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resorption of TCP depended on the amount of stress placed upon it. The loading was based 
on the weight of the animal; the less loaded TCP was resorbed slower than the highly loaded 
TCP. In contrast, the Ca/P with a ratio of 2 did not resorb under the various loaded 
conditions. 
b. Hvdroxvapatite 
i. Introduction Hydroxyapatite (HA) has a chemical formula of 
Caio(P04)6(OH)2 that gives a Ca/P ratio of 1.67. Dense HA ceramics are well accepted by 
bone tissues and tend to allow the formation of a somewhat direct bond to living bony tissue. 
The essential feature of this bonding to bone is due to the layer of tiny hydroxyapatite 
particles that are deposited by the body onto the implant surface that in turn initiates a 
continuous bond formation (Heimke, 1990). The bone that bonds to the ceramic is free of 
clefts or inclusions of giant cells. The cell processes of the adjacent osteocytes are in 
intimate contact with the ceramic. Ceramic surfaces without bone contact are typically 
covered by a thin layer of fibroblasts, mono- or multinuclear macrophages (giant cells). The 
new lamellar bone has a structure of part bone and part ceramic (Heimke, 1990). 
Many researchers have shown some very promising biocompatibility results with 
hydroxyapatite ceramics. Completely dense implants of HA show very slow rates of 
resorption, if any (Jarcho, 1981). Jarcho et al. (1977,1978) reported that within one month 
of implantation of dense HA implants, the surface had fibroblasts differentiating into 
osteoblasts forming bone in direct apposition to the implant surface. Newly formed bone was 
reported to deposit around fibroblasts and osteoblasts at six weeks of implantation. After six 
weeks the surface was predominated by osteocytes and at six months compact bone formed 
directly onto the surface with no fibrous encapsulation. Denissen et al. (1980) proposed that 
a chemical bond occurs between bone and the ceramic and the union is often so strong that 
removing the implant would be impossible without fracturing surrounding bone. 
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ii. Transcortical implants Hayashi (1993b) compared hydroxyapatite-
coated Ti-6A1-4V, dense sintered hydroxyapatite, and uncoated Ti-6A1-4V (control) 
implants. The cylindrical shaped implants were placed transcortically in the middiaphyseal 
region of canine femurs. The interface shear strengths at 4 and 12 week for the HA-coated 
Ti-6A1-4V and HA were similar but much higher than the uncoated Ti-6A1-4V as seen in 
Table 3. The histological results at 4 weeks for the uncoated Ti-6A1-4V showed many 
regions of thick intervening fibrous membranes with few regions of direct bone contact. The 
sintered HA zuid HA coated Ti-6A1-4V displayed direct bone contact in all specimens at both 
4 and 12 weeks. 
Li (1993) compared cylinders produced fi-om titania, titania-HA composite, HA, and 
commercially pure titanium (c.p. Ti) in the femur of New Zealand white rabbits. Titania 
and titanium had similar shear strengths at 1 and 3 month's post-implantation. The titania-
HA composite had significantly larger shear strength results compared to titania. HA showed 
the largest shear strengths as seen in Table 3. SEM evaluation of the bone-HA interface 
revealed fully mineralized bone while the bone-Ti interface had a gap less than two 
micrometers wide. 
Transcortical implant studies have consistently shown higher shear strengths for 
HA-coated implants when compared to other materials. Flat implant surfaces coated 
with HA show a five- to sevenfold increase in shear strength compared with uncoated 
implants (Thomas, 1987, Cook et al., 1988b, and Poser et al., 1990). These three research 
groups grit blasted the uncoated implants to a roughness similar to the HA-coated implants so 
different surface roughnesses wouldn't be the reason for higher bone apposition or 
attachment. 
iii. Bone bridging implants Patka et al. (1990) performed an experiment 
with four mongrel dogs that used semi-circumferential femoral midshaft defects that were 15 
mm long. The defects were filled with proper size implants that were 45% porous HA in one 
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group and 45% porous TCP in another group. The implants were stabilized with stainless 
steel plates and screws for six months and then the plate and screws were removed for 
another six months. Fast bioresorption of the TCP was found to have occurred while the 
HA did not degrade. This result has been observed by many researchers, including Patka 
(1984) and Klein et al. (1983). The biocompatibility of the HA was found to be better 
because there were inflammatory reactions with the TCP implants. However, new bone 
formed where TCP resorbed. These researchers reconmiended using porous HA implants for 
filling bone defects and supporting bone tissue in places where compressive forces mainly 
occur. In a similar experiment using hydroxyapatite, Patka (1984) used dense and porous HA 
implants in the shape of half and full cylinders. He concluded that porous HA materials can 
be used in natural, load-bearing areas if sufficient mechanical support is given in the early 
stages after implantation. Longer periods of support were recommended for the full 
cylindrical implants. Here again, no degradation of the porous or dense HA was found even 
after two years of implantation. Also, the ingrowth of bone in porous HA resulted in a 
composite material with better mechanical properties than dense HA or the porous HA prior 
to implantation. 
c. Tricalcium phosphate/ spinel 
i. Introduction Tricalcium phosphate implants have shown that they are 
very compatible with the body, as discussed above. However, pure tricalcium phosphate 
ceramic, as is true for most ceramics, has low fracture strength and poor fatigue resistance 
due to instability of the OH groups. This limits its use for load-bearing conditions (Li et al., 
1995). Also, it loses strength due to biodegradation. The strength of this material can be 
increased with the addition of magnesium aluminate spinel (MgAl204), which was initially 
suggested by Janikowski and McGee (1969). Another benefit of adding MgAl203 spinel to 
tricalcium phosphate is the insolubility of the spinel in aqueous solutions. Ceramic materials 
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that are composed of calciimi phosphate and MgAl203 spinel and are used for the permanent 
replacement of bone were called osteoceramic by McGee and Wood (1974). These 
researchers tested porous and dense osteoceramic implants in the mandible and maxilla of 
dogs and found bone immediately adjacent to the implant with no fibrous encapsulation. 
They also found mineralized bone several millimeters into the porous implants. Karagianes 
et al. (1974) used magnesiimi aluminate spinel as a dental anchor in swine and found very 
high tissue biocompatibility with no inflammatory response. Aksaci (1981) used a porous 
fluorapatite (Caio(P04)6F2)' spinel (MgAl204) ceramic as a bone bridging implant in the 
femur of canines. She found that bone filled the pores of the implants with no inflammation 
or fibrous capsule. Tweden (1987) used TCP/ spinel as a dental implant and compared it to 
three other commercial materials. The TCP/spinel was tested against: single-crystal sapphire 
(Bioceram ®), pyrolytic carbon (Pyrolite ®), and a titanium alloy (Core-vent ®). The TCP/ 
spinel was found to have the lowest inflammation rate and earliest bone contact of the 
materials tested. Within 3 months of implantation, approximately 80% of the implant had 
direct bone contact. This action was nine months sooner than maximum bony contact by the 
sapphire or titanium alloy implant. 
ii. Bone bridging implants In the research experiment by Olson (1992), 
bone bridging devices were placed in the femoral midshaft of seven canines after a surgical 
ostectomy measuring approximately 25 mm was created. Internal fixation using a dynamic 
compression bone plate and screws stabilized the proximal and distal osteotomies. The bone 
bridges were composed of 50 v/o tricalcium phosphate and of 50 v/o magnesium aluminate 
spinel. The unique hollow cylindrical design of the bone bridge included: an outside 
diameter similar to the outside diameter of bone except in one case discussed in the next 
section, different wall thicknesses to determine which thickness is the best design for the 
transferring of imposed loads, dovetail slots and tenons at each end of the implant for 
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fixationai interlocking, hollow axial canal for ingrowth of bone and possible medullary canal 
reconnection, and longitudinal grooves on the outside wall of the implant to encourage the 
growth of bone along the outer wall of the implant with eventual encapsulation. This design 
was created to: (1) provide the geometry for direct skeletal attachment into, through, and 
around the implant and thus, (2) assist bone in permanently securing the implant as a 
permanent part of the bone and ultimately allow bone to retain its normal function even after 
removal of the bone plate and screws. Two different methods were utilized to fasten the bone 
bridge to the plate using cerclage wire. The first method involved a single wire wrapped in a 
hemicerclage fashion through the center holes of the implant and around the bone plate. The 
second method involved two wires wrapped in a full cerclage fashion around the implant and 
bone plate. Macro and microradiographic evaluation showed that the design of the implant 
was successful at offering bone the chance to reconnect through the axial canal, join with the 
dovetail slots and tenons at the ends of the implant, and encapsulate the outside of the 
implant. The encapsulation of the implant strengthened the area in compression, tension and 
bending while the bone interlocking with the slots and tenons provided torsional and tensile 
rigidity. The connection of bone through the axial canal helped maintain the normal blood 
flow, nutrient movement and nerves so the bone could be completely viable. The 
microradiographic evaluation displayed the intimate contact that bone often had with the 
osteoceramic. This close bonding with bone indicates that this material was very 
biocompatible under loaded conditions. Excessive micromotion sometimes prevented bone 
firom achieving close contact with the osteoceramic. However, in other interface regions 
experiencing less micromotion, the osteoceramic still had direct bone contact. The bone 
growth on the outside and inside wall of the implant indicates that this material encourages 
the growth of bone along its siorface. 
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iii. Bone bridge research that led to the concept of a guide tube device 
In the previous bone bridge experiment by Olson (1992) most of the implants had a similar 
outside diameter as the ostectomy section they were replacing. However, in one subject the 
ostectomy section was replaced with a much larger outside diameter implant than the outside 
diameter of the bone. The macroradiographs showed radiolucencies along the distal and 
proximal end of the implant indicating that implant movement was occurring. Even with this 
movement, the microradiographs show a very well organized cancellous and compact bone 
structure connecting the proximal and distal ends of the femur through the axial canal (Figure 
4). The ends of the bone in contact with the implant must have developed toward the center 
of the bone prior to entering the implant and continued until rejoining. The hollow center 
region of the implant provided the bone with a pathway to follow so that it could reconnect. 
This reconnection is the main source of transport of blood and nutrients between the ends of 
the bone. This allows bone the chance to maintain its normal development in addition to 
healing the region. Even though the reconnection is only through the center of the implant, 
there is an increase in the strength and stabilization of the region. The narrowing of cortical 
bone through the canal of the implant (Figure 4) indicates that if there was a smaller outside 
diameter tube spanning the marrow cavity of an even larger defect, bone could possibly be 
guided across the osteoceramic surface and reconnect. The observations from this bone 
bridge implant led to the concept of a different type of bridging device, called an 
osteoceramic guide tube, (described later in the materials and methods' section) that would 
allow bone to rebuild, spanning a larger gap. The implant would direct the bone growth to 
self union rather than having the defect filled with an implant that would have to support the 
bone under loaded conditions. Thus, it is not important in its load bearing capacity after the 
bone recovers. Also, unlike other bone bridging implant experiments, this new implant 
would span a bone defect that exceeds the potential of bone to repair itself in accordance to 
Key's hypothesis. 
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Figure 4. Microradiograph of the bone bridge in dog 2 after 9 months of implantation 
G. Steel, Steel and Ceramic Composites, and Polyethylene and Ceramic Composites 
Used for Transcortical Implants 
1. Stainless Steel 
a. Introduction Iron-based alloys make up one of the largest groups of metallic 
materials for biomedical applications. Stainless steel type 316L is typically used for the 
manufacture of implants used in weight-bearing or articulating devices. This material has 
excellent corrosion resistance, good mechanical properties, and has gained a large degree of 
success because of minimal adverse tissue reaction (Williams, 1990). The tissue reaction that 
occurs is caused by the corrosion products of the metal not the metal itself. A very thin layer 
of jSbrous tissue lining the stainless steel implant is an ideal situation (Greco, 1994). 
b. Transcortical implants Hayashi, et al. (1993a) compared non-textured 
cylindrical-shaped stainless steel, dense sintered hydroxyapatite, alumina ceramic, and 
zirconia ceramic implants after four and twelve weeks using the transcortical implantation 
43 
method in the canine femur. The interface shear strength of the HA was considerably higher 
than the stainless steel, alumina ceramic, and zirconia ceramic as seen in Table 3. The shear 
strengths of the bio-inert ceramics (alumina and zirconia ceramic) were comparable to the 
stainless steel. The overall results after twelve weeks showed the stainless steel having the 
lowest shear strength results. Histologically, many of the stainless steel, alumina and 
zirconia ceramic specimens even after twelve weeks showed a thick fibrous membrane at the 
bone-implant interface. The HA displayed bone directly in close contact with the surface at 
four and twelve weeks. They noted that the stainless steel seemed to have the same ability to 
bond with bone as the bio-inert ceramic. They also noted that in load bearing situations it is 
important to remember that the shearing stress at the interface becomes greater as the 
difference between Young's modulus of the implant and the bone increases (described earlier 
in section n. D. Mechanical Push-Out Testing of Implants). This increase is believed to 
decrease the useful compatibility of the implant. Young's modulus of stainless steel is higher 
than that of cortical bone, but bio-inert ceramics have a Young's modulus considerably higher 
than cortical bone or stainless steel. 
Verheyen et al. (1993) used a transcortical implantation model in the femur of goats 
to test the bone-implant interface of smooth 316L stainless steel. Push-out results were not 
obtained for the stainless steel because the implants were either loose in the bone marrow 
or had failed during preparation for the push-out test. They concluded that 316L stainless 
steel and other smooth non-bone bonding materials should have shear strength values near 
zero. 
2. Stainless Steel/ Calcium Phosphate Ceramic Composites 
Metal materials offer the desired mechanical properties for load bearing applications 
but lack the bioactivity for direct bonding with bone. On the other hand, bioceramics are 
bioactive but can not be used alone for load bearing applications because they are inherently 
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brittle and fracturing can occur. The development of reinforced bioactive ceramic with 
metals can offer the desired properties of each while limiting their undesirable properties. 
One problem that may occur with combining ceramics and metals is the reduction of bone 
tissue formation at the bioactive ceramic surface (Ducheyne and McGuckin, 1990). Schepers 
et al. (1989) concluded that a composite of 316L stainless steel and bioactive glass when 
exposed to body fluids reduced the bonding of bone to the bioactive glass . However, they 
found that titaniimi did not afifect osteoconduction with bioactive glass-titanium 
compositions. Composite material combinations of stainless steel and calcium phosphate 
ceramics have had very limited use for transcortical or orthopedic implants. 
3. Polvethvlene/ Calcium Phosphate Ceramic Composites 
a. Introduction Some polymer materials used for replacing bone include 
polyethylene, polyvinyl, acrylic compounds and methyhnethacrylate (de Wijn, 1982). One 
of the main problems with these and other polymer implants is their inferior mechanical 
properties, especially for loaded regions (Patka, 1984). Another major problem with 
polymers is the fibrous tissue that usually siurounds the implant (Kerr, 1981). The 
incompatibility of polymers is generally caused by certain additives that cause toxic reactions 
(Leininger, 1972). Additives such as plasticizers, fillers, heat stabilizers, pigments, and 
lubricants have been added to increase mechanical properties and inertness but may lead to 
the increased toxicity of the polymer (Patka, 1984). 
Polymers and ceramic materials have specific advantages and disadvantages for use 
as bone replacing materials or for load bearing applications. Bioactive ceramic materials 
have excellent bone bonding characteristics but lack mechanical strength, especially in 
tension, and have a brittle fracture behavior. Polymers lack bone bonding properties and 
mechanical strength but there are ductile polymers with comparable values of Young's 
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modulus as the collagen found in bone. Therefore, combining these two materials can create 
a desirable material for certain applications (Verheyen et al., 1993). 
Bone is considered to be a composite material and a composite structure. Bone is a 
heterogeneous material consisting of hydroxyapatite crystals in a bed composed primarily of 
collagen. The collagen has mechanical properties similar to those of polymers while the 
hydroxyapatite has mechanical properties similar to ceramics. The collagen matrix helps 
minimize the chance for brittle fracture of the hydroxyapatite (Williams, 1990). In major 
support bones, the osteons (concentric layers of hydroxyapatite and collagen) are arranged 
parallel to the long axis of the bone. This structure helps reinforce the load bearing 
properties of the bone (Katz, 1980). 
Cortical bone typically has an elastic modulus in the range of 10-20 GPa. 
Researchers have tried to reproduce the elastic modulus and structure of bone using 
hydroxyapatite scattered in synthetic polymers. High volume fractions of hydroxyapatite in 
polyethylene can produce elastic moduli of 1 GPa to 9 GPa (Williams, 1990). Increasing the 
volume fraction increases the elastic modulus but decreases the elongation to fracture and 
fracture toughness (Bonfield et al., 1983). Brittleness of the these composite materials can 
occur above 40 vol% hydroxyapatite (Williams, 1990). 
It could be highly desirable in certain situations to have composite materials that have 
elastic properties similar to those of bone. However, the hydroxyapatite in composite 
materials can not reinforce the polyethylene in the same way it reinforces the collagen in the 
complex structure of bone. The hydroxyapatite at the surface of the composite could enhance 
the response of bone to the material (Williams, 1990). 
b. Transcortical implants Verheyen et al. (1993) used a transcortical implantation 
model in the femur of goats to test the bone-implant interface of poly (L-lactide) (PLLA), 
PLLA incorporated with 30 and 50 wt% HA, and sandblasted PLLA (PLLAs). Their push-
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out study shows that at three months most of the implants had reached maximum push-out 
strength. Table 3 shows that the incorporation of 50 wt% HA particles in the poly (L-lactide) 
displayed the largest increase in interface strength with the bone at three months. The reason 
given for no increase in shear strength at six months for PLLA, PLLA with 30 and 50 wt% 
HA might have been the resorption of the PLLA. Implants removed after one year of 
resorption had become jelly-like material. The histological investigation at the bone-implant 
interface showed increased bone contact for the composites compared to the unfilled poly (L-
lactide). Good bone bonding occurred even at low particle volume fractions of 25% or less. 
In a device situation, this bone bonding could more uniformly distribute stress between the 
bone and implant. 
Bonfield (1988) evaluated hydroxyapatite (volume fraction .3, .4 and .5) reinforced 
polyethylene composite implants with a diameter of 2.3 mm and length of 5 mm. The 
implants were placed into a 2.4 mm hole in the lateral condyle of the femur of mature New 
Zealand white rabbits. Unfilled high density polyethylene implants were used as controls. 
The mechanical results from the polyethylene control implants that developed a fibrous 
encapsulation had a shear strength of approximately 1.4 MPa. The .4 volume fraction 
hydroxyapatite composite showed an increase of almost a factor of 5 at the same time period 
(approximately 6.6 MPa). 
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CHAPTER in. MATERIALS AND METHODS 
A. Transcortical Implants 
1. Introduction 
There are many synthetic materials used for bone and joint replacement applications. 
These biomaterials are generally classified as metals, polymers, ceramics and composites. 
Biomaterials used for orthopedic devices need to be biocompatible with the tissues they 
contact. In addition, the material must be able to withstand any anticipated physiological 
loading. However, many metal, polymer and ceramic biomaterials do not completely satisfy 
these requirements. This limits their use in orthopedic devices. Commonly used metals for 
orthopedic implants, such as 316-L stainless steel and cobalt chrome alloys, are fairly inert 
materials except when wear debris increases tissue's reaction to them. These metals have a 
much higher strength and a higher modulus of elasticity than bone. This higher strength and 
modulus can lead to stress concentrations and "stress shielding" in bone. Polymeric materials 
such as ultra high molecular weight (UHMW) polyethylene are often chosen over other 
polymers for implantable devices because of their inertness. Polyethylene has good ductility 
but has a lower modulus of elasticity than bone. This low rigidity limits the use of 
polyethylene for orthopedic applications. Inert materials, like metals, polymers and some 
ceramics, will eventually become surrounded, to various degrees, by a fibrous tissue layer. 
This fibrous tissue layer presents a seriously weak link between the implant and bone. In 
order to overcome this fibrous tissue interface, calcium phosphate ceramics can be used. 
These ceramic materials are the only known materials that are not walled off by a fibrous 
capsule. Calciimi phosphate ceramics, such as tricalcium phosphate and hydroxyapatite, are 
an appealing material for prosthesis applications since they offer bone the chance to 
chemically bond to their surface. Thus, healthy osseous tissue can attach and remodel next to 
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the implant while providing increased stabilization. However, calcium phosphate ceramics 
have had limited use for load bearing applications because of their brittleness, high elastic 
modulus, inability to withstand high impacts and low tensile strength. 
2. Design Considgrations fei the Matgrial 
There is a still a need for a new material to interface with bone in bone and joint 
replacement devices. The bioactive nature of calcium phosphate ceramic materials, along 
with the mechanical properties of the metals and polymers, were some very desirable 
characteristics for a material that would interface with bone in an orthopedic device 
application. If the biocompatibility of calcium phosphates could be combined with the good 
mechanical properties of metals or polymers, a new composite might have a better 
combination of properties than either would have alone. In order to take advantage of each 
material's desirable properties, composite materials were designed and manufactured. The 
calcium phosphate ceramic material used as the tissue interface material for this research was 
a ceramic-ceramic composite material made from tricalcium phosphate and magnesium 
aluminate spinel. This material, called an osteoceramic, has shown excellent 
biocompatibility with osseous tissue and enduring strength (Olson, 1992). Because of these 
desirable properties the osteoceramic was chosen as the bioactive material to be used in the 
new composites. The first composite was made by dispersing large osteoceramic particles 
within a 316L stainless steel matrix. This composite material would provide improved 
mechanical properties compared to the osteoceramic, especially tensile strength and ductility. 
The support of the stainless steel would greatly reduce the stress placed on the osteoceramic 
under loaded conditions. Exposure of the ceramic on the surface of the material would 
provide bone with the chance to bond with the implant. The second composite material was 
made by dispering large osteoceramic particles within a UHMW polyethylene matrix. The 
addition of the osteoceramic increased the Young's modulus of the composite while the 
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polyethylene increased its fracture toughness. This composite would have a modulus of 
elasticity in the region of cortical bone. A similar modulus was desirable so that stress 
concentrations could be minimized at the biomaterial/ bone interface. The osteoceramic 
exposed on the surface was intended to provide the opportunity for bone to bond with the 
surface. Three other materials, osteoceramic fired in air, osteoceramic fired in hydrogen and 
316L stainless steel were made to compare their tissue response with that of the composites. 
The osteoceramic is normally fired in an air atmosphere. However, since the osteoceramic 
would need to be fired in a hydrogen atmosphere when it was mixed with the stainless steel, 
its tissue compatibility after firing in hydrogen was tested. Processing of these material 
combinations was a very difficult task since each material had different manufacturing 
techniques. Difficulties included bonding the polyethylene and stainless steel with the 
osteoceramic, overcoming different firing atmospheres, different shrinkages on firing, and 
exposing the osteoceramic on the surface of the composite material. 
3. Purpose 
The overall purpose of the transcortical implant study was to make a new composite 
material for use in orthopedic applications. This new material would have both bone bonding 
capabilities and appropriate mechanical properties for highly loaded conditions. In future 
research projects, this material could be used to interface with bone tissue in certain locations 
on a total knee or total hip replacement. 
4. Design Considerations for the Shape of the Transcortical Implants 
The design of the transcortical implants was chosen for use in mechanical push-out 
tests and histological evaluations. The implant was made with a solid cylindrical shape with 
an outside diameter of 3.2 millimeters (mm). This outside diameter was larger than the 
American Society for Testing and Materials (ASTM) recommended outside diameter of 2.0 
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mm for implants inserted into the bone of rabbits (designation F981). Some of the composite 
materials contained very large aggregates and in order for these aggregates to be reinforced in 
the supporting material and at the same time expose both materials on the surface of the 
implant, a larger outside diameter implant was required. Since a uniform outside diameter of 
3.2 mm was important, especially for a precise fit during implantation and accurate push-out 
test results, each implant was shaped with a centerless grinder. All of the implants were 
manufactured with an oversized diameter and ground to a diameter of 3.2 millimeters using 
aluminum oxide wheels with a water/ oil mixture as a coolant. 
The length of the implant was also revised fi-om the length of 6 mm recommended by 
the ASTM standards. The 6 nun implant would only span one cortex of the bone and 
longitudinal cutting of the bone would be required before push-out testing could be 
performed. This would require fixation and impregnation of the specimen that would modify 
push-out strength. Instead, for this research the implants spanned both cortices so 
mechanical testing could be accomplished without disrupting the interface between the bone 
and implant after the implantation period. The length of the implant allowed an additional 1 
to 2 mm protruding on each side of the bone for alignment purposes during push-out testing 
and projection into soft tissue for soft tissue response evaluation. The lengths of the implants 
ranged fi-om 12.3 to 22.0 mm as shown in Figure 5. 
Figure 5. Transcortical implant design showing the outside diameter (O.D.) and length 
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5. Manufacturing Considerations for the Stainless Steel/ Osteoceramic and Polyethylene/ 
Osteoceramic Composites 
Manufacture of the 316L stainless steel with the osteoceramic was initially attempted 
using bars made from each material and adhering them together before firing. Some of the 
problems with manufacturing these materials together are their different firing atmospheres 
and final firing temperatures. The osteoceramic is normally fired to 1450°C in air to obtain a 
dense, strong material while the stainless steel is fired to ISSO^C in a hydrogen atmosphere. 
The hydrogen atmosphere is required so oxidation of the steel doesn't occur. The final firing 
temperature of 1330°C is the maximimi temperature obtainable without changing the 
properties of the material. Therefore, to maintain the properties of the stainless steel, the 
osteoceramic/ steel bars were fired to 1330°C in a hydrogen atmosphere. After firing the 
material it became obyious, because of the lifting and separating of the laminate, that the 
materials had different shrinkage characteristics. Comparable shrinkage characteristics for 
the stainless steel and the osteoceramic were desirable to prevent separation of the materials, 
stress fi-actures or other related problems caused by the heating and cooling during firing. In 
order to try to overcome this problem, the osteoceramic was altered by adding pre-fired 
osteoceramic material, called grog, to obtain shrinkage similar to stainless steel. Adding the 
grog material causes porosity and reduces the strength of the osteoceramic while firing the 
osteoceramic to a final temperature of 1330°C also makes a lower density, porous, weaker 
material. However, this was not considered a major concern because the stainless steel 
would provide the strength for the composite. Another concern was effects that firing the 
osteoceramic under a hydrogen atmosphere would have on its bioactivity and strength. 
The manufacture of a polymer/ osteoceramic composite began with the selection of 
the proper plastic to replace bone. After considering the many polymers, ultra high 
molecular weight polyethylene was chosen because of its high toughness and low adverse 
tissue reaction with osseous tissue. Specifically, Hostalen® (UHMW) polyethylene (GUR 
415) was chosen because it was manufactured to comply with ASTM standards (designation 
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F648) and most provisions of the International Standards Organization (ISO) 5834-1/-2 
surgical implant specifications. This polyethylene has an extremely high molecular weight of 
5 to 6 million g/ mol that provides superior abrasion resistance, impact strength and low 
frictional resistance. The osteoceramic material used to distribute within the matrix of the 
polyethylene was made from large aggregates of 1450°C grog. Grog material was used for 
mixing with the polyethylene powder since the polymer was only heated to 210°C to achieve 
polymerization. The polymer encapsulated and tightly bonded to the osteoceramic 
aggregates without modifying the manufacturing process. 
6. The Material Combinations Used to Make the Transcortical Implants 
The transcortical implants were made from the following five material combinations: 
osteoceramic fired in air; osteoceramic fired in hydrogen; stainless steel/ osteoceramic; 
stainless steel; and polyethylene/ osteoceramic. The first type of implant material, 
osteoceramic fired in air, was mixed using 30 weight percent (w/o) prefired components 
(1450 °C grog) and 70 w/o unfired components (Table 4). This combination was used 
because the overall shrinkage was determined to be similar (Figxire 6) to the 21 to 23 % 
shrinkage for the stainless steel. As explained above, the shrinkage rates for the stainless 
steel and osteoceramic needed to be similar if they were placed together in a composite 
situation. The osteoceramic was fired to 1330°C instead of 1450°C because in a composite 
situation with stainless steel, 1330°C would be the maximum allowable temperature for the 
metal. Even though the lower firing temperature would make a porous and thus weaker 
osteoceramic, it was necessary to test how the push-out test results and histological results of 
the ceramic would be affected. The second type of implant material, osteoceramic fired in 
hydrogen, was manufactured using the same components used for the osteoceramicmaterial 
fired in air except the firing was completed under a hydrogen atmosphere (Table 4). Again, 
since the osteoceramic would have to be fired in the hydrogen atmosphere if mixed with 
Table 4. Processing of the five transcortical implants 
Design Material Mix Dry Press Atmosphere Heating Rate 
Final 
Temperature 
Ml 30 w/o 1450 C grog 70 w/o virgin OCM 33528 psi Air 
25 to 370C(g2C/min 
370 to 500 @ 3 C/min 
500 to 1300 @ 5 C/min 
1300 to 1330 (g 3 C/min 
1330 C 
U2 30 w/o 1450 C grog 70 w/o virgin OCM 33528 psi Hydrogen 
25 to 370 C(g 2 C/min 
370 to 500 (g 3 C/min 
500 to 1300 @ 5 C/min 
1300 to 1330 @3 C/min 
1330 C 
U 
40 w/o 1450 C grog 20-30 mesh 
60 w/o Hostalen GUR 415 
(polyethylene) 
Hand Pressed (8500 psi max) 
10 min @ 775 psi (after 
heating) 
36 min (g 1291 psi 
Air 30 min (g 210 C @ 70 psi 210C 
U% Pure 316L Stainless Steel 44705 psi Hydrogen 
25 to 370 C @ 2  C/min 
370 to 500 @ 3 C/min 
500 to 1300 (g 5 C/min 
1300 to I330@3C/mm 
1330 C 
#9 
21.6 w/o 1450 C grog (30-50 mesh) 
5.4 w/o virgin OCM 
73 w/o 316L SS 
44705 psi Hydrogen 
25 to 370 C (g 2 C/min 
370 to 500 @ 3 C/min 
500 to 1300 @ 5 C/min 
1300 to 1330 (§3 C/min 
1330 C 
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Figure 6. Plot of volume shrinkage of the osteoceramic with different percentages of 
fired (calcined to HSO^C) osteoceramic material. 
stainless steel, it was necessary to determine the effect the hydrogen atmosphere would have 
on the material's biocompatibility. The third implant material, stainless steel/ osteoceramic 
was a combination of three components, 21.6 w/o 1450°C grog osteoceramic (30-50 mesh), 
5.4 w/o unfired osteoceramic and 73 w/o 316L stainless steel as seen in Table 4. The high 
percentage of stainless steel was essential for reinforcement and fixation of the osteoceramic 
aggregate. The large aggregate size of the grog material was desired so exposure of the 
osteoceramic would occur after centerless grinding the implant. Centerless grinding was 
required for all of the implants because they were manufactured with an oversized outside 
diameter and then ground to the same diameter for implantation. The fourth implant 
material, pure 316L stainless steel, was manufactured to be a control implant. The results 
from implanting this material could be used to compare with the stainless steel/ osteoceramic 
composite results to determine if the addition of the osteoceramic increased the tissue 
interface response. The final implant material, polyethylene/ osteoceramic, was produced 
fi-om 40 w/o 1450°C grog osteoceramic (20-30 mesh) and 60 w/o Hostalen® ultra high 
molecular weight polyethylene (Table 4). Once again, the grog material was used in the form 
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of large aggregate sizes so after centerless grinding the composite, the osteoceramic would be 
exposed to provide bone with the chance to bond with the implant. The osteoceramic would 
be shielded from excessive stress with the polyethylene supplying the framework for 
protection. A complete listing of the dry pressing pressures, heating rates and final firing 
temperature for the different material combinations are shown in Table 4. 
7. Manufacture of the Osteoceramic Material 
The manufacture of the osteoceramic material for the transcortical implants, 
and the aggregate used to mix with composite materials, began with two raw material 
powders, calcium phosphate tribasic (Mallinckrodt, St. Louis, MO) and magnesium 
aluminate spinel (Baikowski International Corporation, Charlotte, NC). Fifty volume 
percent (v/o) of calcium phosphate tribasic was used. This material has a true density 
of 3.14 g/ cm^ and a non-stoichiometric, nominal chemical composition of Ca3(P04)2, 
but actually has a Ca:P ratio of 1.58 instead of 1.50. The other fifty volume percent 
used to make the osteoceramic material was magnesiirai aluminate spinel, which has 
a true density of 3.57 g/ cm^ and a chemical composition of MgAl204. The spinel 
powder was a single calcined, high purity, very fine powder with a particle size of 0.03 
micrometers. 
The manufacture of the osteoceramic material began with placing the osteoceramic 
powder (90.83 w/o) and methylcellulose (Methocel ®) binder (2.75 w/o) into a one gallon 
ball mill jar. Equal volume amounts of grinding media (alimiina balls) and powders were 
added. After placing 700 ml of distilled water per 200 gm of ceramic powder and binder into 
the ball mill jar, the contents were ball milled for 24 hours to obtain a uniform mixture. The 
water was removed by suction using a round slab of plaster of Paris that was covered with 
325 mesh dacron cloth. After the material dried, it was ground using a mortar and pestle 
until passing through a #30 mesh stainless steel sieve. After adding 6.42 w/o distilled water 
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to the sieved powder, the powder was mixed using a mortar and pestle. This powder, called 
virgin osteoceramic, was ready for use in the different material applications. 
The osteoceramic implants (for air and hydrogen firing) contained 30 w/o prefired 
osteoceramic. This prefired material was manufactured using the same procedures as 
described above except the final material was placed into a crucible and fired to 1450°C with 
a heating rate of 100°C/ hour. After grinding the prefired product until it passed through a 
#30 mesh sieve, 2.75 w/o Methocel® (Dow Chemical Company, Midland, Michigan) binder 
and 6.42 w/o water were added again, since they were burned off during firing. This powder 
combination, called 1450°C grog, is ready to be used in different material applications. For 
the osteoceramics (air and H), the 30 w/o prefired material and 70 w/o virgin material were 
mixed together using a mortar and pestle before dry pressing. For the stainless steel/ 
osteoceramic and polyethylene/ osteoceramic implants, the pre-fired osteoceramic was 
crushed and passed through different sized sieves to produce larger aggregate sizes (Table 4). 
8. Matgdal Analysis 
a. Scanning electron microscopv and energy dispersive spectrometrv The surface 
topography of each of the five transcortical implant material types was observed using a 
Hitachi Scanning Electron Microscope (SEM) (model S-2460N). This SEM has a low-
vacuum specimen chamber. When viewed in the backscattered mode, the implant need not 
be coated with a conductive material, but detailed images up to lOOOx magnification can be 
obtained. Thus, the specimens that are placed into the chamber and viewed can still be used 
for implantation purposes. Using this same system, energy dispersive spectrometry (EDS) 
revealed the surface elemental distribution found in the osteoceramic (air), osteoceramic (H), 
stainless steel/ osteoceramic, stainless steel and polyethylene/ osteoceramic materials. 
b. Surface roughness The surface roughness of the transcortical implants was 
determined using a Sloan Dektak profilometer (Model IIA). This machine uses a sensitive 
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diamond stylus (12.5 micron radius) to move along a path on the surface of the sample. A 
slow scan speed was used and each measurement taken was .5 mm long. The measurement 
display range was 200 to 655,000 angstroms. After the surface profile is recorded, the 
average roughness can be calculated. 
c. Porosity and density measurements The density and porosity measurements 
were obtained for the five different transcortical implant materials using two different 
methods. For the first method, external volume was found by measuring the diameter and 
length with a precision micrometer. The bulk density was found using the standard equation 
of mass divided by the exterior volume. Total porosity was determined firom the difference 
between the true density of the material and its bulk density. 
The second method of density and porosity measurements for the osteoceramic (air 
and H) transcortical implants were obtained by the Archimedes method using water as a 
suspending mediimi (density = 1). Equation 2 was used to calculate the open pore porosity 
(%Pa) and equation 3 to calculate bulk density(pb). 
Equation 2. % Pa = (Wg - Wj/ Wg - Wsg) x 100 
Equation 3. pb = (Wj x density of water)/ (Wg -Wgs) 
where Wg = saturated weight 
Wgs = saturated suspended weight 
Wj = dry weight 
9. Animal Model Selection 
Rabbits were selected for the transcortical implant research because of their 
accelerated healing rates. Table 5 shows the timetable for rabbit, dog, and man. This table 
shows that the compacta matures after 18 weeks for rabbits so this length of implantation was 
chosen for the transcortical implant study (Roberts et al., 1987). 
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Table 5. Timetable of interface formation for an endosseous implant in cortical bone 
(Roberts, 1987) 
Rabbit(x) Dog(2x) Man(3x) 
Surface Modeling 
Stage 1: Woven Callus 2wk 4 wk 6 wk 
Stage 2: Lamellar Compaction 6wk 12 wk 18 wk 
Remodeling, Maturation 
Stage 3: Interface Remodeling 6wk 12 wk 18 wk 
Stage 4; Compacta Maturation 18 wk 36 wk 54 wk 
10. Animal Selection 
Twenty-five New Zealand white rabbits, weighing 7.0 to 11.0 pounds, were used for 
the transcortical implant study. This weight range was chosen to ensure rabbits with large 
femurs. The individual weight, sex, and implantation date for each rabbit are shown in 
Appendix I. 
11. Surgical Procedures for Implantation of Transcortical Implants 
In the trial stages of the transcortical implant research, one implant fi-om each of the 
five groups was to be placed in the lateral-medial position of a femur from each rabbit. 
Because of the small size of the rabbit femur, the five unplants would have to be distributed 
along the entire length of the bone. It became obvious from the fracturing of bone during 
drilling that the bone was very brittle, especially near midshaft, so the number of implants 
placed into the bone would have to be decreased or the diameter of the implant reduced. 
Since the composite nature of the implants did not allow for changing the outside diameter of 
the implants, the number of implants per femur was reduced. Several trial surgeries helped 
determine that two implants in the medial-lateral position could be placed proximally near 
the greater trochanter without fracturing the bone. 
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The surgical procedure for implanting the transcortical implants began with 
anesthetizing the rabbit. Anesthesia was induced by intramuscular administration of a drug 
combination of acepromazine maleate, xylazine and ketamine. The rabbits were maintained 
under general anesthesia with isofluorine. 
The rear right quarter of the rabbit was clipped and prepped using, alternating four 
times, chlorhexidine scrub and 70% alcohol. A five minute sterile scrub using chlorhexidine 
was performed following the initial prep. The leg was then draped using aseptic technique 
and covered with a sterile stockinette. 
A skin incision was made along the cranial border of the biceps femoris muscle from 
the level of the greater trochanter to the proximal patella. This skin was sutured to the 
stockinette using 2-0 monofilament nylon sutures. The skin margins were retracted and the 
fascia lata was incised along the cranial border of the biceps femoris muscle. This incision 
was the same length and directly below the skin incision. The biceps femoris was retracted 
caudally and the vastus lateralis muscle was retracted cranially to expose the shaft of the 
femur. The vastus intermedins was retracted from the cranial surface of the bone at the same 
level. Two transverse drill holes were made lateral-medial in the proximal femur. The initial 
drill bit used had a 1.5 mm diameter. The hole diameter was increased in small increments to 
reduce the chances of fracture by using 2.0 mm, 2.5 mm, 3.2 mm and 3.26 mm drill bits. The 
3.26 mm drill bit produced a tightly fitting hole for the implants. The final drill hole was 
flushed with saline to remove any debris. After the hole was drilled, its depth was measured 
so that a pre-prepared implant 2 to 3 mm longer could be selected. The longer length of 
implant was desired to insure that both cortices would be spanned for alignment purposes 
during push-out testing and to allow projection into soft tissue for soft tissue response 
evaluation (Figure 7). 
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Figure 7, Proximal and distal transcortical implants in position in the 
proximal rabbit femur 
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Closure consisted of using 3-0 PDS sutures in a simple interrupted pattern to 
suture the fascia lata to the cranial border of the biceps. The subcutaneous fat and fascia 
were also closed using 3-0 PDS sutures. The skin was apposed using 3-0 nylon 
sutures. 
The health of the rabbit was monitored daily after surgery. A high protein diet 
was administered. The 3-0 nylon sutures were removed after ten days. 
12. Bone Labeling 
Bone labeling in calcified tissue allows improved histological evaluation of the 
growth, regeneration, and repair of bone. Certain chemicals that fluoresce under ultraviolet 
illumination can be administered into the body where they permanently bind to calcium. 
When viewed in tissue sections under appropriate illumination these chemicals 
fluoresce to reveal colored bands where calcium was being deposited at the time of 
administration. These bone labels can have dififerent colors if different fluorochromes 
are used to mark the calcifying front of growing bone surfaces. Different bone labels 
can be very helpful for finding the amoimt of bone growth between dififerent time 
periods. 
Three different fluorochrome labels were used to identify the new bone formation in 
the transcortical implant study. Oxytetracycline hydrochloride was administered 
intramuscularly at a dose of 30 mg/ kg. Alizarin complexone was administered 
subcutaneously at a dose of 30 mg/ kg and xylenol orange was administered subcutaneously 
at a dose of 90 mg/ kg. Oxytetracycline produces a yellow fluorescence band, alizarin 
complexone has a red fluorescence band, while the xylenol orange produces an orange 
fluorescence band. Bone labeling markers were given at one week, three weeks and five 
weeks post implantation. 
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13. Euthanasia 
Euthanasia of the twenty-five rabbits occurred after 18 weeks of implantation. 
The rabbits were euthanized using a 1 mJ/ 5 kg dose of euthanasia solution (Sleep 
Away®, Fort Dodge Laboratories, Inc., Fort Dodge, lA). A section from the kidney, liver, 
spleen, and brain was extracted and placed into 10% buffered formalin for later use if further 
testing is desired. The femur containing the implant was removed from each rabbit and 
immediately placed into sterile saline until prepared for mechanical testing. There were no 
signs of inflammation, gross infection or adverse tissue reaction near the implant sites in any 
of the rabbits. 
14. Mechanical Testing 
a. Introduction The pvish-out test is a common method of quantitative evaluation 
of the strength of the healed interface between bone and an implant. It can be used to 
determine differences between various materials, coatings and surface properties. Excellent 
push-out test results do not ensure similar results under actual loaded conditions. However, 
poor push-out test results gives a good indication that the implant will not perform well under 
higher loaded conditions (Thomas, 1994). 
b. Preparation for mechanical testing After removal of the rabbit femur, the 
attached soft tissue, composed mostly of muscle, was carefully removed from the femur 
using a scalpel. The soft tissue was removed to expose the distal implant for mechanical 
testing. The proximal implant was left covered with soft tissue so its response to the implant 
could be examined histologically. Initially, the distal implant was aligned axially with two 
fixtures that fit around the ends of the implant (Figure 8a). After proper bone placement, 
plaster of Paris (white material on left side of bone in holder) was used for holding the bone 
in this exact position. When the plaster hardened, the top fixture (Figure 8a) was removed so 
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the slightly undersized push-out pin seen in the figure (Figure 8b) could be brought in contact 
with the end of the implant. The lower fixture (Figure 8 and 9) was left in place but the 
central bolt seen in Figure 10c, that was used for alignment, was removed (Figure 9d). Then 
the implant could be pushed through the hole that remained (Figure 9d). The histron test 
machine with a 1 kilo-newton load cell was operated at a constant displacement rate of .2 
mm/ minute. The peak force required to move the implant is considered the push-out force. 
The push-out force is used when calculating the interfacial shear strength. All samples fi-om 
each animal were mechanically tested within 4 hours of death. The femurs were kept moist 
by spraying them with physiologic saline during mounting and testing procedures. 
15. Histologv 
a. Histological preparation After mechanical testing, the rabbit femurs were 
sectioned transversely at midshaft so that the proximal bone containing tested and untested 
implants could be prepared for histological evaluation. The samples were prepared for 
undecalcified histological evalxiation using the procedure presented in Table 6. Dehydration 
of the sample was accomplished using 70% to 100% ethyl alcohol solutions and ended with 
100% acetone. 
Table 6. Dehydration procedures for proximal section of femurs 
Total Days Medium Environment 
11 70 percent ethanol Changed every 48 hours 
4 90 percent ethanol Changed every 48 hours 
2 95 percent ethanol Changed every 24 hours 
6 100 percent ethanol Changed every 48 hours 
6 100 percent acetone Changed every 48 hours 
Figure 8. Rabbit femur and bone alignment equipment; (a) Illustration 
of the bone and the implant aligned in the test fixture 
(b) Illustration of the test fixture aligned for mechanical testing 
Figure 9. Schematic drawing of the push-out equipment: (a) Complete bone holder (b) Top and bottow 
fixture removed from jig (c) Cross section of top and bottom fixture (with cross section of center 
bolt) (d) Cross section of top and bottom fixture with bolt removed 
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After completing this process, each individual specimen was placed into a 
polypropylene container filled with 50 v/o acetone and 50 v/o Spurr embedding plastic using 
a fume hood. Spurr embedding plastic is a low viscosity embedding media mixed for this 
application with the following components. 
*10.0 g vinylcyclohexene dioxide, 
* 6.0 g diglycidyl ether of polypropyleneglycol, 
*26.0 g nonenyl succinic anhydride, and 
* 0.4 g dimethlyamino ethanol (mixed last). 
The container consisting of Spurr plastic, acetone and the specimen was placed into a 
desiccator under 27 torr vacuimi and set onto a shaker table for 24 hours. All specimens were 
inverted 2-3 times during this time period. Finally, the specimen was placed into a I x2x 1 
inch container filled with 100% Spurr plastic and placed into a desiccator under 27 ton-
vacuum for 24 hours. Final polymerization was completed by curing the specimen for 
twenty-four hours in a 70°C oven. 
The excess plastic was trimmed from the specimen before mounting it into a chuck 
that held it m the desired position for sectioning. This chuck was secured to an Isomet low 
speed saw machine (Buehler, model 11-1180). The distal implant used for push-out testing 
was sectioned transversely (Figure 10). The proximal implant used for histological 
purposes was cut transversely until reaching the axial center of the implant (Figure 10). 
Then the remaining portion of this specimen was reoriented in the chuck and longitudinal 
sections were cut (Figure 10). The longimdinal and transverse sections, which were cut in 
the range from 150 to 250 micrometers, were thoroughly cleaned with soap and water, and 
allowed to dry. The sections were stored in complete darkness to prevent fading of the 
fluorescent dyes. 
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Figure 10. Schematic drawing of the transcortical implant sectioning procedure 
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b. Microradiographs Microradiographs of the transcortical implant sections, 
both longitudinal and transverse, were obtained at the University of Iowa College of 
Dentistry using a Torrex (Torr X-ray Corp., Van Nuys, CA) X-ray Inspection System 
with 4489 EM film (Eastman Kodak Co., Rochester, NY). This system operated at 70 Kv, 
2.5 milliamperes, for 22 seconds. The specimens were placed 30 cm from the X-radiation 
source. 
c. Image analysis of bone contact with implants To measure the bone in contact 
with the transcortical implants, images from the microradiographs were analyzed by the Iowa 
State University Image Analysis Facility using a Zeiss image analysis system (Zeiss-
Kontron; IBAS version 2.00). Images were captured from the radiographs using a Sony 3 
CCD color video camera. The internal scaling feature of the software was calibrated to 
measure in millimeters. 
d. Soft tissue staining The soft tissue in contact with the ends of the proximal 
implants was not removed from its surface so the type of tissue in contact with the implant 
could be determined. Gomori's tri-chrome stain was used. This stain will stain connective 
tissue red and muscle tissue blue. 
B. Guide Tube Implants 
1. PmpQs? 
The purpose of the second research project, guide tube implants, was to test the 
hypothesis that bone could be guided by an osteoceramic tube to obtain natural bone repair 
and remodeling imder conditions where such repair and remodeling would not occur if the 
guide tube were not used. If this hypothesis is correct then osteoceramic guide tubes could 
69 
be used in situations where bone grafting would normally be required. Therefore, it was 
necessary to design, implant and evaluate the growth and guiding of bone along this new 
bone-bridging device. Surgical ostectomies were performed to make mid-diaphyseal defects 
measuring approximately 40 mm in length. Cylindrical implants with a unique design were 
used to bridge these bone defects. The implants were made by extruding the osteoceramic 
material before firing. 
2. Evolution of the Guide Tube Concept 
In the osteoceramic bone bridge experiment by Olson (1992), most of the implants 
had an outside diameter similar to that of the ostectomy segments they were replacing. 
However, m one subject, the ostectomy segment was replaced with a much larger outside 
diameter implant. The macroradiographs showed radiolucencies along the distal and 
proximal end of the implant indicating that implant movement was occurring. Even with this 
movement, the microradiographs show a very well organized cancellous and compact bone 
structure cormecting the proximal and distal ends of the femur through the axial canal of the 
implant. The ends of the bone in contact with the implant must have developed toward the 
center of the bone prior to entering the implant and continued imtil they joined together. The 
hollow center region of the implant provided the bone with a pathway to follow so that it 
could reconnect. This reconnection is the main source of transport of blood and nutrients 
between the ends of the bone. This allows bone the chance to maintain its normal 
development in addition to healing the region. Even though the reconnection is only through 
the center of the implant, there is an increase in the strength and stabilization of the region. 
The narrowing of the cortical bone through the axial canal of the bone bridge implant 
demonstrated the wound repair process of bone. This response indicated that instead of using 
an implant that had an outside diameter similar to bone, an implant with a smaller diameter 
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that would fit within the medullary canal of bone, would provide growing bone with a better 
opportunity to bridge an even larger defect. 
The observations fi-om the research described above led to the concept of a different 
type of bone bridging device, called an osteoceramic guide tube. Experiments were 
conducted to test the hypothesis that this osteoceramic guide tube would direct bone to 
complete union and remodeling across an ostectomy that exceeds the natural healing 
potential of bone. According to Key's hypothesis, the long bones of adult dogs are unable to 
span a defect that exceeds 1 times the diameter of the femoral midshaft (Key, 1934). Thus, 
the concept of the guide tube implant was to provide a new way of overcoming this bridging 
limit. The guide tube was not supposed to support the bone but instead use the 
osteoconductive nature of the osteoceramic material and the design of the implant to help 
direct the bone healing and remodeling processes. Encapsulation of the guide tube across the 
ostectomy with natural bone tissue would increase the region's strength in compression, 
tension, and bending while the continuity of bone would bring the bone back to optimal 
health. The stress levels experienced by this newly formed bone would be maintained by the 
remodeling process of bone. 
3. Design and Materials of the Guide Tube Implants 
The osteoceramic guide tubes were designed to fit into the midshaft medullary canal 
of an adult canine's femur. So it was important that the outside diameter of the implant be 
slightly smaller than the endosteal diameter of the bone to help prevent firacture of the 
implant because of a tight fit. The smaller outside diameter of the implant was intended to 
provide a scaffold for the periosteum, cortical bone and endosteum to develop onto, follow 
and cross with relative ease. The space between the outside wall of the tube and the cortical 
bone could also provide the bridging bone with a blood supply and vascularization from the 
medullary canal. The axial hole in the tube could allow the medullary components, such as 
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cancellous bone and vascular systems, to reconnect. The length of the implant had to span 
the ostectomy and insert into the proximal and distal medulla. Since the two ends of the bone 
would be supported by a bone plate and screws, described later in the surgical procedure, 
axial movement of the implant would be restricted by the proximal and distal screws nearest 
midshaft. Here again, the length of the implant was designed to have a loose fit between the 
screws because a tight fit could cause fracture, especially if the sharp threads of the screws 
were rubbing on the implant. 
The implant, as seen in Figure 11, was produced with a hollow cylindrical shape that 
had an inside diameter of 3.4 to 4.2 mm and an outside diameter of 6.0 to 7.7 mm (Table 7). 
The length of the implant ranged from 47.6 to 62.4 mm (Table 7). 
4. Manufacture of the Osteoceramic Guide Tube Implants 
The manufacture of the osteoceramic guide tube implants was accomplished using 
many of the same manufacturing procedures used to make the osteoceramic transcortical 
implants. The osteoceramic material was made with 90.83 w/o osteoceramic powder and 
2.75 w/o methylcellulose binder (Methocel®). The weighed amoimts of ceramic powder 
and binder were placed into a one gallon ball mill jar. Equal volume amoimts of grinding 
media (alumina balls) and powders were added. After placing 700 ml of distilled water 
per 200 gm of ceramic powder and binder into the ball mill jar, the contents were ball milled 
for 24 hours to obtain a uniform mixture. Some of the water was removed by suction using a 
round slab of plaster of Paris that was covered with 325 mesh dacron cloth. The material 
was allowed to dry on the dacron cloth to a uniform water content of 35 to 40 w/o before 
being placed into a sealed container to prevent further dehydration. This material was then 
ready for extrusion. Extrusion consisted of the following procedures: 1) Fill extruder body 
with small pieces of plastic osteoceramic material; 2) Obtain a 27 torr vacuum in the 
chamber; 3) Seal the chamber at this pressure; 4) Use the Instron test machine for 
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Table 7. Canine, guide tube, ostectomy, and lengthening plate information 
Ostectomy Ostectomy 
Outside Inside 
Dog Dog Weight Sex Implant Inside Outside Ostectomy Diameter Diameter Lengthening 
Number Number (lbs) Length Diameter Diameter Length (nun) (nun) Plate 
(L.A.R.) (L) (ID.) (O.D.) (mm) Size 
(mm) (mm) (mm) Cranial-
Caudal 
Cranial-
Caudal 
(mm) 
1 246 60 F 52.6 4.2 7.3 40.0 18.1 11.0 50 
2 256 65 F 52.0 3.7 7.3 40.1 16.3 10.5 50 
3 322 110 M 62.4 3.4 6.7 55.4 25.1 18.7 60 
4a 421 65 F 54.3 3.5 7.0 42.3 17.8 11.1 50 
5 408 65 F 47.6 3.6 6.0 36.8 16.3 9.4 50 
6 406 65 F (control) 36.0 18.2 12.9 50 
7 619 65 M 54.8 3.7 7.7 43.1 18.0 13.1 50 
8 709 70 F 55.6 3.7 7.5 48.1 15.8 9.8 50 
9 924 65 F (control) 47.6 16.7 13.1 50 
10 790 60 M (control) 43.7 15.2 10.0 50 
^ This canine was euthanized at two days post-implantation due to complications. 
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uniform displacement of the ram into the extruder body to extrude the osteoceramic through 
a die; 5) Dry the tubes at room temperature and fire the tubes with a heating rate of 100°C/ 
hour to 1450°C. 
5. Animal Model Selection 
Canines were chosen for the guide tube research. This research project followed 
some of the guidelines of previous research using canines (Key, 1934). According to Key's 
hypothesis, dog bone is imable heal a defect that exceeds a certain size. Therefore, canines 
were chosen to observe the ability of bone to heal an oversized defect with the osteoceramic 
guide tube spanning the gap. Dogs have often been used for ceramic bone implant research 
because they have bone healing and mechanics that are similar to those in himians (Von 
Recum, 1986). Dogs also have a turnover rate of bone that is faster than humans (Table 5). 
6. Animal Sglgction 
Ten mongrel dogs with an average age of approximately two years were used for the 
guide tabe implant study. These dogs consisted of seven females and three males with a 
weight of 62 to 100 pounds. This weight range was chosen to have dogs with large femurs. 
Information on each dog is shown in Table 7. 
7. Surgical Procedure for Implantation of Guide Tube Implants 
Anesthesia was induced by intravenous administration of thiopentothal. The dogs 
were maintained under general anesthesia with halothane. 
The rear right quarter of the dog was clipped and prepped using, altemating four 
times, chlorhexidine scrub and 70% alcohol. A five minute sterile scrub using chlorhexidine 
was performed following the initial prep. The leg was then draped using aseptic technique 
and covered with a sterile stockinette. 
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Exposing the shaft of the femur was accomplished using the same surgical procedure 
as described above for the rabbit. After exposure, an eight hole, 316L stainless steel, 
AO/ASIF lengthening plate was contoured to the lateral side of the femur, placed into proper 
position, used as a giiide to drill a lateral-medial hole in the proximal and distal holes of the 
plate nearest midshaft (to obtain proper alignment), and then set aside. A section of the 
adductor muscles, which insert on the caudal aspect of the femur, was elevated away at mid-
diaphysis. The vastus intermedius was retracted from the cranial surface of the bone at the 
same level. Two transverse osteotomies were made, each approximately twenty millimeters 
from midshaft, using an oscillating saw with a one inch blade. After the cut was made, the 
inside diameter of the medullary canal and length of the ostectomy was measured so that a 
pre-prepared implant with a similar diameter and oversized length could be implanted (Table 
7). For the three control dogs, all of the same surgical procedures were followed along with 
the removal of a similar sized ostectomy. However, a guide tube was not placed across the 
ostectomy. These controls were used to analyze bone growth without an implant. 
After the bone and implant were aligned appropriately with the guide tube inserted 3 
to 5 mm into the proximal and distal canal, four cortical screws (4.5 mm diameter) were 
placed on each side of the implant (Figure 12). Each screw hole was drilled, measured to 
insure both cortices would be spaimed, and tapped. Since a lengthening plate was used, all of 
the screws on each side of the implant were placed in a neutral position in the center of the 
allotted screw hole. After the screws were tightened, the area was irrigated with sterile 
saline. Finally, the intact bone marrow was removed from the ostectomy segments (only for 
the dogs receiving guide tube implants) and placed on the cranial side of the implant possibly 
to help stimulate bone growth. The marrow extended axially along the implant and bone 
plate filling most of the ostectomy's length. Closure consisted of using O monofilament 
polyglyconate sutures to imite the fascia lata to the cranial border of the biceps. The 
subcutaneous tissues and fascia were closed using 2-0 monofilament polyglyconate sutures. 
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Figure 12. Schematic drawing of the femur with tiie guide tube and internal fixation in position 
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The skin was apposed using 2-0 siirgical steel sutures. The implants were radiographed 
immediately post-surgery. 
8. Bone Labels 
One fluorochrome, oxytetracycline hydrochloride, was administered orally to each 
dog at a dose of 250 mg every eight hours for three days on October 18-20, 1995 for Dogs 1-
7 and May 1-3, 1996 for Dogs 8-10. 
9. Macroradiographs 
Macroradiographs were taken directly after implantation and every four to seven 
weeks thereafter. Since the calciimi phosphate tribasic/spinel implants are radiodense, they 
are easily identified with radiographic techniques. The radiographs were taken using 
standard conditions, so the exact angle was not reproduced each time. The clinical 
examination included medial - lateral and cranial - caudal radiographs. 
10. Euthanasia 
The guide tube research is still in progress. Radiographic evaluation of the growth 
and remodeling of bone at the implant site will continue until approximately eighteen months 
post-implantation. At that time the animals will be euthanized using a 1 ml/ 5 kg dose of 
euthanasia solution (Sleep Away®, Fort Dodge Laboratories, Inc., Fort Dodge, lA). After 
removal of the implanted femur, dehydration and sectioning of the defect region will be 
completed. Microradiography and histo-pathology will be performed on the cut sections to 
evaluate the type of tissue that healed across the defect and the amount of bone-implant 
contact. 
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CHAPTER IV. RESULTS AND DISCUSSION 
The results will be discussed in two parts, first the results from the transcortical 
implant experiments and then the results from the guide tube implant experiments. 
A. Transcortical Implant Results 
1. Introduction 
The results from the transcortical implants placed into the femurs of twenty-five 
rabbits will be discussed as follows: material analysis of the transcortical implants, including 
scanning electron microscopy, energy dispersive spectrometry, surface roughness, and 
porosity and density measurements; mechanical push-out test results (distal implants only); 
microradiograph evaluation of bone-implant contact areas after push-out testing; and image 
analysis of bone contact with proximal implants. 
a. Scanning electron microscopv Figures 13-17 show the surface structures of the 
different transcortical implant materials viewed at 250x magnification. The centerless 
groxmd surfaces of the osteoceramic (OCM) fired in air (Figure 13) and hydrogen (Figure 14) 
have similar surface stmctures. The images show some higher (light) and lower (dark) areas. 
The higher areas seem to have been smeared or smoothened by the centerless grinding 
process. The lower areas look as if they were roughened by the grinding wheels tearing the 
ceramic particles from the surface. The average surface roughness values for these materials 
show they have very smooth surfaces (Table 8). 
Figure 13. Scanning micrograph of the osteoceramic fired in air (250x) 
Figure 14. Scanning micrograpii of the osteoceramic fired in hydrogen (250x) 
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Table 8. Surface roughness measurement results for the five different implant materials 
Implant Material Surface Preparation Surface Roughness 
V. (n)'' 
Osteoceramic (air) Centerless ground w/coolant 0.50 ± 0.23 um, (n = 20) 
Osteoceramic (H) Centerless ground w/coolant 0.67 ± 0.30 um, (n = 23) 
Steel/ Osteoceramic (H) Centerless ground w/coolant 3.76 ± 3.31 um, (n = 23) 
Steel (H) Centerless ground w/coolant 0.46 ± 0.21 um, (n = 20) 
Polyethylene/ Osteoceramic (air) Centerless ground w/coolant 2.99 ± 1.72 um, (n = 22) 
^ Mean ± standard deviation 
^ n = number of .5 mm lengths used for evaluation, see Appendix 2 for individual results 
The steel (lighter regions) with large osteoceramic aggregates (dark gray regions) was 
centerless ground to expose the ceramic surface (Figure 15). The composite nature of the 
steel/ OCM implant made a rougher surface due in part to the small voids (black regions) 
between the steel and ceramic. The ceramic portion of this material has a similar structure as 
described above, both smooth and tom, with the addition of crystal like structures. Within 
the ceramic there are areas of smeared and round particles of steel (light spots within gray 
regions). This figure shows that very good bonding occurred between the two materials. The 
grinding process produced circumferential grooves in the steel portion of the implant. This 
composite material had the highest average surface roughness values (Table 8). 
The steel implants show similar circumferential grooves along the surface 
of the implant as seen in the steel/ OCM implant (Figure 16). This view shows holes or 
pores in the surface with smearing of the steel in some areas. The average surface roughness 
of the steel is similar to the values found for the osteoceramic (air and H) (Table 8). 
The polyethylene/ OCM (Figure 17) shows the ceramic surface (light region) is 
Figure 15. Scanning micrograph of the stainless steel (white) with large aggregates of osteoceramic (dark gray) 
fired in hydrogen (250x) 
Figure 16. Scanning micrograph of the stainless steel fired in hydrogen (250x) 
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Figure 17. Scanning micrograph of the polyethylene (gray) with large aggregates of osteoceramic (white) (250x) 
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very similar to the ceramic surface seen previously. The polyethylene (dark region) has a 
feathered or torn surface caused by the grinding process. The OCM and plastic are very 
tightly bonded together. This material combination produced a rougher surface as seen 
in Table 8. 
b. Energy dispersive spectrometrv Energy dispersive spectrometry (EDS) 
revealed the surface elemental distribution for the transcortical implants. Figures 18 
and 19 show the expected elements for the osteoceramics, a combination of tricalcium 
phosphate (Ca, P and O) and magnesium aluminate spinel (Mg, A1 and O). These figures 
show that the same elements are found in both osteoceramic types with only a minor 
indication of carbon contamination in the OCM (H). Although the peak is small, carbon 
is difficult to detect using EDS. The detection of the carbon peak is consistent with oil 
or furnace contamination. There aren't any signs of contamination firom Fe, Si, S, or CI 
(Figure 19). 
The stainless steel/ OCM spectrum (Figure 20) shows the stainless steel elements in 
addition to the osteoceramic elements seen in the previous spectrums. The steel spectrum 
(Figure 21) shows the same elements as seen for the steel in the steel/ OCM. Table 9 is a 
listing of the percentages of each element according to the inspection certificate fi-om the 
supplier of the stainless steel. 
The polyethylene/ OCM spectrum (Figure 22) shows the elements for the 
polyethylene in addition to the osteoceramic. The main elements for the polyethylene are (C, 
Si, and O) with trace amounts of CI, Ca, and Ti possible. 
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Figure 18. EDS spectrum of the osteoceramic fired in air 
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Figure 22. EDS spectrum of the polyethylene with large aggregates of osteoceramic 
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Table 9. The percentage of each element found in Anval® (Rutherford, New Jersey) 
316L stainless steel 
Elements in Stainless Steel 316L Percentage of Each Element (%) 
Carbon (C) 0.040 
Silicon (Si) 0.69 
Manganese (Mn) 0.57 
Chromium (Cr) 16.08 
Nickel (Ni) 4.11 
Phosphorus (?) 0.020 
SulfiiT (S) 0.001 
Molybdenum (Mo) 0.10 
Niobiirai (Nb) and Tantalum (Ta) 0.21 
Copper (Cu) 3.05 
Iron (Fe) Balance 
c. Surface roughness For the surface roughness study, two implants from each of 
the five different transcortical implant types were evaluated. Each implant was examined at 
ten different areas with each location tested measuring 0.5 mm. Table 8 gives the average 
surface roughness results from each material. Appendix 2 contains the complete set of values 
used to find these average roughnesses. The surface roughness measurements show that the 
stainless steel/ OCM and polyethylene/ OCM had higher roughnesses than the other 
materials. The roughness difference was not statistically significant for the steel/ OCM 
implants compared to the other implants. 
d. Porositv and densitv measurements The density and porosity values were 
obtained for the transcortical implant materials using two different methods. For the first 
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method, external volume was found for the five different materials by measuring the diameter 
and length with a precision micrometer. Then the bulk density values, as seen m Table 10, 
were found using the standard equation of mass divided by the exterior volimie. Total 
porosity values, also listed in Table 10, were determined from the difference between the true 
density of the material and its bulk density. 
Table 10. Bulk density and total porosity results for the transcortical implants fired 
to 1330°C 
Material Bulk Density 
(g/ cm3)a, (n)b 
True Density 
(g/ cm^)/ Source 
Total Porosity 
(%) 
OCM (air) 2.63 (n=3) 3.37/Graves, 1988 22.0 
OCM(H) 2.15 (n=3) 3.37/Graves, 1988 36.0 
Stainless Steel/ OCM 4.50 (n=3) 5.91C 23.9 
7.93/ Parks and Lakes, 
Stainless Steel 6.72 (n=3) 1992 15.3 
Polyethylene/ OCM 1.34 (n=2) 1.32C 0 
^ Mean value for (n) number of implants 
b Number of implant's measured, individual results are listed in Appendix 3 
c Calculated from 1/ p = (1/ Poc) Wqc + (1/ Px) 
For the second method of measuring density and porosity, the individxial biilk density 
and open porosity values were obtained by the Archimedes method for the osteoceramic (air 
and H) transcortical implants (Table 11). The open porosity and bulk density values were 
found using the equations described in the materials and methods. The other implant 
materials were not tested using Archimedes principle. Additional testing was not completed 
on these implants to reduce the chance of contamination if future in-vivo testing of the 
implants was desired. The osteoceramic's porosity and density were tested a second time to 
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Table 11. Porosity and density results for osteoceramic (air and H) using Archimedes's 
principle 
Material Open Porosity (%)^ Bulk Density (g/ cm3)^ 
(n=3)b (•>=3)1> 
Osteoceramic (air) 25.16 ±.34 2.42 ± .03 
Osteoceramic (H) 33.52 ± .57 2.08 ± .04 
^ Mean ± standard deviation 
^ Number of implants used for evaluation, see Appendix 4 for individual values used to 
determine these results 
more accurately determine if coolant could have been absorbed into their bulk during the 
centerless grinding process. 
As seen in Tables 10 and 11, the high open porosity values for the osteoceramic 
materials (air and H) are a serious defect, rendering them imsuitable for implant applications 
due to loss of strength and absorption. Open pores, unlike closed pores, have the ability to 
absorb contanMnants from the surrounding environment. The absorption of the coolant and 
its later release during implantation would have prevented the bone from adhering to the 
osteoceramic surface. These specimens should have been made from 100% unfired 
osteoceramic materieil fired at MSO'C. Previous testing of the 100% unfired osteoceramic 
fired at 1450°C found that its open pore volume was .3% with a bulk density of 3.09g/ cm^ 
(Graves, 1988). 
The total porosity of 23.9% for the steel/ OCM and 15.3% for the steel implants was 
very high for metal implants made using powder processing. The possibility for porosity was 
more likely for the composite material because of trapped pores at the material boundaries. 
However, the high porosity and low density for the steel material are not typical for stainless 
steel materials, indicating a problem with the manufacturing process. For this application. 
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the reduction in strength due to the porosity was not a major concern since the implant was 
not placed in a highly loaded situation. Also, the majority of the steel's porosity was 
probably closed pores because during manufacturing the deformation of steel's individual 
particles tend to encapsulate and seal pores on the surface. Thus, absorption of the coolant 
did not occur during centerless grinding. Therefore, the high porosity values were not 
considered a major concern for affecting the biocompatibility of these implants. 
3. Mechanical Push-Out Test Results (Distal Implants Onlv) 
The results from the distal transcortical implants mechanically push-out tested 
after 18 weeks of implantation in the rabbit femur are presented in Table 12. Appendix 5 has 
a listing of the individual values related to the mechanical testing and the individual XY line 
chart data collected from the Instron test machine. The location of the position values given 
in Appendix 5, upper left (u.l,), lower left (1.1.), upper right (u.r.) and lower right (l.r.), are 
shown in Figure 23. The left side refers to the medial cortex of the femur and the right side 
refers to its lateral cortex. These position values were measured using the equipment at the 
image analysis facility. Appendix 5 has a listing of the peak push-out force required to move 
the implants. These values were used in the equation to calculate the shear strength values. 
Shear strength of the bone/ implant interface was found using the following formula: 
Equation 4. S = F/ 7ixdxt 
where S is the interface shear strength (MPa), F is the peak push-out force (N), d is the plug 
diameter (mm), and t is the average cortical bone thickness (mm) in contact with the implant 
for both cortices. For this experiment, the implant diameter was 3.2 mm and t was called the 
total average contact length (Appendix 5). 
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Table 12. Bone-implant interface shear strength data after 18 weeks implantation 
Material Shear Strength (MPa)^, (n)'' 
Osteoceramic (air) 1.11 ±0.57 (n=5) 
Osteoceramic (H) 0.35 ±0.11 (n=3) 
Steel/ Osteoceramic 1.58 ±0.67 (n=5) 
Steel 1.60 ±0.66 (n=5) 
Polyethylene/ Osteoceramic 0.22 ±0.14 (n=5) 
^ Mean ± standard deviation 
^ n = number of implants used for evaluation, see Appendix 5 for individual results 
In examining the shear strength data, it must be noted that for the OCM (H), only 
three implants were mechanically tested. Thus statistical comparisons must be made with 
caution. The lower number of specimens tested was the result of bone fracture at the implant 
site resulting in a large, mostly non-mineralized callus formation around the ends of the 
implant. This prevented the alignment of the implant for push-out testing. It was not related 
to a problem with the material. 
The interface shear strength values did not show a significant trend with the elastic 
modulus of the implant. The implants with a higher modulus than bone, such as OCM 
(air and H), steel and steel/ OCM implants, should have had higher interfacial shear stress 
weakening the implant-bone interface. This would lead to lower push-out strengths. 
However, since this was not the result for these implants, other factors such as tissue 
compatibility or surface roughness could have had a larger influence on the push-out strength 
than the elastic modulus mismatch. The push-out strength should have been higher for the 
implants with elastic moduli more closely matching the modulus of bone, such as the 
polyethylene/ OCM implants, because of their lower stress concentrations at the interface. 
However, even with the matching elastic modulus, the polyethylene/ OCM had the lowest 
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mean shear strength values. Here again, this was probably attributable to the 
biocompatibility of these implants and the modulus did not dominate the shear strength 
values. 
The results showed higher interfacial shear strength for the stainless steel and steel/ 
OCM than for the osteoceramics (air and H) and polyethylene/ OCM (Table 12). The 
difference was not statistically significant for the OCM fired in air, but the difference was 
significant for the OCM fired in hydrogen and the polyethylene/ OCM (Appendix 5). The 
lower overall shear strength value for the osteoceramics is not typical of previous research 
results using bioactive ceramic materials and metals (Hayashi et al., 1993a and Li, 1993). 
Since bioactive ceramic materials have the ability to form a chemically bonded interface 
between the implant and bone, these ceramic materials were expected to have much higher 
push-out strengths than inert materials like steels or plastics. It is difficult to make 
comparisons with previous shear strength results because different animals, implant materials 
and methods of push-out testing were used. However, the stainless steel push-out results are 
typically much lower than calcium phosphate based ceramics (Hayashi et al., 1993a). 
Although this osteoceramic material hasn't been mechanically tested before, other calcium 
phosphate materials like hydroxyapatite and tricalcium phosphate have consistently 
demonstrated excellent shear strength results. 
The high shear strength value of the steel/ OCM combination verses the 
osteoceramics could have been caused by its higher surface roughness values (Table 8). This 
may have given bone the chance for increased surface ingrowth and surface area to contact. 
However, this reasoning doesn't hold true for the stainless steel implants, since they had 
higher shear strength values than the osteoceramic materials even with similar surface 
roughness values (Table 8). This indicates that there was some type of problem with the 
biocompatibility of the osteoceramics. The typical response of osseous tissue to steel is to 
form a soft tissue interface. Thus, the roughness is of little attachment value if there is a thick 
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layer of soft tissue in the interface. There was the opportunity for the bone to bond with the 
ceramic along the surface of the steel/ OCM implant but when compared with the shear 
strength results of the steel implants, the osteoceramic didn't increase or decrease the bonding 
strength. Overall, the high push-out strength of the stainless steel and steel/ OCM does not 
seem to be attributed to its surface roughness or addition of osteoceramic aggregate. 
There are many processing factors that may have caused the low shear strength values 
of the osteoceramic implants. Both of the osteoceramic materials were mixed with 30 w/o 
1450°C pre&ed OCM (grog) and 70 w/o unfired OCM (virgin) and &ed to a final 
temperature of 1330°C. One group of implants was fired in an air atmosphere and the other 
group were fired in a hydrogen atmosphere because in a composite material with stainless 
steel the hydrogen atmosphere would be required to prevent oxidation of the steel. However, 
firing the OCM in a hydrogen atmosphere could cause reduction of the phosphorus and 
change the surface properties of the material. Unlike the white color of the osteoceramic 
fired in air, the osteoceramic material fired in hydrogen had a dark gray color that continued 
throughout its bulk. From the results of the push-out strengths in Table 12, the mean values 
for the OCM (H) mdicate that the hydrogen atmosphere affected the surface's 
biocompatibility with bone. The osteoceramic was fired to 1330°C instead of 1450°C 
because in a composite situation with stainless steel, 1330°C would be the maximum 
allowable temperature for the metal. The lower firing temperature along with the addition of 
the 30 w/o grog powder caused the large open pore volume of the OCMs seen in Tables 10 
and 11. Since the grog OCM previously went through the shrinkage process but the virgin 
OCM had not, combining them caused different shrinkage rates during the final sintering 
process. Therefore, firing this combination could cause the faster shrinking particles to break 
away from the slower shrinking prefired particles, creating a very porous material. 
Also, firing this material at 1330°C instead of 1450°C would not allow the material to 
complete its shrinkage process and thus, increase the material's porosity and reduce 
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its mechanical integrity. This material is not representative of the strong, dense osteoceramic 
previously used. For previous implant purposes, the osteoceramic material was fired to 
1450°C using 100% uniired material to assure high density and low porosity of the final 
product. 
The processing of the steel/ OCM included adding large aggregates of osteoceramic 
grog for exposure on the surface of the implant. These implants may have had a lower 
adverse tissue reaction and higher shear strength than the OCM implants (air and H) 
because the OCM that was mixed with the steel was composed mainly of prefired material 
(1450°C). This high density material woiild not have been porous material with the ability to 
absorb coolant during grinding. Therefore, it is possible that bone did not have a coolant 
boimdary to overcome with this material as it did with the osteoceramic materials. The steel 
portion of this implant consisted of closed pores so it would not have been able to absorb the 
coolant. 
After making the transcortical implants, they were centerless ground with coolant to 
obtain the desired 3.2 mm outside diameter. This centerless grinding could have introduced 
some of the following undesirable materials into the surface or bulk of the implants: 
detergents or salts firom the coolant, abrasive materials firom the grinding media, or metals 
such as nitinol or stainless steel fi:om previous grinding runs. Although the final product was 
ultrasonically cleaned, there is a very good chance that the coolant was absorbed deep within 
the implants with porous surfaces. The imwanted materials or coolant from the grinding 
process would not be removed by the cleaning process or autoclave sterilization. This could 
have led to the lower push-out results for the osteoceramic implants due to the slow leaching 
of the coolant from the surface of the implant in contact with the bone. The bone would have 
walled off the implant as a foreign body due to the presence of the coolant instead of forming 
a direct bond with the surface. 
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4. Micrnradiograph Evaluation of Bone-Implant Contact After Push-Out Testing 
The microradiographs of sections showing the distal implants after the push-out 
testing are shown in Figiires 23-27. Figures 23 and 24 show the bone's response to the 
osteoceramic materials. Instead of the mineralized bone spreading along the surface in close 
contact with the implant, as seen for the materials in Figures 25-27, the bone seems to be 
pulling away from or avoiding the material. This is demonstrated with the rounding of the 
bone at the comers in contact with the surface. There are many implant-bone interface areas 
where bone does not seem to be growing along or adhering to the surface of the implants. 
The radiologist at ISU veterinary teaching hospital thought there was a strong indication of 
some type of adverse tissue reaction occurring at the surface of the osteoceramic implants 
(Riedesel, 1996). In previous research, the typical bone response to the osteoceramic 
material has shown the bone to be very conductive to the siuface properties, growing along 
its surface with very intimate contact. 
Figure 25 and 26 show the general type of bone response seen in many of the 
microradiographs of the stainless steel/ OCM and stainless steel implants. Note that in some 
of the specimens, the steel did smear or spread into the bone to various degrees during 
sectioning so analysis of the microradiographs and surface attachment values should be made 
with caution. Bone shows a different type of response to these implant materials compared to 
the osteoceramics. Bone has spread out along the surface more, indicating a higher 
affinity for bone growth, which could explain the high shear strength results of these 
materials. The tissue contact area for the steel/ OCM and steel were more extensive than the 
contact area for the osteoceramics as seen in Appendix 5. These radiographs and the tissue 
contact values for these materials indicate that the different surface roughnesses did not 
affect the response of bone to the material. As seen previously, the addition of the 
osteoceramic aggregates to the steel composite did not increase the bone tissue response 
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Figure 23. Transverse microradiograph 
of the distal osteoceramic (air) 
implant in rabbit 4 after 18 
weeks of implantation 
Figure 24. Transverse microradiograph 
of the distal osteoceramic (H) 
implant in rabbit 9 after 18 
weeks of implantation 
Figure 25. Transverse microradiograph 
of the steel/ osteoceramic 
implant in rabbit 12-34 after 
18 weeks of implantation 
Figure 26. Transverse microradiograph 
of the distal stainless steel 
implant in rabbit 20-224 after 
18 weeks of implantation 
Figure 27. Transverse microradiograph 
of the polyethylene/ osteoceramic 
implant in rabbit 24-95 after 18 
weeks of implantation. 
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either. This is atypical to have more bone contact with steel materials than calcium 
phosphate based materials. 
Figure 27 shows the general type of response that bone had with the polyethylene 
(black region) and OCM (white region) composite material. Bone grew along the surface 
of the material but in many of the microradiographs the direct contact is low. There is a 
thin but well-defined region of soft tissue between the bone and implant in many of the 
specimens. This is the type of response that is typically observed with polyethylene 
materials placed in bone. The addition of the osteoceramic to the polyethylene was 
intended to provide bone with the chance to bond to the implant. However, in many 
of the radiographs, it seems that fibrous tissue encapsulated the implant separating the 
bone from the polyethylene and the osteoceramic. The cortical bone increased its wall 
thickness in many of the specimens. It is possible that the polyethylene was either 
walled off as a foreign body or did not provide the proper support like the other 
materials offered so the bone accommodated by thickening its cortex. Increased 
mineralization and thickening of the cortical bone helped strengthen the region. Overall, 
this composite material had the least amount of osseous tissue contact. The osteoceramic 
aggregates that were intended to provide attachment benefits did not do so in these 
specimens. 
5. Image Analvsis of Bone Contact with Proximal Implants 
There were two implants placed into the rabbit femur. The distal implant, described 
previously, was used for the mechanical push-out test. Histology was not possible after this 
testing procedure since the implant-bone interface was disturbed. Therefore, the proximal 
implant was used to evaluate histological features. 
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After microradiographs were taken of the proximal transcortical implants, 
measurement of the bone contact with their surface was done using the image analysis 
facility. Table 13 has the overall results derived from the individual set of results found in 
Appendix 6. The position designations seen in Appendix 6, upper left (u.l.), lower left (1.1.), 
upper right (u.r.) and lower right (l.r.), are explained in Figure 23. The left side refers to the 
medial cortex of the bone and the right side refers to its lateral cortex. 
Table 13. Bone-implant contact length results for the proximal implant 
Implant Material Total Average Contact Length (mm)^, (n)'' 
Osteoceramic (air) 4.58 ± 0.53, (n=5) 
Osteoceramic (H) 4.24 ± 1.73, (n=5) 
Steel/ Osteoceramic 6.77 ± 2.45, (n=5) 
Steel 5.71 ± 2.06, (n=4) 
Polyethylene/ Osteoceramic 4.22 ± 1.34, (n=5) 
^ Mean ± standard deviation, 
^ n = nxraiber of implants used for evaluation, see Appendix 6 for individual results 
The contact length results show that the materials with the greatest affinity with 
bone are the steel and steel/ OCM composite. It should be noted that there were only four 
steel specimens measured instead of five specimens for the other materials. The mean 
values of contact length for OCM (air and H) and the polyethylene/ OCM are considerably 
lower. Statistically there isn't a significant difference between the contact lengths of 
the implants (Appendix 6). Here again, some of the same reasons used to explain the low 
shear strength values and siuface attachment of the distal osteoceramic implants could be 
used to explain the low bone contact results of the proximal osteoceramic implants. 
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Reasons included processing considerations such as firing temperature and atmosphere, 
surface roughness, porosity and density, and coolant contamination. There is a consistent 
pattern of results showing the steel and steel/ OCM, both the proximal and distal implants, 
having a better osseoiis tissue response than the osteoceramics. This is inconsistent with 
previous results (Hayashi et al., 1993a and Li, 1993). 
6. Soft Tissue Response to the Proximal Transcortical Implants 
The soft tissue in contact with the five different proximal implant materials was 
evaluated with Gomori's tri-chrome stain. Two sectioned implants were evaluated from each 
material type. The soft tissue in close contact with the implant materials was connective 
tissue. Connective tissue is the normal tissue response with the implant. There were some 
areas of tissue that did not stain next to the surface of some of the implants but there weren't 
indications of inflammation or adverse tissue reaction at the surface of any implants. 
7. Non-Implanted Osteoceramic Transcortical Implants Refired at 1450°C to Compare 
Six extra osteoceramic (fired in air at 1330°C) and five extra osteoceramic (fired in H 
at 1330°C) transcortical implants, made at the same time as the previously implanted 
transcortical implants using the same manufacturing procedures, were fired again to 1450°C 
in an air atmosphere. These implants, called osteoceramic (air-air) and osteoceramic (H-air), 
were refired to determine changes from the previous firing in hydrogen, firing to a final 
temperature of 1330°C, and centerless grinding. Also, firing to 1450°C would remove any 
coolant contamination that remained from the previous centerless grinding procedure. Their 
bulk density values were found by dividing their mass by their exterior volume. Then the 
total porosity values were determined from the difference between the true density of the 
material and its bulk density. After refiring the implants, their surface roughness was 
measured. These implants were not centerless ground so they were expected to have 
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different surface properties. The surface roughness was found using the same profilometer 
and techniques used for the other implants. 
The scamiing electron micrographs for the osteoceramics refired to 1450°C show a 
different surface than seen for the osteoceramics fired to 1330°C. The as-&ed surface of the 
osteoceramic (air-air) has a rougher looking surface with projecting crystal like structures 
(Figure 28). The as-fired osteoceramic (H-air) had more of a roimded, smooth surface with 
black holes that were probably open pores (Figure 29). The EDS spectra do not show any 
signs of contamination (Figures 30 and 31). 
The total porosity and bulk density measurements show that the osteoceramics have 
considerably lower porosity and higher density after firing to 1450°C (Table 14). The 
osteoceramic (H-air) had much higher porosity and lower density than the osteoceramic (air-
air). This indicates that the structure of the osteoceramic material (H-air) was previously 
affected permanently because of firing in a hydrogen atmosphere. 
Since these implants were not centerless ground before surface roughness testing, 
they had a rougher surface (Table 15). The surface roughness testing shows that the 
roughness for the as-fired surface of the osteoceramics (air-air) and (H-air) was higher than 
the centerless ground surface of the osteoceramic (air) and (H). 
Table 14. Bulk density and total porosity residts for the osteoceramic implants fired to 
1450°C 
Material Bulk Density True Density Total Porosity 
(g/ cm3)a (n)b (g/ cm^)/ source (%) 
OCM (air-air) 3.19, (n=6) 3.37/ Graves, 1988 5.3 
OCM (H-air) 2.39, (n=5) 3.37/Graves, 1988 29.0 
^ Mean value for (n) number of implants 
^ Nimiber of implants measured, individual results are listed in Appendix 7 
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Figure 28. Scanning micrograph of the osteoceramic (air-air) fired to 1450°C (lOOOx) 
Figure 29. Scanning micrograph of the osteoceramic (H-air) fired to 1450 °C (lOOOx) 
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Figure 30. EDS spectrum of the osteoceramic (air-air) fired to HSCC 
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EDS spectrum of the osteoceramic (H-air) fired to 1450°C 
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Table 15. Surface roughness of osteoceramic implants re&ed to 1450®C 
Material Surface Preparation Surface Roughness 
Osteoceramic (air-air) as fired 2.31 ± .44 um (n = 19)^ 
Osteoceramic (H-air) as fired 1.78 ±.11 um(n = 20)b 
^ Mean ± standard deviation 
^ n = number of .5 mm lengths used for evaluation, see Appendix 8 for individual results 
These osteoceramics (air-air) and (H-air) were implanted in the proximal femur of six 
rabbits between 3-22-1996 and 4-3-1996. All of the same surgical procedures and 
positioning of the implants were used for this study. Since possible coolant contamination of 
the osteoceramic implants used in the previous study may have occurred, the testing of non-
contaminated implants was very desirable. The implant-bone shear strength will be 
mechanically tested and contact areas will be measured after 18 weeks of implantation. 
B. Guide Tube Implant Results 
1. Introduction 
The second research project, guide tube implants, examined the results from the seven 
canines receiving guide tubes placed into surgically created defects and the results from the 
three canines used as controls. The results will be discussed as follows: implantation of the 
guide tube and recovery observations, macroradiograph evaluation, and overall evaluation of 
the canines' reactions to the guide tube implant. 
2. Implantation of the Guide Tube and Recoverv Observations 
The surgical procedure used for all of the dogs was performed without complications. 
The size of the ostectomy segment removed from each femur was determined by measuring 
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the diameter of the femur at midshaft (cranial-caudal). The length of segment removed was 
at least one and a half times the diameter of the femur's midshaft so the healing ability of 
bone would be exceeded in accordance with Key's hypothesis (Key, 1934). Most of the time 
the segment removed was more than two times the diameter of the midshaft as seen 
previously in Table?. After removal of the bone section, the guide tube with the appropriate 
length and diameter was matched with the space available within the medulla of the bone. 
Alignment of the implant and internal fixation was difficult because the implant had to fit 
within the medullary canal and have a loose fit between the screws. However, successful 
alignment was achieved for each dog. Even though the guide tube fit loosely between the 
screws and between the cortical walls of the femur, it was unable to move from the defect 
area. The first radiograph of each dog also shows the guide tube, lengthening plate, and ends 
of the femur in theu: appropriate positions with proper alignment. 
All of the dogs recovered from the surgery without complications except for dog 4. 
This dog was a greyhound that may have been exposed to some type of drugs or chemicals 
during racing that interfered with its blood clotting flmctions. Therefore, this dog had to be 
euthanized after two days of implantation because of these complications. Otherwise, the 
dogs recovered quickly and were partially weight bearing within a week. Full weight-bearing 
and normal use of the limb usually occurred at three to four weeks post-implantation. 
3. Macroradiograph Evaluation 
Macroradiographs were taken while the guide tube was in the femur of the dog to 
evaluate the internal fixation, the reaction of bone to the osteoceramic material, and the 
effectiveness of the implant design at directing bone to imion. Macroradiographs were also 
taken of the femur of each of the control dogs to evaluate the internal fixation and the 
reaction of bone to the non-implant situation. All of the radiographic exposures were made 
under standard conditions so comparisons could be made between each radiograph. The 
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cranial-caudal views will be shown more frequently than the medial-lateral views because the 
bone plate does not obstruct the view of the bone. Some of the medial-lateral views showing 
bone activity are included. 
a. Macroradiographs of dog 1 The first radiograph taken immediately after 
implantation of the guide tube in dog 1 occurred on 4-18-1995. Figxire 32 shows the guide 
tube spanning the ostectomy with the ends of the implant held within the proximal and distal 
medullary canal. The guide tube is shown in the proper position with the placement of the 
lengthening plate and screws on the lateral side of the femur. The lengthening plate and 
screws are providing the support between the remaining distal and proximal ends of the 
femur. This plate was very strong due to its very thick and wide construction along with the 
solid mid-section between the inside screw holes. The screws will be numbered to make it 
easier to identify specific areas of the femur and internal fixation. Starting with the proximal 
screw, the screws will be nimibered 1 through 8 with the distal screw being number 8. As 
expected, a radio lucent region or lack of bone content is evident between the osteotomies in 
the initial radiographs of each dog. The implant is held in place by the cortical bone that 
surrounds each end of the implant. This implant, similar to all of the guide tubes implanted, 
has a loose fit axially between the screws and also has a loose fit within the walls of the 
cortical bone. It should be noted that the marrow in the region of the ostectomy was removed 
from each of the dogs receiving guide tube implants. This marrow was placed on the cranial 
side of the implant along the bone plate and implant. The marrow was not added to the 
defect region of the control dogs. 
After five weeks of implantation (5-24-1995), woven bone with a moderate amoimt of 
mineralized tissue spanned the length of the ostectomy. This tissue fills most of the 
radiolucencies along the implant's medial side (Figxire 33). The periosteum of the femur's 
proximal section has widened the bone next to the implant. This new bone together with the 
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endosteum and cortical bone next to the implant has extended distally across the guide tube. 
The distal section of the femur also has widened surrounding the end of the implant. This 
new periosteal bone and the bone next to the implant are growing proximally across the tube 
and have coimected with the new distal tissue. Within the new tissue there are lucent lines 
and open regions. These lucencies could be fibrous tissue, vessels or any other type of non-
mineralized tissue. The lucent tissue is more than likely precursor cells that will eventually 
turn into mineralized woven bone. Bone has quickly reconnected on the medial side of the 
implant. The medial and lateral cortexes normally react very fast during repair while the 
medullary region is active but normally more stable. One reason for this type of growth is 
that the bone is trying to balance the loading on the unsupported side. 
After eleven weeks of implantation (7-13-1995), there is a very large amount of 
mineralized bone spanning the ostectomy (Figiire 34). The thickness of the proximal end of 
the femur has increased over the outside of screw 4 with the bone starting near the end of 
screw 2 (periosteal activity). The original haversian bone of the medial cortex is still well 
defined. The mineralized tissue on the medial side of the implant is very thick with regions 
of large trabeculae next to the implant. Bone has not directly attached to all of the implant's 
surface since there are some small lines of lucencies at the bone-implant interface The axial 
hole in the tube, near the distal end of the implant, is possibly filling with bone since its 
density (opacity) is increasing. The new bone density is increasing (radiographically 
becoming more opaque) indicating that bone is remodeling within the defect. The lateral side 
of the implant also shows some signs of bone growth possibly from bone growing along the 
cranial and caudal side of the implant. The distal section of the femur shows a very large 
increase in the medial wall thickness near screws 5 through 7 indicating that there may have 
been micromotion or stress placed on the plate and screws in this area. The medial bone in 
the area of screw 5 is remodelling and changing to more of an even layer of cortical bone. It 
is hard to see the original cortical bone because this area is becoming very well organized 
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with new bone, probably haversian system type bone (lamellar bone). Thus, the bone growth 
across the ostectomy together with the guide tube, supported by bone growth at its ends, is 
supporting the loads so less support is reqiiired by the internal fixation. Bone is 
strengthening the region to support the loading. 
The medial-lateral view taken at this same time period (7-13-1995) shows the large 
diffiision of cells on the caudal side of the implant (Figure 35). Some of this activity was 
created by the periosteum. 
At five and a half months post-implantation (10-5-1995), there is a dense medial 
cortex along the entire length of the femur (Figure 36). This bone has increased in density 
and has become more defined. There are still some linear lucencies along the bone-implant 
interface but more bone is in direct contact with the implant. The medial bone just distal to 
screw 4 shows the original lamellar cortex is not as dominant because remodeling is 
occurring and more medial lamellar bone is being laid down. There are some dense lines on 
the medial side of the implant that could be stress lines caused by loading. 
At seven months post-implantation (11-16-1995), there is a well-defined medial 
cortex and medulla developed (Figure 37). The implant and bone are very closely bonded 
together on the medial and lateral side. Lateral bone has filled the region between the 
implant and plate. 
At nine months post-implantation (1-25-1996), the medial cortex is very well 
developed with excellent bone density (Figure 38). The increased density indicates that bone 
is still remodelling. The thickness and mineralization of this bone are providing the femur 
with very high strength to support loading. There are still regions of large linear trabeculae 
on either side of the guide tube indicating that the bone plate and screws, medial cortex, and 
possibly the guide tube are supporting the region so well that increased remodeling is not 
important or necessary. Therefore, the cortex and medullary canal are becoming well 
organized and defined. Distally in the region of screws 5 and 7 there is more dense bone 
Figure 32. Cranial-caudal macroradiograph of dog 1, post-implantation 
(4-18-1995) 
Figure 33. Cranial-caudal macroradiograph of dog 1, five weeks post-
implantation (5-24-1996) 
Figure 34. Cranial-caudal macroradiograph of dog 1, eleven weeks post-
implantation (7-13-1995) 
Figure 35. Medial-lateral macroradiograph of dog 1, eleven weeks post-
implantation (7-13-1995) 
Figure 36. Cranial-caudal macroradiograph of dog I, five and a half 
months post-implantation (10-5-1995) 
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indicating that this region is being stressed and haversian bone is rebuilding to strengthen the 
area. 
After eleven months of implantation (3-13-1996) (Figure 39), bone does not show any 
significant remodeling changes since the radiographs of Figure 38. Additional mineralization 
These will be removed before the final copy of the midshaft of the femur will probably not 
occur because bone has appropriately strengthened the region for the loading. Additional 
healing would require the removal of the internal fixation. The radiographs strongly suggest 
that the plate and screws could be removed firom the femur of this dog without complications. 
The medial-lateral view taken at this same time (3-13-1996) (Figure 40), shows more 
new woven bone on the caudal side of the plate compared to Figure 35. Bone density has 
increased into stress lines showing where stress is being transferred between the original 
cortices. 
b. Macroradiographs of dog 2 The first radiograph taken immediately after 
implantation of the guide tube in dog 2 occurred on 4-19-1995. Figure 41 shows the guide 
tube spanning the ostectomy with the ends of the implant placed within the proximal and 
distal medullary canal. The implant is held in the proper location by the cortical bone that 
surrounds each end of the implant. 
After five weeks of implantation (5-24-1995), bone has not advanced along the guide 
tube (Figure 42). At this time the internal fixation does not show any signs of loosening or 
other problems. There are no signs of periosteal activity or of mineralized tissue within the 
ostectomy. At this time, the distal and proximal ends of the femur look as they did post-
implantation. The medial-lateral views of this dog do not show bone activity. 
At five and a half month's post-implantation (10-4-1995), bone still does not show 
much activity along the tube's surface (Figure 43). The bone near the ends of the implant 
shows some signs of roimding with only minimal advancement of tissue along the implant's 
Figure 37. Cranial-caudal macroradiograph of dog 1, seven months post-
implantation (11-16-1995) 
Figure 38. Cranial-caudal macroradiograph of dog 1, nine months post-
implantation (1-25-1996) 
Figure 39. Cranial-caudal macroradiograph of dog 1, eleven months post-
implantation (3-13-1996) 
Figure 40. Medial-lateral macroradiograph of dog 1, eleven months post-
implantation (3-13-1996) 
Figure 41. Cranial-caudal macroradiograph of dog 2, post-implantation 
(4-19-1995) 
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distal end. The lack of tissue response indicates that the bone plate and screws have 
supported the load and prevented micromotion (stress protected). Another reason for the lack 
of new bone could be a lack of blood supply. Bone will not resorb or grow if the blood 
supply is not available. There may be some reason the flow of blood to the ostectomy has 
been restricted. For some reason, the stimulus for bone to regenerate and bridge across the 
guide tube in this dog has been prevented. 
After six months of implantation (10-18-1995) and litde sign of tissue repair along the 
guide tube, four screws were removed from the bone plate (Figure 44). These screws were 
removed to hopefiilly destabilize the region and stimulate the growth of bone across the 
implant due to micromotion. Proximally, screws 1 and 3 were removed from the original 
group of four screws. Distally, screws 5 and 8 were removed from the original group of four 
screws. The lip of bone around the hole left by screw 8 shows the growth of periosteal bone 
that had helped support this screw. 
Ten weeks after the four screws were removed (1-5-1996), eight and a half months 
total, there is only minor evidence of increased bone activity (Figure 45). The bone growth 
that is occurring is rounding near the distal and proximal osteotomy sites. Here again, there 
seems to be something preventing the growth of bone across the implant. Micromotion, 
possibly caused by the removal of four screws, should have stimulated the growth of bone 
across the defect by now. Clinically, this would be considered an atrophic non-union. 
Nineteen weeks after the four screws were removed (3-20-1995), eleven months total, 
bone shows signs of new growth suggesting movement and stress is occurring (Figure 46). A 
uniform layer of thin bone is covering the medial side of the implant. This is a positive sign 
that bone will completely encase the implant. The narrow growth of bone that has advanced 
along the implant is the normal, more expected way that bone should heal the defect region. 
Bone has definitely progressed along the siuface of the implant. However, the thickness of 
this medial bone is much smaller than the bone growth seen in dog 1, suggesting a different 
Figure 42. Cranial-caudal macroradiograph of dog 2, five weeks post-
implantation (5-24-1995) 
Figure 43. Cranial-caudal macroradiograph of dog 2, five and a half 
months post-implantation (10-4-1995) 
Figure 44. Cranial-caudal macroradiograph of dog 2, six months post-
implantation (10-18-1995) (post-screw removal) 
Figure 45. Cranial-caudal macroradiograph of dog 2,  eight and a half 
months post-implantation (1-5-1996) 
Figure 46. Cranial-caudal macroradiograph of dog 2, eleven months post-
implantation (3-20-1996) 
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process of bone growth. There is some bone activity between the plate and implant and there 
are large dense regions near the lateral cortex of screws 4 and 7. This bone activity and 
increased density indicates that there is higher stress in this region indicating destabilization 
has been accomplished and bone is remodeling accordingly. This could be the normal 
healing process of bone repairing the defect and the extra stress caused by the screw removal 
did not affect the results. However, bone might not have reconnected across the defect 
without the guide tube spanning the gap. The bone healing seen in this radiograph is more 
like the type of bone repair expected to cross along the implant. 
c. Macroradiographs of dog 3 The fost radiograph taken immediately after 
implantation of the guide tube in dog 3 occurred on 4-21-1995. Unlike the other dogs in this 
study, this dog had a marrow cavity with a very large inside diameter that required the use of 
bone sections to fill the defect Figure 47 shows the guide tube placed within the much larger 
proximal and distal medullary canal. Distally, sections of bone from the ostectomy were 
used to fill some of the marrow region. As seen in the radiograph, the curved shape of the 
cut bone fit between the implant and inner wall of the femur. These bone sections helped 
stabilize the implant and prevented the implant from experiencing excessive movement. 
After four weeks of implantation (5-24-1995), woven bone has successfiilly spanned 
the ostectomy (Figure 48). This is very similar to the large bony response seen in Dog 1. 
The mineralized tissue has grown medially away from the implant forming a curved loop of 
bone that connects both ends of the femur. Therefore, a non-mineralized region exists 
between the implant and the lateral wall of the new medial bone. There is more new bone 
growth near the distal portion of the femur. Within this new bone there are vessels or some 
type of soft tissue that are still lucent. Distally, periosteal activity near the screws is 
widening the original bone on the medial side. This bone and the bone next to the implant 
are growing proximally with a very large amount of tissue that continues and narrows before 
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the connection with the proximal end of the femur. The large pieces of bone that were added 
to the distal medullary canal are still visible and have stayed m their proper position. 
After four months of implantation (8-17-1995), the density and thickness of the bone 
have increased extensively (Figure 49). The original medial cortex is shrinking or being 
resorbed near the ends of the implant. The new bone is remodelling the region and is 
replacing it with very dense bone. This medial bone is providing excellent support to this 
side of the femur. The bone still curves out medially, possibly indicating the best load 
transfer from the distal to medial end of the femur due to its large size and high loads. The 
bone has regenerated and filled in most of the lucent region between the implant and bone. 
As expected, the lateral side of the implant has minimal bone growth due to the support of 
the large bone plate. There may be bone growth on the cranial and caudal side of the 
implant. The bone sections that were originally added to the distal medullary canal are no 
longer visible indicating they have already been resorbed and remodeled by the advancing 
bone. 
After eight months of implantation (12-28-1995), remodeling of the bone has 
continued to occur as observed by the increased density and linear appearance of the bone 
encasing the medial side of the implant (Figure 50). There is an increase in bone growth 
along either the cranial or caudal side of the implant as seen by the bone filling ui the region. 
Bone has also been filling in the ostectomy on the lateral side of the implant as seen by the 
decrease of the lucent triangle between screws 4 and 5. There still is a good sized radiolucent 
region between the implant and the plate. 
The medial-lateral radiograph taken on 3-14-1996 shows that the caudal bone has 
increased in density with more stress lines appearing (Figure 51). The original cortex has 
remodelled and is changing its line of direction. 
At eleven month's post-implantation (3-14-1996), the only major change is an 
increased densification of the medial bone next to the implant (Figure 52). There are no 
Figure 47. Cranial-caudal macroradiograph of dog 3,  post-implantation 
(4-21-1995) 
Figure 48. Cranial-caudal macroradiograph of dog 3, four weeks post-
implantation (5-24-1995) 
Figure 49. Cranial-caudal macroradiograph of dog 3, four months post-
implantation (8-17-1995) 
Figure 50. Cranial-caudal macroradiograph of dog 3, eight months post-
implantation (12-28-1995) 
Figure 51. Medial-lateral macroradiograph of dog 3, nine months post-
implantation (3-14-1996) 
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signs of stress bone by any of the screws at this time. It is possible that the bone is carrying 
most of the excess loads on the medial side of the femur. Removal of the plate and screws is 
prevented due to the lack of osseous tissue on the implant's lateral side. 
d. Macroradiographs of dog 4 Two days after implantation of the guide tube with 
internal fixation, this dog was euthanized due to blood clotting complications. The femur 
containing the implant was extracted. The region between the osteotomies of the femur had 
already filled with very dense fibrocellular tissue connecting the two ends of the femur. The 
implant was completely surrounded with this very thick layer of tissue. 
e. Macroradiographs of dog 1 The first radiograph taken immediately after 
implantation of the guide tube in dog 5 occurred on 5-5-1995. Figure 53 shows the guide 
tube and internal fixation spanning the ostectomy with the ends of the implant placed within 
the proximal and distal medullary canal. The first implant used to span this ostectomy fit 
tightly within the medulla and during aligmnent of the femur it fiactured into large pieces. 
Most of the ceramic pieces were removed except for the pieces seen in the distal femur 
between screws 5 and 7. The guide tube shown in this radiograph had a smaller outside 
diameter and thinner wall thickness than the other implants (Table 7). Since the inside 
diameter of this dog's medullary canal was smaller, this implant provided a loose fit similar 
to the other dogs with guide tubes except for the very loose fit of dog 3. 
After nineteen days of implantation (5-24-1995), there is only a slight amount of 
woven bone developing across the medial side of the implant (Figure 54). There are no signs 
of problems with the guide tube or internal fixation. 
At two months post implantation (7-13-1995), the medial side of the implant has been 
bridged with woven bone (Figure 55). Most of this thick layer of bone has very intimate 
contact with the implant. The bone is staying within the boundaries of cortical bone. The 
127 
initial bone activity that occuired in this dog is similar to the type of large bone response seen 
in dogs 1 and 3. Bone is also starting to advance on the lateral side of the implant. 
After five months of implantation (10-4-1995), the medial bone has increased in 
density and has become well defined with a uniform thickness (Figure 56). This bone has 
remodelled to match the density of the sirn'oimding cortical bone. It is very difficult to tell 
where the original medial cortex stopped because of this excellent bone remodelling. 
Laterally, there is only a very small lucent region between the implant and bone plate. 
Distally, the ceramic pieces are becoming hidden because of the high bone density in this 
region. This suggests there are more haversian systems moving into the area and increasing 
mineralization. More opaque regions near screws 2, 3 and the distal end of the bone plate 
indicate were bone is still being stressed. The periosteum is shown trying to reduce the stress 
near the distal end of the plate by building a shoulder support up to the end of the plate. 
At eight and a half months post-implantation (1-25-1996), medial and lateral bone 
have completely encased the implant (Figtare 57). Bone has healed the region with the help 
of the guide tube. The endosteal bone between screws 2 and 3 show less density so stress is 
more uniformly distributed now in this region suggesting the bone is carrying more of the 
load. Complete healing of the bone requires normal loads. This is prevented as long as the 
internal fixation is present and bears part of the load usually carried by the bone. Care must 
be used when removing the bone plate and screws because sudden removal can leave the 
bone temporarily weak with the possibility of fracture. The excellent bone growth and 
mineralization results of this dog indicate the internal fixation could be removed. 
Three weeks after the above radiograph was taken, (9 months and 1 week total) the 
bone plate and screws were removed from the femur and the extremity was allowed to heal 
(2-14-1996). Figure 58 shows that complete encasement on the lateral and medial side of the 
implant has been reached. The holes left by the screws are visible in this radiograph. This 
view shows that in addition to the medial bone, there is a very distinct layer of bone covering 
Figure 52. Cranial-caudal macroradiograph of dog 3, eleven months post-
implantation (3-14-1996) 
Figure 53. Cranial-caudal macroradiograph of dog 5, post-implantation 
(5-5-1995) 
Figure 54. Cranial-caudal macroradiograph of dog 5, nineteen days post-
implantation (5-24-1995) 
Figure 55. Cranial-caudal macroradiograph of dog 5, two months post 
implantation (7-13-1995) 
Figure 56. Cranial-caudal macroradiograph of dog 5, five months post-
implantation (10-4-1995) 
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the lateral side of the implant. The density of the entire diaphyseal region of the femur is 
very high. Resorption of the bone has occurred where the plate had been because the plate 
and screws were carrying most of the loads on this side. Also, resorption may have been 
caused by the excess pressure between the plate and bone due to the tightness of the screws 
or bending stresses. 
Figure 59 is the medial-lateral view taken at the same time period (2-14-1996) 
showing the complete encasement of the implant with very thick cranial and caudal bone. 
This view shows some radiolucencies between the unplant and bone indicating that there 
may have been some excess micromotion occurring. There is a single transverse fracture of 
the implant near the proximal end of the implant. This is a manufacturing defect that 
occurred during the extrusion process and is not a design or material problem. Since the 
implant was not supposed to be load-bearing because the internal fixation and eventual bone 
union would support the region, this fracture is not a major concem. The implant has 
performed its intended function of directing bone to reunion very well. The cortical bone has 
not remodelled into a well-defined cortex at this time. The section of the implant that was 
broken and not retrieved is seen just distal to the implant. 
Four weeks after the internal fixation was removed, (10 months and 1 week total) the 
cranial-caudal view showed an increase in the mineralization of the femur due to remodeling 
to support the new loads (Figiure 60) (3-13-96). The screw holes have filled with minerals 
and are becoming more difficult to view from this angle. The thickness of the lateral bone 
seems to be increasing along the guide tube. This is expected since the plate and screws are 
no longer supporting this side of the femur. The holes left by the screws in the medial cortex 
are becoming covered with bone and the sharp edges have rounded. 
The medial-lateral view at this same time period (3-13-1996) also shows the increased 
density of the femur (Figure 61). The holes left by the screws show signs of bone growth. 
Figure 57. Cranial-caudal macroradiograph of dog 5, eight and a half months 
post-implantation (1-25-1996) 
Figure 58. Cranial-caudal macroradiograph of dog 5,9 months and 1 week 
post-implantation (2-14-1996) (post-removal of internal fixation) 
Figure 59. Medial-lateral macroradiograph of dog 5, 9 months and 1 week 
post-implantation (2-14-1996) 
Figure 60. Cranial-caudal macroradiograph of dog 5, 10 months and 1 week 
post-implantation (3-13-96) 
Figure 61. Medial-lateral macroradiograph of dog 5, 10 months and 1 week 
post-implantation (3-13-96) 
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f. Macroradiographs of dog 6 The first radiograph taken immediately after removal 
of an ostectomy with the internal fixation aligned in dog 6 occurred on 6-2-1995 (Figure 62). 
This was one of three dogs used to analyze bone growth without an implant. All of the same 
surgical procedures and same intemal fixation were used along with the removal of a similar 
sized ostectomy. However, a guide tube was not placed across the ostectomy and a marrow 
graft was not placed in the ostectomy region of these three dogs. 
At one month post-implantation (7-6-1995), there is very little bone growth activity 
(Figure 63). The only change is a roimding of the ends of the proximal and distal femur near 
the implant and small areas of mineralized tissue within the gap. 
At two and a half months post-implantation (8-14-1995), a small increase in 
mineralized tissue is seen within the ostectomy region (Figure 64). This chain of woven 
bone seems to be coming fi'om the inside of the bone instead of the cortical bone. 
The medial-lateral view taken on 9-14-1995 is the first real sign of bone activity from 
this angle (Figure 65). Periosteal bone is very active around the bone plate. Even though 
there is bone activity, the cranial-caudal views do not show lucencies by the screws so plate 
movement is not likely. The only sign of possible screw loosening is the moderate lucency 
seen around screw 2. Since the bone plate and screws are carrying all of the load, bone has 
increased its growth to help support the plate by surrounding it with woven bone. 
After five and a half months of implantation (11-15-1995), mineralization of the 
tissue has only slightly increased within the ostectomy indicating that remodeling is 
occurring very slowly and there could be a lack of blood supply to the region (Figure 66). 
Bone is projecting out around the plate near screw 4 and new bone has formed a shoulder 
near the distal end of the plate to help carry the load. 
At nine and a half months of implantation (3-13-1996), the only change in bone 
activity is the bone plate being encapsulated with distal bone (Figure 67). This bone growth, 
sometimes called "stress bone" because it is growing in response to stress, is trying to help 
Figure 62. Cranial-caudal macroradiograph of dog 6, post-implantation 
(6-2-1995) 
Figure 63. Cranial-caudal macroradiograph of dog 6, one month post-
implantation (7-6-1995) 
Figure 64. Cranial-caudal macroradiograph of dog 6, two and a half months 
post-implantation (8-14-1995) 
Figure 65. Medial-lateral macroradiograph of dog 6, three and a half 
months post-implantation (9-14-1995) 
Figure 66. Cranial-caudal macroradiograph of dog 6, five and a half months 
post-implantation (11-15-1995) 
135 
136 
stabilize the bone plate especially around its distal end. Bone mineralization has not 
increased within the ostectomy. The tissue within the defect seems very weak and probably 
consists of fibrous or cormective tissue. The guide tube implant either by itself or together 
with the marrow graft may have prevented this type of situation. 
The medial-lateral view of 3-13-1996 shows the periosteal activity seen previously 
has increased in density (Figure 68). The large amount of bone indicates that either 
micromovement or excessive loading has been occurring. The distal bone is still trying to 
grow a shelf around the plate to help stabilize or support it. 
g. Macroradiographs of dog 7 The first radiograph taken immediately after 
implantation of the guide tube in dog 7 occurred on 6-20-1995. Figure 69 shows the 
alignment of the guide tube within the ostectomy and the internal fixation. 
At two months post-implantation (8-17-1995), only minimal bone healing has 
occurred (Figure 70). The distal end of the femur is experiencing a very large amoimt of 
periosteal activity on its medial side. This growth of bone has extended proximally and is 
beginning to grow along the implant. The proximal section of the femur also shows some 
bone growth extending distally on the implant's medial side. Overall, new bone growth is 
minimal. 
After four and a half months of implantation (11-1-1995) and insignificant amounts 
of bone trying to bridge the ostectomy, four screws were removed from the bone plate 
(Figure 71). This screw removal, as was the case in dog 2, was intended to destabilize the 
region so that bone would be stimulated to start repairing the defect due to micromotion. 
Proximally, screws 1 and 4 were removed from the original group of four screws and distally, 
screws 6 and 8 were removed. 
Four weeks after the four screws were removed, 11-29-1995 (five months total), there 
is bone growth activity around the implant (Figure 72). The density of the new bone on the 
Figure 67. Cranial-caudal macroradiograph of dog 6, nine and a half 
months post-implantation (3-13-1996) 
Figure 68. Medial-lateral macroradiograph of dog 6, nine and a half 
months post-implantation (3-13-1996) 
Figure 69. Cranial-caudal macroradiograph of dog 7, post-implantation 
(6-20-1995) 
Figure 70. Cranial-caudal macroradiograph of dog 7, two months post-
implantation (8-17-1995) 
Figure 71. Cranial-caudal macroradiograph of dog 7, four and a half 
months post-implantation (11-1-1995) 
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medial side and lateral side of the implant has increased. This is a good sign that the screw 
removal has generated some micromotion. Fracture of the implant near its midshaft indicates 
that bone bonded with the ends of the implant and excess compressive loading caused 
mechanical failure of the implant. The increased compression or bending forces on the 
implant may have been caused by either removal of the screws or by the shifting of the 
implant to a new position. The proximal end of the implant seems to be resting on the distal 
cortical bone of the proximal femur. The implant placed between the end of the bone and a 
bone screw would have put the implant under very highly loaded conditions. This implant 
was not designed to be placed under extreme load-bearing applications so fracture would 
have been inevitable. 
By 3-20-1996, periosteal bone activity had increased on the medial side of the bone 
especially aroimd the end of the remaining screws (Figure 73) (nine months post-
implantation). Bone is also trying to build around the lateral side of the bone plate. There is 
additional bone tissue on the medial side of the implant but reconnection has not occurred. 
Proximal and distal bone has become very dense indicating more haversian systems are 
developing to support the load. 
The medial-lateral view of this leg, taken on 3-20-1996, shows the large amount of 
periosteal activity on the cranial side of the femur (Figure 74). This is a good sign that there 
is moderate micromotion in the region. The smooth, round end of the projecting distal bone 
suggests that it is mature bone. The original proximal and distal bone has increased in 
density. 
h. Macroradiographs of dog & The first radiograph taken immediately after 
implantation of the guide tube in dog 8 occurred on 6-27-1995. Figure 75 shows the guide 
tube in position with the internal fixation. 
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After seven weeks of implantation (8-17-1995), bone growth has already bridged the 
entire medial and lateral side of the implant (Figure 76). This similar type of early bone 
formation occurred with dogs 1,3, and 5. Even though this is woven bone with moderate 
mineralization, remodeling is probably very active. The original cortex of the proximal and 
distal femur can still be seen but it is changing density. 
At three months, one week post-implantation (10-5-1995), the new bone has 
increased in density and the medial cortex has become very well defined because of 
remodelling (Figxire 77). The bone is very tightly bound to the implant on both sides. 
The lateral side of the implant has very dense woven bone with only minor lucent areas. 
Encasement of the guide tube has occurred very rapidly. It is hard to distinguish the new 
bone from the original bone because of its intense mineralization. Distally, there is some 
periosteal growth widening the original femur. 
After seven months of implantation (1-25-1996), the medial cortex has become a very 
distinct, uniform layer of strong bone (Figure 78). Here again, it is very hard to tell where 
the original medial cortex starts and ends because of the uniform density. The density of the 
lateral side of the implant has not remodelled as well as the medial side probably because of 
the plate's support. 
The bone plate and screws were removed on 3-20-1996, after only nine months of 
implantation. The density of the original cortical bone and areas aroimd the screw holes 
suggests that the bone plate and screws were still carrying some of the weight across the 
femur. Figure 79 (cranial-caudal) shows the dense bone on the medial side of the implant 
and the lower density of the lateral bone. There is a small region of non-mineralized tissue 
on this side. Figure 80 (medial-lateral) shows the original cortex of the femur is still well 
defined but the bone surrounding the implant does not have a distinct cortical and medullary 
region. The high density and stress Imes of the bone next to the implant suggests the bone 
Figure 72. Cranial-caudal macroradiograph of dog 7, five months post-
implantation (11-29-1995) 
Figure 73. Cranial-caudal macroradiograph of dog 7, nine months post-
implantation (3-20-1996) 
Figure 74. Medial-lateral macroradiograph of dog 7, nine months post-
implantation (3-20-1996) 
Figure 75. Cranial-caudal macroradiograph of dog 8, post-implantation 
(6-27-1995) 
Figure 76. Cranial-caudal macroradiograph of dog 8, seven weeks post-
implantation (8-17-1995) 
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are very strong. There are no signs of implant fracture. Distally, periosteal activity on the 
cranial side of the bone has increased its thickness. 
i. Macroradiographs of dog 9 The first radiograph taken immediately after removal 
of an ostectomy with the internal fixation aligned in dog 9 occurred on 11-29-1995 (Figure 
81). This was the second dog not receiving a guide tube implant or marrow graft but having 
a similarly sized defect as the other dogs. 
After one month of implantation, (1-5-1996), there is only a trace of minerals within 
the defect region (Figure 82). Periosteal activity is seen along the original medial cortex. 
At three months, three weeks (3-20-1996), bone activity is still very minimal. The 
proximal and distal ends of the femur seem to be trying to grow along the bone plate (Figure 
83). Periosteal and endosteal bone has extended out into the defect area from both sides. 
However, there still are large regions of non-mineralized tissue within the gap. 
j. Macroradiographs of dog 10 The first radiograph taken immediately after die 
ostectomy was removed in dog 10 occurred on 12-1-1995 (Figure 84). This was the third 
dog not receiving a guide tube or marrow graft but having a similarly sized defect. 
After one month of implantation (1-5-1996), there is a very small amount of 
mineralized tissue within the ostectomy (Figure 85). There are some signs of periosteal 
activity along the original medial cortex of the femur. 
At four months, three weeks (3-20-1996), a large amount of mineralized tissue has 
spanned the length of the ostectomy (Figure 86). This bone has low density with lucent lines 
suggesting there are either vessels or some type of soft tissue ui this new bone. The one large 
lucent line could be the location where the bone growing from the distal and proximal 
direction met each other. There still is a large region next to the plate that does not contain 
mineralized tissue. Proximally, the distal cortex shows signs of remodeling because of the 
Figure 77. Cranial-caudal macroradiograph of dog 8, three months, one week 
post-implantation (10-5-1995) 
Figiire 78. Cranial-caudal macroradiograph of dog 8, seven months post-
implantation (1-25-1996) 
Figure 79. Cranial-caudal macroradiograph of dog 8, seven months post-
implantation (3-20-1996) 
Figure 80. Medial-lateral macroradiograph of dog 8, nine months post-
implantation (3-20-1996) 
Figure 81. Cranial-caudal macroradiograph of dog 9, post-implantation 
(11-29-1996) 
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Figure 82. Cranial-caudal macroradiograph of dog 9, one month post-
implantation, (1-5-1996) 
Figure 83. Cranial-caudal macroradiograph of dog 9, four months, three 
weeks post-implantation (3-20-1996) 
Figxire 84. Cranial-caudal macroradiograph of dog 10, post-implantation 
(12-1-1995) 
Figure 85. Cranial-caudal macroradiograph of dog 10, one month post-
implantation (1-5-1996) 
Figure 86. Cranial-caudal macroradiograph of dog 10, four months, three weeks 
post-implantation (3-20-1996) 
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decreased density of the original cortex. Distally, the original cortex is still visible. 
Periosteal bone extends proximally from screw 5 across the ostectomy. 
4. Overall Evaluation of the Canines' Reactions to the Guide Tube Implant 
The canines were regtilarly inspected especially during the time that radiographs 
were taken. Woxmd healing and weight-bearing of the operated extremity were 
watched closely. The dogs applied even pressure to both rear legs after healing. 
This walking behavior continued for all of the dogs except dogs 6 and 7. Dog 6 started 
to carry the operated leg after three months of implantation and continues to carry the 
leg sometimes during normal walking. This dog was one of the control dogs that showed 
very minimal signs of healing across the defect. Thus, the internal fixation had to carry all 
of the weight between the proximal and distal ends of the implant. This may have placed 
too much stress on the bone. The radiographs showed very little sign of plate or screw 
loosening, instead, they show signs that bone was trying to help support the plate. Dog 7 
started carrying its leg soon after four screws were removed from the bone plate (five months 
post-implantation). The first radiograph after screw removal showed the implant had 
firactured but had stayed in its proper position without interfering the surrounding tissue. The 
internal fixation did not show any signs of loosening. The reason this dog is carrying its leg 
is imknown. 
As seen in the macroradiograph observations, some of the dogs receiving implants 
showed excellent bone growth while others showed very little bone activity. Four of the six 
dogs receiving implants, dogs 1,3,5, and 8, showed early encapsulation of the guide tube 
with woven bone. The radiographs show the continual remodeling and mineralization of this 
new bone after surrounding the implant. Complete union and excellent remodeling across the 
implant in dogs 5 and 8 after only nine months of implantation made it possible to remove 
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the internal fixation with no resulting complications. Dog 1 has also healed the defect region 
with very dense bone. Remodeling made a well-defined medial cortex and medullary canal. 
The internal fixation could be removed fi-om this dog's femur without complications. Dog 3 
has a large amount of high density bone on the medial side of the implant but the 
insignificant amoimt of bone growth or mineralization on the lateral side prevented the 
removal of the internal fixation. 
Two of the six dogs with guide tubes, dogs 2 and 7, showed very minimal signs of 
bone growth across the implant after 6 and 4 5^ months of implantation, respectively. Dog 2 
did show signs of bone crossing the implant 14 weeks after screw removal. Dog 7 showed 
some signs of bone growth 4 weeks after screw removal. The bone activity of dog 7 after 
screw removal indicates micromotion had been initiated by this removal. The growth of 
bone for both of these dogs was very limited and inactive, unlike the extensive, fast growing 
bone seen in the four other dogs with implants. It is difficult to know what is causing this 
unsatisfactory bone growth in these dogs. One of the main reasons could be the internal 
fixation supported most of the loading across the femur of these dogs even after screw 
removal. Thus, there would be no reason for bone to regenerate across the defect because it 
was appropriately stabilized and the stimulus for bone to regenerate would have been 
prevented. Another reason for the lack of new bone growth could be a lack of blood supply 
or vasculature to the new bone trying to grow across the implant. This is unlikely because of 
blood flow firom surrounding muscle tissue and blood flow to the periosteum was probably 
not restricted. 
Only the dogs with guide tube implants received the marrow graft, extracted as one 
piece from their ostectomy segment, placed lengthwise along the guide tube and bone plate. 
The effect that this graft had on the growth of new bone in the defect is difficult to determine. 
It could have promoted the excellent tissue growth and mineralization seen in dogs 1, 3, 5, 
and 8. However, dogs 2 and 7, who had received similar guide tubes and marrow grafts, did 
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not experience this type of growth in the region of the defect It is unknown what effect this 
marrow graft had on the growth of bone. Another implant study comparing grafted and non-
grafted guide tubes would more clearly explain these results. 
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CHAPTER V. CONCLUSIONS 
This calcium phosphate ceramic implant research consisted of two separate 
experiments. These experiments, transcortical implants and guide tube implants, will be 
concluded separately since their intended orthopedic applications are different. 
A. Transcortical Implants 
The manufacture of the stainless steel/ osteoceramic and polyethylene/ osteoceramic 
transcortical implants confirms that the osteoceramic material can be successfully added to 
other materials to make composite materials. Also, changes in the manufacturing of the 
osteoceramic material determined that the amount of shrinkage for the osteoceramic can be 
changed with the addition of prefired osteoceramic material. Grinding all of the materials to 
a consistent outside diameter confirms that the ceramic material can be machined after firing 
to approximately 1300°C with only minor complications. 
The solid cylindrical design and length of the transcortical implant were successful 
for the mechanical push-out test and histological application. However, the large outside 
diameter of the implant limited the number of implants per femur and sometimes fi-acture of 
the femur occurred during or post-implantation. The long length of the implant made 
dignment during the mechanical push-out test easy and precise. 
The results from the five different implant materials had shear strength and contact 
area values that were atypical. The differences in surface roughness of the implants did not 
seem to affect the shear strength results. Also, the interface shear strength values did not 
show a significant trend with the elastic modulus of the implant. Mechanical push-out testing 
determined that the mean shear strength values for the stainless steel and stainless steel/ 
osteoceramic implants were higher than the osteoceramics (air and H) and polyethylene/ 
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osteoceramic. The difference was not statistically significant for the OCM fired in air but the 
difference was significant for the OCM fired in hydrogen and the polyethylene/ OCM. 
Mineralized bone tissue in contact with the proximal implant was found to be higher 
for stainless steel and stainless steel/ osteoceramic than for the osteoceramics (air and H) and 
polyethylene/ osteoceramic. However, the difference between the implant groups was 
determined to be statistically insignificant. 
The higher shear strength and tissue contact values for the steel and steel/ 
osteoceramic implants than for the calcium phosphate based osteoceramic material strongly 
suggest that the ceramic material was contaminated. Centerless grinding of the osteoceramic 
implants to create a consistent outside diameter was completed with a coolant to prevent 
fiacture of the implant due to fiiction or heating. The high open porosity of the 
osteoceramics, caused by the addition of pre-fired osteoceramic material and firing the 
material to 1330°C instead of 1450°C, allowed the material to absorb the coolant which was 
not removed by ultrasound cleaning or steam sterilization. Thus, a coolant barrier prevented 
normal chemical bonding between the material and bone. 
The original purpose of the transcortical implant study was to make a new composite 
material with the ability to bond with bone and have mechanical properties for highly loaded 
conditions. It is difficult to compare the bone bonding ability of the steel/ OCM with the 
osteoceramics since the osteoceramics were probably contaminated with coolant. However, 
the comparable mean shear strength and contact length values of the steel and steel/ OCM 
materials indicate that increased bone bonding was not achieved by adding osteoceramic 
aggregates to the steel/ OCM. Also, the low shear strength values for the polyethylene/ OCM 
material indicate that significant bone bonding did not occur for this composite either. 
Therefore, it was not clearly demonstrated in this research project that the tested composite 
materials, steel/ OCM and polyethylene/ OCM, had increased biocompatibility with bone 
tissue due to the addition of the osteoceramic aggregate to their matrix. 
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A new study is currently testing transcortical osteoceramic implants manufactured 
using the same osteoceramic material fired to HSO'C. This produced an uncontaminated 
material with considerably lower porosity and higher density. After 18 weeks of 
implantation, these specimens will be push-out tested and their contact regions will be 
meastu-ed to compare with the previous osteoceramic transcortical implants. These results 
will hopefully demonstrate that the osteoceramics from the first research project were 
contaminated with coolant which lowered their biocompatibility with bone tissue. 
Future recommendations for the transcortical implant material include making an 
osteoceramic material using 100% unfired osteoceramic and firing at 1450°C in air. This 
material would be representative of the strong, dense, low porosity, and bioactive material 
previously used. The use of ultra high molecular weight polyethylene with large aggregates 
of osteoceramic did not provide the biocompatibility results that would encourage the future 
use of this combination for load bearing applications. The stainless steel and stainless steel/ 
osteoceramic implants had shear strength and bone contact results that were similar to each 
other. This indicates the addition of osteoceramic aggregate to the steel did not provide 
increase bone biocompatibility. Therefore, further research using different ratios of steel and 
osteoceramic material could increase the biocompatibility results of this composite material. 
B. Guide Tube Implants 
The unique tubular design of the guide tube device was manufactured successfully by 
extruding the osteoceramic material. Extrusion helped produce a much longer implant than 
could be manufactured using dry pressing procedures. The length and outside diameter of 
the implant were designed appropriately to fit within the medullary canal of the defect region. 
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The surgical procedure and alignment of the guide tube with the intemal fixation were 
completed successfully. The intemal fixation, that included the lengthening plate and screws, 
provides adequate support across the defect region without complications or loosening. 
All of the bones with guide tube implants showed some growth and remodeling along 
the implant surface. Complete bone bridging and mineralization across the ostectomy were 
observed in four of the six canines receiving guide tubes. Two of these canines had excellent 
bone bridging results and have successfully had their intemal fixation removed without 
complications. The results of the other two canines indicate that their intemal fixation could 
be removed in the near future. These results show that the guide tube implant was successful 
at directing bone's repair and remodeling across a defect that exceeds the natural healing 
ability of bone. The non-healing of the other two canine's defects with guide tubes was 
possibly caused by overstabilization by the intemal fixation. Thus, bone was not encouraged 
to repair the region. Therefore, screws were removed firom the bone plate of both dogs to try 
to stimulate bone repair. Screw removal may have stimulated the growth of a thin layer of 
bone across the implant's surface in these canines. However, both of these canines did not 
experience the extensive bone growth results seen in the other four canines with implants. 
For the three control dogs, bone response was very minimal in two dogs. There was only 
minor evidence of bone mineralization occurring within the defects in these dogs. The third 
canine shows more mineralization within the defect but a large area of non-mineralized tissue 
still exists. 
The purpose of the guide mbe research project was to test the hypothesis that bone 
could be guided by an osteoceramic tube to obtain natural bone repair and remodeling under 
conditions where such repair and remodeling would not occur if the guide tube were not 
used. Since four of the six dogs receiving guide tube implants had complete bone bridging 
and mineralization across the implant, with two of these dogs successfully having their 
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internal fixation removed, this research demonstrated that the guide tube implant is an 
excellent bone bridging device and encourages further study. 
Future recommendations include making guide tubes with pure tricalcium phosphate 
or hydroxyapatite, making the tubes using resorbable materials, or changing the outside shape 
of the guide tube. The tricalcium phosphate/ magnesium aluminate spinel (osteoceramic) 
combination may not be required for this application because the loading doesn't require the 
added strength provided by the inert magnesium aluminate spinel. Therefore, since pure 
calcium phosphate based ceramics may have more calcium and phosphorus ions available on 
their surface compared to the osteoceramic material, they may increase the guiding of the 
bone along the surface of the implant. However, it is not known which calcium phosphate 
based ceramic material has better osteoconductive properties. Also, the use of a resorbable 
ceramic material could be beneficial for this application for increased bone bridging. Since 
this is the first time a guide tube implant has been implanted, it is not known if this is the 
ideal design for a bone bridging device. Use of tubes with different shapes, such as tubes 
extruded with a star shape or other shape to provide increased surface area for bone to grow 
along, might provide faster regeneration and remodeling of the defect region. Another 
recommendation would be the use of the guide tube implant without the addition of the bone 
marrow graft. Since the influence of the marrow graft is unknown without further research, 
another study using guide tubes with and without marrow could indicate whether its addition 
is beneficial. It could be that the guide tube and marrow work together to heal the defect in a 
much shorter time period. 
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APPENDIX 1: INDIVIDUAL RABBIT AND IMPLANTATION 
INFORMATION 
Rabbit 
Number 
L.A.R. 
Number 
Sex 
M=Male, 
F=Female 
Weight 
(pounds) 
Implantation 
Date 
Implant Numbers 
and Type 
Implant 
Length(mm): 
Proximal, Distal 
Huthanization 
Date 
1 (Practice) 2432 M 8.25 5-4-1994 1,(9,55) 
OCM(air) 
12.59, 11.59 July 20, 
1994 
2 2430 M 7.75 5-6-1994 1,(102, 103) 
OCM (air)a 
13.65, 12.34 July 22, 
1994 
3B 2508 M 7.00 8-3-1994 1,(136, 110) 
OCM (air) 
15.22, 16.35 December 7, 
1994 
4 2431 M 8.0 5-19-1994 1,(107,111) 
OCM (air) 
16.05, 14.77 August 4, 
1994 
5 2506 F 8.0 5-26-1994 1,(137, 135) 
OCM (air) 
13.98, 12.69 August 11, 
1994 
6 2433 M 7.5 5-26-1994 1,(141,108) 
OCM (air) 
16.64, 15.91 August 11, 
1994 
7 282 A F 11.0 5-27-1994 2,(149,158) 
OCM (U)b 
17.84, 16.05 August 12, 
1994 
8 2507 F 8.25 5-27-1994 2,(50,151) 
OCM (H) 
14.54, 12.56 August 12, 
1994 
9 343 F 9.0 6-7-1994 2, (49,48) 
OCM (M) 
14.75, 13.90 August 23, 
1994 
10 112 F 8.5 6-7-1994 2,(159, 154) 
OCM (11) 
12.45, 14.42 August 23, 
1994 
11 Redone below 
12 34 F 8.5 6-8-1994 9,(195, 192) 
Steel/ OCM 
14.09, 16.45 August 24, 
1994 
13 164 F 9.75 6-8-1994 9,(200, 162) 
Steel/ OCM 
13.10, 16.06 August 24, 
1994 
14 202 F 9.0 6-9-1994 9,(165,168) 
Steel/OCM 
14.81, 17.62 August 25, 
1994 
15 333 F 9.5 6-9-1994 9,(161,164) 
Steel/ OCM 
19.53, 15.95 August 25, 
1994 
16 no F 11.0 6-9-1994 9,(168, 163) 
Steel/ OCM 
15.91, 15.26 August 25, 
1994 
17 272 F 10.5 6-9-1994 8, (34,32) 
Steel 
18.71, 18.01 August 25, 
1994 
18 193 M 9.25 6-10-1994 8. (35,33) 
Steel 
19.25, 15.26 August 26, 
1994 
19 282 B M 8.75 6-10-1994 8, (31,96) 
Steel 
16.11, 15.51 August 26, 
1994 
20 224 F 9.5 6-10-1994 8, (39,38) 
Steel 
18.30, 16.35 August 26, 
1994 
21 452 F 9.25 6-28-1994 8, (37, 28) 
Steel 
18.04, 17.93 September 13, 
1994 
22 2509 F 8.75 6-28-1994 6,(182, 180) 
Poly/OCM 
17.00, 19.50 September 13, 
1994 
11 D 94 F 10.0 6-28-1994 2,(1343,142) 
OCM (H) 
16.61, 17.59 September 13, 
1994 
23 33 F 9.5 6-29-1994 6, (210,213) 
Poly/OCM 
20.60, 17.00 September 14, 
1994 
24 95 F 9.0 6-29-1994 6,(181,179) 
Poly/OCM 
20.70, 17.30 September 14, 
1994 
25 Redone below 
26 2012 M 10.25 6-29-1994 6.(177,211) 
Poly/ OCM 
22.10, 17.20 September 14, 
1994 
25 B 2510 F 8.5 7-11-1994 6,(173,174) 
Poly/OCM 
15.00, 18.10 Septeniber 26, 
1994 
OCM (air) = osteoceramic fired in air atmosphere 
OCM (H) = osteoceramic fired in hydrogen atmosphere 
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APPENDIX 2: INDIVIDUAL SURFACE ROUGHNESS 
MEASUREMENT RESULTS FOR THE FIVE DIFFERENT 
IMPLANT MATERIALS 
Material/Sample RA Value microns 
OCM(air)/#53 3129 0.3129 
374I 0.3741 OCM(air)/^ 53 
4297 0.4297 
2296 0.2296 Mean 0.4298 
Wis 0.7635 Standard Error 0.0543 
4260 0.426 Median 0.3984 
3149 0.3149 Standard Deviation 0.1717 OCM(air)/ itSSand niI6 
4227 0.4227 
3244 0.3244 Mean 0.5020 
6998 0.6998 Standard Error 0.0510 
OCM(air)/#l 16 7601 0.7601 Median 0.4244 
12029 1.2029 OCM(air)/^116 Standard Deviation 0.2281 
S86I 0.5861 
6901 0.6901 Mean 0.5743 
3696 0.3696 Standard Error 0.0829 
5483 0.5483 Median 0.5053 
3721 0.3721 Standard Deviation 0.2621 
4623 0.4623 
3867 0.3867 
3644 0.3644 
OCM(H)/#150 3933 0.3933 
3313 0.3313 OCM(H)/ni 50 
5591 0.5591 
6358 0.6358 Mean 0.5974 
6929 0.6929 Standard Error 0.0378 
6539 0.6539 Median 0.G539 
6617 0.6617 Standard Deviation 0.1253 
5839 0.5839 
7115 0.7115 OCM(H)/#150 and #157 
6653 0.6653 
6832 0.6832 Mean 0.0764 
OCM(II)/#157 541] 0.5411 Standard Error 0.0625 
5885 0.5885 OCM(H)/m 57 Median 0.5913 
10180 1.018 Standard Deviation 0.2997 
5368 0.5368 Mean 0.7488 
5509 0.5509 Standard Error d.iiai 
3556 0.3556 Median 0.5697 . 
5097 0.5097 Standard Deviation 0.3917 
13094 1.3094 
4750 0.475 
59i3 0.5913 
16576 1.6576 • 
8514 0.8514 
Steel-OCM/#l96 25745 2.5745 
12184 1.2184 Steel-OCM/H 196 
38526 3.8526 
84040 8.404 Mean 3.6081 
20049 2.0049 Standard Error 0.9964 
25580 2.558 Median 2.2815 
71089 7.1089 Standard Deviation 3.4517 
112529 11.2529 Steel OCM/m96and #197 
5235 0.5235 
11029 1.1029 Mean 3.7553 
6979 0.6979 Standard Error 0.6897 
19991 1.9991 Median 2.5745 
Steel-OCM/#197 30099 3.0099 Standard Deviation 3.3078 
122835 12.2835 
42378 4.2378 Steel-OCM/n 197 
18875 1.8875 
63002 6.3002 Mean 3.9157 
27494 2.7494 Standard Error 0.9960 
12990 1.299 Median 3.0099 
44951 4.4951 Standard Deviation 3.3032 
6320 0.632 
11299 1.1299 
50489 5.0489 
Sleel/#29 6228 0.6228 
3436 0.3436 Steel/it2S 
4019 0.4019 
3960 0.396 Mean 0.5332 
11559 1.1559 Standard Error 0.0842 
4561 0.4561 Median 0.4290 
8075 0.8075 Standard Deviation 0.2664 Steel/n29 and 
5026 0.5026 
3147 0.3147 Mean 0.4636 
3305 0.3305 Standard Error 0.0467 
Steel/#36 2401 0.2401 Median 0.3988 
4437 0.4437 Steel/mS Standard Deviation 0.2089 
3354 0.3354 
3763 0.3763 Mean 0.3941 
3954 0.3954 Standard Error 6.0323 
G395 0.6395 Median 0.3859 
4016 0.4016 Standard Deviation 0.1022 
4043 0.4043 
3442 0.3442 
3605 0.3605 
Poly-OCM/#175 16141 1.6141 
29022 2.9022 Poly-OCM/m 75 
63223 6.3223 
50654 5.0654 Mean 3.1507 
45434 4.5434 Standard Error 0.4892 
34519 3.4519 Median 2.9022 
21975 2.1975 Standard Deviation 1.6223 
32799 3.2799 Poly-OCM/m 75 and #J 76 
16080 1.608 
26681 2.6681 Mean 2.9871 
10051 1.0051 Standard Error 0.3672 
Poly-OCM/#176 49026 4.9026 Median 2.7852 
54691 5.4691 Poly-OCM/ni76 Standard Deviation 1.7221 
43793 4.3793 
5970 0.597 Mean 2.8234 
10911 1.0911 Standard Error 0.5670 
7423 0.7423 Median 2.6396 
10625 1.0625 Standard Deviation 1.8807 
50426 5.0426 
26396 2.6396 
33222 3.3222 
18094 1.8094 
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APPENDIX 3: BULK DENSITY INFORMATION FOR THE 
TRANSCORTICAL IMPLANTS 
Sample length, in length, cm dia, cm radius, cm vol, cm3 weight, g density, g/cm3 
SS #166 0.592 1.504 0.3175 0.15875 0.119051 0.815 6.85 
SS#29 0.738 1.875 0.3175 0.15875 0.148411 1.02 6.87 
SS #36 0.755 1.918 0.3175 0.15875 0.15183 0.973 6.41 
SS/OC #197 0.551 1.400 0.3175 0.15875 0.110806 0.518 4.67 
SS/OC #198 0.745 1.892 0.3175 0.15875 0.149819 0.69 4.61 
SS/OC #199 0.62 1.575 0.3175 0.15875 0.124682 0.524 4.20 
OC #53 0.531 1.349 0.3175 0.15875 0.106784 0.281 2.63 
OC #106 0.469 1.191 0.3175 0.15875 0.094316 0.32 3.39 
OC #112 0.64 1.626 0.3175 0.15875 0.128704 . 0.263 2.04 
OC(H) #51 0.622 1.580 0.3175 0.15875 0.125084 0.269 2.15 
OC(H) #145 0.695 1.765 0.3175 0.15875 0.139764 0.299 2.14 
OC(H) #157 0.66 1.676 0.3175 0.15875 0.132726 0.285 2.15 
Poly/OC #175 0.801 2.035 0.3175 0.15875 0.161081 0.212 1.32 
Poly/OC #176 0.529 1.344 0.3175 0.15875 0.106382 0.144 1.35 
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APPENDIX 4: INDIVIDUAL TRANSCORTICAL IMPLANT 
INFORMATION USED TO CALCULATE POROSITY AND 
DENSITY 
175 
Sample/ Material Weight Dry 
(g) 
Weight 
Suspended 
Saturated 
(g) 
Weight 
Saturated 
(g) 
Open 
Porosity 
(%) 
Bulk Density 
(g/ cm^) 
138/OCM(air) 0.318 0.220 0.351 25.20 2.43 
139/OCM(air) 0.339 0.236 0.375 25.48 2.44 
140/OCM(air) 0.334 0.229 0.369 24.80 2.39 
157/OCM(H) 0.283 0.191 0.329 33.95 2.05 
160/OCM(H) 0.287 0.193 0.332 32.88 2.06 
177/OCM(H) 0.300 0.207 . 0.348 33.74 2.13 
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APPENDIX 5: INDIVIDUAL MECHANICAL PUSH-OUT 
TEST INFORMATION FOR THE DISTAL TRANSCORTICAL 
IMPLANTS AND STATISTICAL ANALYSIS 
DISTAL IMPLANTS 
Rabbit Frame Material 
Position (See 
Figure 11) 
Contact 
Length 
(mm) 
Avg. 
Contact 
Length 
(mm) 
Tot. 
Avg. 
Contact 
Lenght 
Peak 
Load (N) 
Shear 
Strength 
(MPa) 
Mean Shear 
Strength +/-
Standard 
Deviation 
Comments 
2-2430 3-2 OCM (air) upper left (u. 1.) 1.98 1.11 +/-0.57(n=5) 
2-2430 3-2 lower left (1.1.) 1.77 1.88 
2-2430 3-2 upper right (u. r. 0.93 
2-2430 3-7, lower right (1. r.) 1.67 1.30 3.17 50.31 1.58 
3B-2508 4-3B OCM (air) upper left 2.73 
3B-2508 4-3B lower left 3.71 3.22 
3B-2508 4-3B upper right 3.63 
30-2508 4-3B lower right 1.13 2.38 5.60 94.47 1.68 
4-2431 5-4 OCM (air) upper left 2.24 
4-2431 5-4 lower left 2.75 2.50 
4-2431 5-4 upper right 1.96 
4-2431 5-4 lower right 1.22 1.59 4.09 52.59 1.28 
5-2506 6-5 OCM (air) upper left 2.20 
5-2506 6-5 lower left 3.57 2.89 
5-250'i 6-5 upper right 2.25 
5-2506 6-5 lower right 0.98 1.62 4.50 26.34 0.58 
6-2433 15-6 OCM (air) upper left 5.82 Implant in a large callus 
6-2433 15-6 lower left 1.14 3.48 due to fracture. 
6-2433 15-6 upper right 0.00 
6-2433 15-6 lower right 3.62 1.81 5.29 23.89 0.45 
7-282a 2-7 OCM (H) upper left 4.53 0.35+/-0.11 (n=3) 
7-282a 2-7 lower left 1.46 3.00 . 
7-282a 2-7 upper right 2.68 
7-282a 2-7 lower right 2.20 2.44 5.44 22.04 0.40 
8-2507 10-8 OCM (H) upper left 1.56 
8-2507 10-8 lower left 3.05 2.31 
8-2507 10-8 upper right 0.00 
Rabbit Frame Material 
Position (See 
Figure 11) 
Contact 
Length 
(mm) 
Avg. 
Contact 
Length 
(mm) 
Tot. 
Avg. 
Contact 
Lenght 
Peak 
Load (N) 
Shear 
Strength 
(MPa) 
Mean Shear 
Strength +/-
Standard 
Deviation 
Comments 
8-2507 10-8 lower right 0.00 0.00 4.61 0.00 No push-out test 
9-343 2-9 OCM (H) upper (eft 2.21 value because both 
9-343 2-9 lower left 0.75 1.48 ends of implant covered 
9-343 2-9 upper right 1.91 with bone from callus. 
9-343 2-9 lower right 2.01 1.96 3.44 7.65 0.22 
10-112 4-10 OCM (H) upper left 2.65 , 
10-112 4-10 lower left 4.17 3.41 
10-112 4-10 upper right 2.44 
10-112 4-10 lower right 1.55 2.00 5.41 23.54 0.43 
ilB-94 3-llB OCM (H) upper left 0.57 Not used for push out 
110-94 3-llB lower left 1.19 0.88 test evaluation because 
118-94 3-llB upper right 0.00 one end of Implant 
IIB-94 3-llB lower right 0.00 0.00 1.76 1.181 0.07 covered with bone. 
12-34 2-12 SS + OCM upper left 4.19 1.58 +/- 0.67 (n=5) 
12-34 2-12 lower left 5.57 4.88 
12-34 2-12 upper right 2.88 
12-34 2-12 lower right 1.44 2.16 7.04 51.46 0.73 
13-164 4-13 SS + OCM upper left 2.97 
13-164 4-13 lower left 3.48 3.23 
13-164 4-13 upper right 2.35 
13-164 4-13 lower right 1.04 1.70 4.92 104.6 2.12 
14-202 2-14 SS + OCM upper left 1.89 
14-202 2-14 lower left 3.90 2.90 
14-202 2-14 upper right 2.58 
14-202 2-14 lower right 2.94 2.76 5.66 121.8 2.14 
15-333 5-15 SS + OCM upper left 1.44 
15-333 5-15 lower left 3.14 2.29 
15-333 5-15 upper right 2.43 
15-333 5-15 lower right 2.21 2.32 4.61 46.31 1.00 
16-110 2-16 SS + OCM upper left 4,31 
Rabbit Frame Material 
Position (See 
Figure 11) 
Contact 
Length 
(mm) 
Avg. 
Contact 
Length 
(mm) 
Tot. 
Avg. 
Contact 
Lenght 
Peak 
Load (N) 
Shear 
Strength 
(MPa) 
Mean Shear 
Strength +/-
Standard 
Deviation 
Comments 
16-110 2-16 lower left 3.75 4.03 
16-110 2-16 upper right 3.87 
16-110 2-16 lower right 2.75 3.31 7.34 141.5 1.92 
17-272 4-17 Stainless upper left 7.62 1.60 +/- 0.66 (n=5) 
M-ni 4-17 lower left 5.79 6.71 
17-272 4-17 upper right 2.19 
17-272 4-17 lower right 1.68 1.94 8.64 86.12 0.99 
18-193 4-18 Stainless upper left 3.59 
18-193 4-18 lower left 3.09 3.34 
18-193 4-18 upper right 3.34 
18-193 4-18 lower right 2.72 3.03 6.37 147.2 2.30 
19-282B 3-19 Stainless upper left 2.64 
I9-282B 3-19 lower left 5.34 3.99 
19-282B 3-19 upper right 2.39 
I9-282B 3-19 lower right 1.41 1.90 5.89 125.5 2.12 
20-224 3-20 Stainless upper left 3.28 
20-224 3-20 lower left 5.62 4.45 
20-224 3-20 upper right 3.66 
20-224 3-20 lower right 3.17 3.42 7.87 139.1 1.76 ' 
21-452 3-21 Stainless upper left 5.34 
21-452 3-21 lower left 3.77 4.56 
21-452 3-21 upper right 2.10 
21-452 3-21 lower right 2.60 2.35 6.91 58.55 0.84 
22-2509 11-22 Poly + OCM upper left 2.64 0.22 +/-0.14 (n=4) Proximal implant used 
22-2509 11-22 lower left 3.93 3.28 for push-out test, 
22-2509 11-22 upper right 1.71 
22-2509 11-22 lower right 1.40 1.56 4.84 2.04 0.04 
23-33 2-23 Poly + OCM upper left 1.54 
23-33 2-23 lower left 1.73 1.64 
Rabbit Frame Material 
Position (See 
Figure 11) 
Contact 
Length 
(mm) 
Avg. 
Contact 
Length 
(mm) 
Tot. 
Avg. 
Contact 
Lenght 
Peak 
Load (N) 
Shear 
Strength 
(MPa) 
Mean Shear 
Strength +/-
Standard 
Deviation 
Comments 
23-33 2-23 upper right 1.89 
23-33 2-23 lower right 1.40 1.65 3.28 5.25 0.16 
24-95 4-24 Poly + OCM upper left 3.42 
24-95 4-24 lower left 3.55 3.49 
24-95 4-24 upper right 2.57 
24-95 • 4-24 lower right 2.63 2.60 6.09 68.11 I.II 
25B-2510 4-25B Poly + OCM upper left 3.34 
258-2510 4-25B lower left 3.78 3.56 
25B-25I0 4-25B upper right 1.68 
25B-25JO 4-25B lower right 1.26 1.47 5.03 18.39 0.36 
26-2012 3-26 Poly + OCM upper left 4.24 
26-2012 3-26 lower left 3.29 3.77 
26-2012 3-26 upper right 1.49 
26-2012 3-26 lower right 1.05 1.27 5.04 15.04 0.30 
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Material Duncan Test 
Using Statistical Analysis 
System (SAS) 
Shear Strength (MPa)^ 
(n)b 
Steel/ Osteoceramic AC 1.58 ±0.67 (n=5) 
Steel A 1.60 ±0.66 (n=5) 
Osteoceramic (air) A B 1.11 ±0.57 {n=5) 
Osteoceramic (H) B 0.35 ±0.11 (n=3) 
Polyethylene/ 
Osteoceramic 
B 0.22 ±0.14 (n=5) 
^ Mean ± standard deviation 
^ n = number of implants used for evaluation, see appendix 5 for individual results 
^ Means with same letters are not significantly different, 95% confidence 
182 
APPENDIX 6: INDIVIDUAL PROXIMAL TRANSCORTICAL 
IMPLANT - BONE CONTACT LENGTH RESULTS AND 
STATISTICAL ANALYSIS 
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PROXIMAL IMPLANTS 
Rabbit Implant Material Frame 
Position Contact (mm) 
Avg. Contact 
(mm) 
Tot. Avg. 
Contact 
(mm) 
2-2430 9-2 up left \20 
2-2430 9-2 low left 2.92 2.06 
2-2430 9-2 up rt 4.10 
2-2430 OCM (air) 9-2 low rt 1.27 2.68 4.74 
3b-2508 ll-3b up left 0.58 
3b-2508 11-3b low left 4.73 2.66 
3b-2508 ll-3b up rt 2.39 
3b-2508 OCM (air) 11-3b low rt 1.06 1.73 4.38 
4-2431 12-4 up left 1.73 
4-2431 12-4 low left 2.94 2.34 
4-2431 12-4 up rt 2.56 
4-2431 OCM (air) 12-4 low rt 0.85 1.70 4.04 
5-2506 12-5 up left 0.00 
5-2506 12-5 low left 0.00 0.00 
5-2506 12-5 up rt 2.77 
5-2506 OCM (air) 12-5 low rt 2.65 2.71 5.42 
6-2433 17-6 low rt 0.00 
6-2433 17-6 low left 0.00 0.00 
6-2433 17-6 up rt 3.05 
6-2433 OCM (air) 17-6 low rt 1.28 2.16 4.33 
7-282a 7-7 up left 4.62 
7-282a 7-7 low left 4.34 4.48 
7-282a 7-7 up rt 2.02 
7-282a OCM (H) 7-7 low rt 3.55 2.78 7.27 
8-2607 16-8 low left 2.91 
8-2607 16-8 up left 1.33 2.12 
8-2607 16-8 up rt 0.71 
8-2607 OCM (H) 16-8 low rt 0.98 0.85 2.97 
9-343 7-9 up left 1.29 
9-343 7-9 low left 2.79 2.04 
9-343 7-9 up rt 1.13 
9-343 OCM (H) 7-9 low rt 1.60 1.37 3.40 
10-112 13-10 up left 2.21 
10-112 13-10 low left 4.21 3.21 
10-112 13-10 up rt 1.08 
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10-112 OCM (H) 13-10 low rt 0.58 0.83 4.04 
llb-94 12-1 lb up left 0.84 
lIb-94 12-llb low left 1.45 1.15 
llb-94 12-lIb up rt 1.00 
llb-94 OCM (H) 12-1 lb lowrt 3.77 2.38 3.53 
12-34 12-12 up left 6.48 
12-34 12-12 low left 4.26 5.37 
12-34 12-12 up rt 4.05 
12-34 SS + OCM 12-12 low rt 2.57 3.31 8.68 
13-164 11-13 up left 5.04 
13-164 11-13 low left 3.69 4.36 
13-164 11-13 up rt 2.57 
13-164 SS + OCM 11-13 low rt 2.45 2.51 6.87 
14-202 8-14 up left 2.30 
14-202 8-14 low left 1.88 2.09 
14-202 8-14 up rt 2.20 
14-202 SS + OCM 8-14 low rt 3.21 2.71 4.80 
15-333 4-15 up left 2.49 
15-333 4-15 low left 0.31 1.40 
15-333 3-15 up rt 2.81 
15-333 SS H OCM 3-15 low rt 2.16 2.48 3.88 
16-110 11-16 up left 6.39 
16-110 11-16 low left 6.83 6.61 
16-110 11-16 up rt 4.10 
16-110 SS + OCM 11-16 low rt 1.94 3.02 9.63 
17-272 4-17 up left 2.72 
17-272 4-17 low left 1.52 2.12 
17-272 4-17 up rt 1.97 
17-272 Stainless 4-17 low rt 3.65 2.81 4.93 
18-193 10-18 up left 3.57 
18-193 10-18 1 low left 3.16 3.36 
18-193 ! 10-18 |uprt 3.43 
18-193 jstainless 10-18 low rt 2.77 3.10 6.46 
20-224 9-20 up left 5.30 
20-224 9-20 low left 3.14 4.22 
20-224 9-20 up rt 4.17 
20-224 Stainless 9-20 low rt 3.66 3.91 8.13 
21-452 9-21 1 up left 1.70 
21-452 9-21 1 low left 1.62 1.66 
21-452 9-21 lupn 0.00 
21-452 1 Stainless 9-21 low It 0.00 0.00 3.32 
22-2509 1 5-22 i up left ! 1.50 
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22-2509 5-22 low left 1.55 1.52 
22-2509 5-22 up rt 1.15 
22-2509 Poly + OCM 5-22 low rt 0.84 0.99 2.52 
23-33 6-23 up left 1.05 
23-33 6-23 low left 1.25 1.15 
23-33 6-23 up rt 5.02 
23-33 Poly + OCM 6-23 low rt 4.56 4.79 5.94 
24-95 9-24 up left 2.45 
24-95 9-24 low left 4.09 3.27 
24-95 9-24 up rt 2.06 
24-95 Poly + OCM 9-24 low rt 1.14 1.60 4.87 
25B-25I0 8-258 up left 3.04 
25B-25I0 8-25B low left 1.60 2.32 
25B-2510 8-25B up rt 1.14 
25B-25I0 IPoly + OCM 8-25B low rt 0.84 0.99 3.31 
26-2012 8-26 up left 3.64 
26-2012 8-26 low left 2.90 3.27 
26-2012 1 8-26 up rt 1.18 
26-2012 IPoly + OCM 8-26 low rt 1.19 I . I 8  4.46 
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Material Duncan Test 
Using Statistical Analysis 
System (SAS) 
Total Average Contact 
Length (mm)^ (n)t' 
Steel/ Osteoceramic AC 6.77 ±2.45 (n=5) 
Steel A 5.71 ± 2.06 (n=4) 
Osteoceramic (air) A 4.58 ±0.53 (n=5) 
Osteoceramic (H) A 4.24 ±1.73 Cn=5) 
Polyethylene/ 
Osteoceramic 
A 4.22 ± 1.34 (n=4) 
^ Mean ± standard deviation 
^ n = number of implants used for evaluation, see appendix 6 for individual results 
^ Means with same letters are not significantly different, 95% confidence 
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APPENDIX 7: BULK DENSITY INFORMATION FOR THE 
TRANSCORTICAL OSTEOCERAMIC IMPLANTS FIRED TO 
1450°C 
OC(air) refired to 1450 C (air) 
design/implant # length, mm diameter, mm weight, g density, g/cc 
18/101 9.470 2.950 0.197 3.044 Statistical Data for OC(air-air) 
IB/106 11.350 3.030 0.261 3.189 
IB/109 14.010 2.940 0.303 
0.319 
3.186 Mean 3.190 
18/112 14.810 2.890 3.284 Standard Error 0.033 
18/139 
18/140" 
15.780 2.910 0.337 3.211 Median 3.200 
15.860 2.870 0.331 3.226 Standard Deviation 0.080 
Sample Variance 0.0064 
OC(H) refired to 1-
Count 6.000 
50 C(air) Confidence Level(95.000%) 0.064 
design/Implant # length, mm diameter, mm weight, g density, g/cc 
Statistical Data for OC(H-air 
28/51 15.080 3.080 
3;070 
0.266 2.367 Mean 2.389 
2B/145 16.630 0.299 2.400 Standard Error ^ 0.009 
28/146 16.780 3.080 0.298 2.384 Median 2.384 
28/157 15.910 3.060 0.283 2.419 Standard Deviation 0.021 
18/160 16.070 3.090 0.286 2.373 Sample Variance 0.0004 
Count 5,000 
0.018 Confidence LeveK95.000%) 
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APPENDIX 8: INDIVIDUAL SURFACE ROUGHNESS 
VALUES FOR THE TRANSCORTICAL OSTEOCERAMIC 
IMPLANTS FIRED TO 1450°C 
Surface Roughness Values for the Osteoceramic (air-air) and (H-air) at 1450C 
Material Implant# Roughness Implant// Roughness 
OCM(a-a) 139 24845 112 12847 
OCM(a-a) 139 
139 
30884 
27495 
112 13807 
OCM(a-a) 112 10618 
OCM(a-a) 139 20664 112 20702 
OCM(a-a) 139 16234 112 10385 
OCM(a-a) 139 
— [39 
139 
139 
24667 
21829 
26393 
112 22854 
OCM(a-a) 
OCM(^a) 
112 26962 
112 28976 
44251 112 22816 
112 30330 Stats, for OCM(air-air) implants 
Column l(iH3 p; Column 2 (U1I2) Column 1 and 2 
Mean 26362.44 Mean 20029.7 Mean 23196.07 
Standard Error 2641.852 Standard Error 2408.999 Standard Error 3166.37 
Median 24845 Median 21759 Median 23196.07 
Mode #N/A Mode #N/A Mode #N/A 
Standard Deviation 7925.556 Standard Deviation 7617.924 Standard Deviation 4477.923 
Sample Variance 62814431 Sample Variance 58032765 
— -
Sample Variance 20051798 
Range 28017 Range 19945 
10385 
Range 6332.74 
Minimum 16234 Minimum Minimum 20029.7 
Maximum 44251 Maximum 30330 
200297 
10 
4721.544 
Maximum 
Sum 
26362.44 
46392.14 Sum 237262 Sum 
Count 9 Count Count 
Confidence Levei95 
20 
Confidence Level95 5177.927 Confidence Level95 
OCM(H-a) 160 
160 
20086 145 25859 
OCM(H-a) 17652 145 22338 
OCM(H-a) 160 28136 145 19322 
OCM(H-a) 160 17021 
15786 
145 2 I 1 I 1  
OCM(H-a) 160 
160 
145 25880 
OCM(H-a) 19452 145 13561 
OCM(H-a) 
dCM(n-a) 
160 
160 
" l60 
10563 145 10467 
13287 145 15412 
OCM(H-a) 
OCM(H-a) 
13842 
14488 
145 16425 
145 15551 
Stats, for OCM(H-air implants 
Column l(i(l60) Column 2 (UN Columnl (i{160) and 2(U145) 
Mean 17031.3 Mean 18592.6 Mean 17811.95 
Standard Error 1538.181 Standard Error 1640.52 Standard Error 780.65 
Median 16403.5 Median 17873.5 Median 17811.95 
Mode #N/A Mode #N/A Mode m / A  
Standard Deviation 4864.157 Standard Deviation 5187.78 Standard Deviation 1104.006 
Sample Variance 23660021 Sample Variance 26913062 Sample Variance 1218829 
Range 17573 Range 15413 Range 1561.3 
17031.3 
18592.6 
Minimum 10563 Minimum 10467 
— • • 
Minimum 
Maximum 28136 Maximum 25880 Maximum 
Sum 170313 Sum 185926 
10 
3215.356 
Sum 35623.9 
20 Count 10 Count Count 
Confidence Level95 3014.776 Confidence Level95 Confidence Level95 1530.044 
